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INVESTIGATION OF OXIDATIVE STRESS RESPONSE IN YEAST AND 
RAT 
SUMMARY 
Oxidative stress, one of the most important and common stresses that activate the 
stress response elements, is caused by an imbalance between the production of 
reactive oxygen and a biological system's ability to readily detoxify the reactive 
intermediates or easily repair the resulting damage. Under normal, physiological 
conditions, these molecules, also known as reactive oxygen species (ROS) are 
produced in low amounts as a result of metabolism. Organisms show different 
response mechanisms against oxidative stress and ROS. Thus, in this study, the 
complex oxidative stress response was investigated using two different eukaryotic 
model organisms, rat and yeast.  
The first part of the study was based on the microarray data analysis of an 
experimental study conducted with 96 rat kidney samples under ischemia and 
reperfusion conditions with and without heat-preconditioning as well as with and 
without ischemic-preconditioning. The global expression analysis of gene response 
to ischemia-reperfusion and preconditioning was performed. Genes were grouped 
according to their response type and levels to the given conditions. 
In the second part of the study, evolutionary engineering strategies were designed 
and employed to obtain oxidative stress resistant S. cerevisiae mutant yeasts. During 
selection of the mutant generations in the presence of continuous H2O2 stress, 
preconditioning was also applied as pulse exposure to either H2O2 stress or heat 
stress, mimicking oxidative and heat preconditioning, respectively. The mutant 
individuals obtained from selection under H2O2 stress with and without oxidative and 
heat preconditioning were tested for their resistance to oxidative (H2O2) as well as 
other stress types. It was observed that the mutants selected from oxidative stress 
selection with heat preconditioning were significantly more resistant to oxidative 
stress and other stress types such as osmotic, ethanol, heat and freeze-thaw stress. 
Apparently, application of heat preconditioning prior to oxidative stress selection 
seems to have a positive effect on improving the general stress resistance in S. 
cerevisiae and needs to be studied further. 
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MAYA VE SIÇANDA OKSİDATİF STRES TEPKİSİNİN İNCELENMESİ 
ÖZET 
Oksidatif stres en önemli ve en genel stres mekanizmalarından biri olmakla birlikte 
hücre içinde üretilen reaktif oksijen türlerin (ROS) neden olduğu dengesizlik sonucu 
ortaya çıkan bir stres mekanizmasıdır. Normal fizyolojik koşullarda bu reaktif 
oksijenlerin üretimi düşük miktardadır. Organizmaların oksidatif strese ve de 
ROS‘lara karşı oluşturdukları savunma mekanizmaları farklılıklar göstermektedir. 
Bu nedenden dolayı, bu çalışmada, sıçan ve maya gibi iki farkli ökaryotik 
organizmada kompleks oksidatif stres tepkimesi incelenmektedir. 
Çalışmanın ilk kısmında, 96 sıçan böbrek örneğine iskemi ve reperfüzyon koşulları 
iskemik ve ısı önkoşullamalarına bağlı olarak mikroarray veri analizleri yapılmıştır. 
Genlerin iskemi-reperfüzyona ve ön koşullamalara yönelik genel ekspresyon 
analizleri yapılmıştır. Genler ilgili koşullardaki tepki türlerine ve düzeylerine göre 
gruplandırmıştır. 
Çalışmanın ikinci kısmında ise evrimsel mühendislik stratejisi kapsamında, S. 
cerevisiae maya hücreleri oksidatif strese dirençli hale getirilmiştir. Dirençli mutant 
maya hücrelerinin eldesi sırasında ön koşullama olarak hidrojen peroksit ve ısı stresi 
bir saat süreyle uygulanmıştır. Elde edilen dirençli maya hücrelerinin hem oksidatif 
(H2O2) strese hem de diğer stres koşullarına karşı dirençleri test edilmiştir. Isı ön 
koşullaması ile elde edilen mutant maya hürelerinin çeşitli stres koşullarına (ozmotik, 
etanol, donma-erime stresi), diğer seleksiyonlardan elde edilen mutant mayalara göre 
daha dirençli olduğu saptanmıştır. Sonuç olarak, ısı ön koşullamasının oksidatif stres 
seçiliminde yapılan ısı önkoşullamasının maya hücrelerinin genel stres direnci 
üzerine olumlu bir etkisi olduğu gözlemlenmiştir. 
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1 
1. INTRODUCTION 
1.1 A Model Organism for Common Human Diseases: Rattus norvegicus 
The brown rat, common rat, Hanover rat, Norwegian rat also known as Rattus 
norvegicus is one of the best known model organisms and the most common rat type 
to study the common human diseases (Figure 1.1). It is not known why it is named as 
Rattus norvegicus, because it was originally native to south-east Siberia, north-east 
China and parts of Japan. It was the first mammalian species domesticated for 
scientific research, with work dating back to before 1850 [1]. The Wistar rat is also 
known as one of the first laboratory rats, and to a lesser extent, the Sprague-Dawley 
rat, gradually became the most popular rat for laboratory research. It had been 
created by Helen Dean King at the Wistar Institute in Philadelphia by 1909 and it is 
the oldest purpose-bred strain of inbred rats called the PA strain [2,3]. 
Today it has spread right around the globe in company with humans. Because the 
unique power of the laboratory rat resides in the extensive biological characterization 
of a wide range of inbred strains, rats have served as an important animal model for 
research fields such as physiology, pharmacology, toxicology, nutrition, behavior, 
immunology, neoplasia, addiction, aging, anatomy, autoimmune diseases, behavior, 
blood diseases, cardiovascular diseases, cancer, comparative genomics, dental 
diseases, diseases of the skin and hair, endocrinology, eye disorders, growth and 
reproduction, hematologic disorders, histology, kidney diseases, metabolic disorders, 
neurological and neuromuscular diseases, nutrition, pathophysiology, pharmacology, 
pulmonary diseases, reproductive disorders, skeletal disorders, sleep apnea, 
transplantation and immunogenetics, toxicology, and urological disorders for over 
150 years [4]. 
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Figure 1.1: Wistar rat (Rattus norvegicus) [6] 
The common laboratory rat was developed from the wild brown Norway rat. Outbred 
strains which are Wistar (albino rat), Sprague-Dawley (albino rat- faster growing 
than the Wistar) and Long-Evans (hooded rat -smaller than the Wister or Sprague-
Dawley) are used more commonly today in laboratories than inbred strains. Most 
investigators are aware that the rat remains a major model system inside the 
pharmaceutical industry and they prefer to use rat instead of mouse, although there is 
a high level of success in the mouse genome project, including the initiation of the 
mouse genomic sequencing project and the prospect of having every mouse gene 
knocked out [4,5]. 
Brown rats that have acute hearing are also sensitive to ultrasound, and also it is 
known that they possess a very highly developed olfactory sense. Their average heart 
rate is 250 to 600 beats per minute, with a respiratory rate of around 100 per minute 
[6]. Generally, here are the some physiological facts about the rat (Table 1.1): 
Table 1.1: Physical and physiological data of Rattus norvegicus [6] 
Body temperature 35.9° -37.5° C 
Heart rate 250 to 600 per minute 
Respiration rate 66-144 per minute 
Weight Adult male, 300-500 gr: adult female, 200-400 gr 
Water consumption 24-60 ml per day, or 10-12 ml per 100 grams body weight daily 
Food Consumption 15-30 grams per day, or 5-6 grams per 100 grams body weight 
Feces: Firm, dark brown, elongated mass with rounded ends. 
Life span 2.5-3.5 years 
The Length Up to 25 cm 
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The development of the first inbred rat strain was done by King in 1909. Since then, 
over 500 inbred rat strains have been developed for a wide range of biochemical and 
physiological phenotypes and different disease models. These strains have led to 
many disease gene discoveries in rats, frequently translated to humans [2]. 
1.1.1 Organ transplantation and reperfusion injury 
Transplantation helps to extend and improve the quality of life for the majority of 
patients. Organs that can be transplanted are the heart, kidneys, liver, lungs, 
pancreas, eyes and intestine. Tissues include bones, tendons, cornea, heart valves, 
veins, arms, and skin. Kidney is one of the most important transplanted organs and 
generally its transplantation is applied with end stage renal disease. Kidney 
transplantation has also become a routine clinical practice in the treatment of chronic 
renal failure and it is well established that it confers a significant survival advantage 
and quality of life in these patients compared to dialysis therapy. Kidney used for 
transplantation needs effective ex
 
vivo preservation from the moment the organ is 
retrieved to the time of transplantation. Hypothermic preservation reduces the 
metabolic activity and accumulation of toxic substances during the cold ischemic 
period and therefore maintains the tissue viability. However, organs that undergo for 
long periods cold ischemic storage after devascularization can have increased 
susceptibility to damage upon reperfusion. In addition, recent studies showed that 
there is also up-regulation of the co-stimulatory molecule B7, and that blockage of T 
lymphocyte co-stimulation through the B7-CD28 pathway by CTLA4Ig protects 
against acute and chronic consequences of renal ischemia, suggesting that a T-cell 
immune response emerges in ischemic kidneys. As a matter of fact, the change to 
this ―inflammatory-immunological‖ state of the kidney can increase the appearance 
of early acute rejection in allografts. Therefore, just like all transplantation types, 
during the renal transplantation, kidney undergoes varying degrees of cold 
ischemia
 
and reperfusion injury after transplantation. Moreover, ischemia-
reperfusion has more negative effects during the transplantation, because it causes 
ischemia-reperfusion injury which has an effect on primary non-function and this 
primary non-function ranges between 10 and 50 %. Ischemia reperfusion-based 
injury during kidney transplantation can cause the clinical and morphological picture 
of acute tubular necrosis that can affect acute rejection episodes as well as early and 
late graft losses [7,8,9]. 
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Ischemia-reperfusion causes cell damages through a bi-phasic process. Ischemia 
which came from Greek words (isch- is restriction, hema or haema is blood) is a 
restriction in blood supply, generally due to factors in the blood vessels, with 
resultant damage or dysfunction of tissue. Reperfusion means the restoration of 
blood flow to an organ or tissue. Thus, it is known that ischemia sets going the injury 
by deficiency of the energy needed to maintain ionic gradients and homeostasis, 
which may ultimately lead to cellular dysfunction or death. Reperfusion aggravates 
this damage by triggering an inflammatory reaction in which oxygen free radicals, 
endothelial factors and leukocytes participate. Ischemia-reperfusion disturbs the 
harmony of the system that maintains homeostasis in the microcirculation with 
attraction, activation, adhesion and migration of neutrophils causing local tissue 
destruction by release of proteases and further oxygen free radicals. A mean effect of 
I/R injury is formed at the reperfusion phase. In that phase, free oxygen radicals that 
appear in the reoxygenized tissue are thought to be responsible for this mechanism. 
But the whole disruption is also related to duration of ischemia, temperature and the 
nature of the organ [10,11,12,13]. 
Just like the bi-phasic process for ischemic damage to cells, death process can also 
happen through two different processes which are ‗apoptosis‘ and ‗necrosis‘. In the 
apoptotic way, apoptotic cells are ingested by macrophages or neighboring cells 
without release of proteolytic enzymes or toxic oxygen species and the process is not 
accompanied by inflammation; while in the necrotic way, there is a process that 
affects populations of cells and results in focal tissue destruction, inflammation and 
often serious systemic consequences. In kidney, ischemic lesion occurs in the inner 
stripe of the outer medulla. However, distribution of the apoptotic and necrotic cells 
depends on the different response to ischemia between parts of the tubules. 
Moreover, apoptosis takes place in the distal tubules while necrosis can be observed 
in the proximal tubules [11,12]. 
The preservation of renal function is the main goal in renal transplantation, and in 
many other vascular and urological procedures where renal functional impairment 
follows ischemia-reperfusion (I-R) injury that can lead to cardiovascular disorders, 
infarcts, dehydration, and iotragene damage resulting from operations especially, 
kidney transplantation. In transplantation medicine, the kidney allows the longest 
ischemic time relative to heart, liver, pancreas and lung. The resulting damage is not 
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only confined to ischemia but also to reperfusion which is also necessary for 
survival. Renal ischemia followed by reperfusion leads to acute renal failure (ARF, 
also known as acute kidney injury) which is a rapid loss of renal function due to 
damage to the kidneys, resulting in retention of nitrogenous (urea and creatinine) and 
non-nitrogenous waste products that are normally excreted by the kidney, in both 
native kidneys and renal allograft. Its mortality rate still is more than 30% [14]. But 
in recent years, important advances have been made in defining the genes related 
with ischemia-reperfusion injuries. Genome wide analysis enables the analysis of not 
only the effects of ischemia-reperfusion, but also the effects of preconditioning, 
which has not been studied extensively, yet. 
1.1.2 Importance of preconditioning on organs 
Scientists try to prevent ischemic injury by generally trying to block events 
associated with irreversible ischemic injury. In surgical operations, ischemic damage 
also occurs, especially in transplantation. Several general supplemental 
measurements may need to be taken to prevent ischemia-reperfusion injury. In 1986, 
Murray et al defined the ischemic preconditioning (IP) for the first time to describe 
this endogenous inducible protection. The reason for applying preconditioning is to 
increase the organ tolerance and the resistance to more severe stress conditions. 
Preconditioning refers to one or more brief periods of stress condition prior to the 
prolonged one. Thus, initially, it was thought that each ischemic episode caused 
cumulative ATP depletion and intermittent reperfusion washed out the ischemic 
catabolites. However, it was later observed that ATP levels were not depleted by 
subsequent ischemic challenges and no infarction occurred after a series of four 5-
min coronary branch occlusions; each separated by 5 min of reperfusion. It was 
shown that the brief occurrence of ischemia and reperfusion to the myocardium led 
to the development of tolerance to subsequent ischemia and reperfusion. Ischemic 
preconditioning (IP) was mostly studied in the myocardium, but there are also other 
studies which show the effect of IP has on skeletal muscle, brain, liver, intestine and 
lung. All of these studies showed that ischemic preconditioning is a powerful 
endogenous phenomenon which induces robust protection against lengthy and lethal 
future ischemia [14,15,16,17]. 
The classic IP is short lived and fast decayed with antiischemic effects disappearing 
completely within 2 hours. According to that, the studies related to preconditioning 
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effect has shown that ischemic preconditioning time in rats was after one to three 
cycles of ischemia/reperfusion (I/R), a single 5-min cycle of I/R in rabbits and a 2.5-
min cycle of I/R in dogs [16]. 
It is thought that protection against I-R injury was induced by preconditioning which 
is related with some common protective pathways. Therefore, the roles of kinins, 
ATP-sensitive K
+
 channels, adenosine A1 receptors, activation of protein kinase C, 
and synthesis of heat shock proteins have been examined [14]. 
Another preconditioning type is heat preconditioning (HP). It is thought that heat 
preconditioning also has some effect on protecting organs against some stress 
conditions. Heat shock produces cellular tolerance against severe conditions that 
occurs in organs. This phenomenon is thought to be due, in part, to the expression of 
a family of highly conserved proteins (HSPs, closely linked to cytoprotection) [18, 
19]. Even though the protective role of heat preconditioning is thought to be due to 
HSP's ability to facilitate refolding, assembly, and stabilization of denatured proteins, 
exact mechanisms of such a beneficial effect are not well established. A well known 
HSP that has a protective effect on this mechanism is HSP-70 which is partially 
mediated through inhibition of NF-κB pathway–related inflammation, as well as 
modulation of cell necrosis or apoptosis [20]. On the other hand, there were no 
reports about the in vivo effect of heat preconditioning on inflammation and tubular 
cell necrosis or apoptosis in ischemic ARF until the study of Jo et al (2006). They 
examined the effect of heat preconditioning on NF-κB activation and subsequent 
inflammation, as well as on tubular cell necrosis, and apoptosis in ischemic ARF in 
rats. As a result, they observed that the beneficial effect of heat preconditioning is 
mediated partially by its inhibitory effect on NF-κB pathway–mediated inflammation 
as well as by attenuation of tubular cell apoptosis and necrosis [18,19,20,21]. 
1.1.3 DNA microarrays - A technology that is reshaping molecular biology: 
General Information about microarray technology 
To solve the mystery of life, information is required about thousands of genes and 
their products (i.e., RNA and proteins). However, traditional methods in molecular 
biology usually work on a "one gene in one experiment" basis. Recently, new 
technologies allow global analysis of biological data. For example, DNA microarrays 
are part of a new class of biotechnologies that allows highly parallel and quantitative 
monitoring of specific transcripts. DNA microarrays provide a simple and natural 
  
7 
vehicle for exploring the genome in a way that is both systematic and 
comprehensive. The power and universality of DNA microarrays as experimental 
tools is derived from the exquisite specificity and affinity of complementary base-
pairing. Simultaneously, the expression levels of thousands of genes can be 
monitored. By using a single chip, researchers can get a better view of important 
genes of interest simultaneously. In a typical microarray experiment, spotted arrays 
methods are used where two mRNA samples are reverse transcribed into cDNA, and 
labeled using two different fluorophores (Cy5 is a red fluorescent dye, Cy3 is a green 
fluorescent dye). After labeling, hybridization is done to the glass slide (sometimes 
on nylon substrates). Intensity values generated from hybridization to individual 
DNA spots are indicative of gene expression levels; according to the intensity ratios, 
results are obtained from gene expression levels between the two samples [21,22,23]. 
There are two major application forms for the DNA microarray technology: 1) 
Identification of sequence (gene/gene mutation) and 2) Determination of expression 
level (abundance) of genes [23]. 
There are two types of the DNA microarray technology in which probe cDNA or an 
array of oligonucleotide is used [23]. 
Type I: probe cDNA (500~5,000 bases long) is immobilized to a solid surface using 
robot spotting and exposed to a set of targets either separately or in a mixture. 
Stanford University developed this methodology and called it DNA microarray [23]. 
Type II: an array of oligonucleotide (20~80-mer oligos) or peptide nucleic acid 
(PNA) probes is synthesized either in situ (on-chip) or by conventional synthesis 
followed by on-chip immobilization [23]. 
1.1.3.1 Principle of microarray methodology 
Hybridization between nucleic acids which are immobilized on a matrix and the test 
provides important advancement in molecular biology. It provides sensitivity and 
specificity of detection. Immobilizing mRNA or total RNA (electrophoretically 
separated or in bulk) are used to assay the transcript abundance on membranes. After 
that, incubation with a radioactively labeled probe is done. If multiple RNA samples 
are immobilized on the same matrix, one obtains information about the quantity of a 
particular message present in each RNA pool. A complete system consists of three 
parts which are involve sample preparation ('the front end'), array generation and 
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sample analysis ('middleware'), and data handling and interpretation ('back end'). 
(Figure 1.2). In an array study, 3´ end of RNA transcripts that are gene-specific 
polynucleotide are individually arrayed on a single matrix which is then 
simultaneously probed with fluorescently tagged cDNA representations of total RNA 
pools from test and reference cells. The measurement is then done according to a 
'test' cell state and a 'reference' cell state (an internal control is thus provided for each 
measurement) [25].   
Quantitation based on two-color hybridization is then done by using a software. 
Quantitative changes in gene expression can be detected using several schemes for 
which the limits of detection vary (Figure 1.3) [25]. 
 
Figure 1.2: Expression analyses by using microarray [26] 
  
9 
 
Figure 1.3: Quantitation based on two color hybridization: a) Highly differential 
hybridization is visible at the detectors for CDKN1A and MYC, b) 
signal intensities: highly expressed ones have higher values whereas the 
others are at threshold level [25]. 
1.1.3.2 Data management and mining 
Microarray analysis involves many genes. These genes are represented on the array 
and to examine the outputs from single and multiple array experiments, primary 
results of hybridization and the construction of algorithms are required. To do that, 
the construction of databases for the management of information must also be 
established. Microarray data analysis methods have essentially been correlation-
based approaches that apply methods developed for the analysis of data which are 
more highly constrained (such a protein or amino acid sequence comparisons) than at 
the transcript level. This level of analysis helps to provide useful insights into the 
molecular pathogenesis of a variety of diseases. However, high number of data 
requires the scientist to find a way to reconsider the perception of transcriptional 
control. To be successful in data mining, biologists must expand the arsenal of tools 
they use to analyze expression data — recruiting statisticians and mathematicians to 
consider multivariant problems of a size never attempted before [25,27]. 
1.1.3.3 Clustering 
At the end of the microarray analysis, from thousands of genes, a small number of 
genes are revealed as related to the particular research of interest. The classification 
of these genes in subcategories is then necessary. Some of these genes can be 
expressed at the same level and can have the same effect on the organism. Therefore, 
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by arranging these genes according to their expression level, important gene groups 
can be identified and used for further analysis such as pathway or SNP analysis etc.  
Clustering can be defined as dividing the elements of a set into related subsets based 
on a distance metric among elements. In other words, arranging the genes according 
to their expression ratio results is known as clustering. Clustering has a potential to 
reveal biologically meaningful patterns in microarray data. Moreover, clustering is a 
common method for statistical data analysis, which is used in many fields, including 
machine learning, data mining, pattern recognition, image analysis and 
bioinformatics and it can be useful for discovering 'types' of behavior, for reducing 
the dimensionality of the data, as well as for the detection of outliers in the data. 
Thus, it can be said the main objective of clustering analysis is to find similarities 
between experiments or genes (given their expression ratios across all genes or 
samples, respectively), and then group similar samples or genes together to assist in 
understanding relationships that might exist among them [30,31,32]. 
Clustering is a well established field and there are various clustering algorithms that 
are considered as 'classic'. These include hierarchical agglomerative clustering that is 
based on iteratively grouping together the objects which are the most similar and also 
by MacQueen in 1967, K-means clustering was introduced [28]. In this clustering 
method, firstly the number of clusters is defined and then the clustering is iteratively 
improved by adjusting the cluster centers in Euclidean space. Kohonen's self 
organizing maps [29], graph theory-based algorithms [30,31] and methods that are 
used for Principal Component Analysis (PCA) are newer clustering algorithms [32]. 
Clustering procedures can be divided into two broad categories which are 
Hierarchical methods, either divisive or agglomerative and Partitioning methods. 
Hierarchical clustering algorithms generally build a tree that represents a hierarchical 
structure in the data set, a hierarchy of clusters, from the smallest through to the 
largest set. In the smallest set, all objects are in one cluster, whereas in the largest 
cluster, each observation is in its own cluster [32]. 
Besides these, the oldest method and the most famous clustering algorithm is K-
means which is also called non-hierarchical methods or flat clustering. K-means is 
one of the simplest unsupervised learning algorithms that solve the well known 
clustering problem. 
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K-means is the most common method of partition-based clustering which starts with 
defining k centroids, one for each cluster. After defining centroids, distance from the 
centroids to every object is calculated, and each object is assigned to the cluster 
defined by the closest centroids. But it should be known that these centroids should 
be placed in a cunning way because of different location causes different result. 
Therefore, it is better to choose to place them as much as possible far away from 
each other. The distance from each object to each of the new centroids is calculated 
and by this way the boundaries of the partitioning are revised. This process continues 
until the centroids are stable or until an a priori defined maximum number of 
iteratations have been reached. In other words, centroids do not move any more 
(Figure 1. 4). [32]. 
As an overview for algorithm [34], 
1. Firstly, choosing K as the number of clusters (Determining the number of 
clusters in a data set, a quantity often labeled k, is fundamental to the problem 
of data clustering, and is a distinct issue from the process of actually solving 
the clustering problem) 
2. Then, generating k clusters and determining the cluster centers, or directly 
generate k random points as cluster centers. 
3. For every new sample vector (assigning each point to the nearest cluster 
center): 
 a. Computing the distance between the new vector and every cluster's 
codebook vector 
  b. Recomputing the closest codebook vector with the new vector, using a 
learning rate that decreases in time. 
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Figure 1.4: K-means clustering scheme: The large circles are centroids and the small 
ones are the objects [32] 
Unfortunately, there is no general theoretical solution to find the optimal number of 
clusters for any given data set. Although various clustering methods can usefully 
organize tables of gene expression measurements, the resulting ordered but still 
massive collection of numbers remains difficult to assimilate. But, it should be noted 
that K-means is one of the most scalable algorithms for large datasets. 
1.1.3.4 Data visualization 
Large amounts of data are often obtained as a result of differentially expressed genes 
between different sample sets. The next task is to identify the functional relevance of 
the observed expression changes. After clustering, there are several methods to 
compare results from multiple microarray experiments. Methods can be used to 
validate results from similar experiments performed under different conditions. Some 
visualization tools can be used for this purpose, which are very powerful data mining 
tools to find the patterns for gene expression analysis. For example, Venn diagram 
which was introduced by John Venn in 1881 is the simplest and most effective 
method for demonstrating the extent that clusters of gene expression data overlap as 
well as to show the mathematical or logical relationships between different groups of 
sets with Gene Ontology (GO) functional annotation (Figure 1.5) [35,36,37]. 
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Figure 1.5: General Venn diagram with three data sets A, B and C with their 
intersections [37] 
Clustering helps to allow reduction of the dimensionality in the data when it is 
coupled with visualization. The most popular visualization technique for gene 
expression profile analysis is a heat map which was introduced by Michael Eisen 
[38]. Heat map is used for the representation of the gene expression matrix by using 
different colors. For example, in microarray analysis, there are some negative and 
positive values. Red color can be used for positive value whereas negative values are 
represented with green color (Figure 1.6) [32,39]. 
 
Figure 1.6: The heat map from the article by Xu et al., (2008) showing the two-
group (good- and poor-outcome) supervised clusters of the integrated 
training data for the 112 signature genes [39] 
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1.2 The Baker’s yeast Saccharomyces cerevisiae: Brief Information About a 
Eukaryotic Model Organism 
S. cerevisiae is unicellular, simple eukaryote and its typical characteristics are highly 
similar to those of the higher eukaryotic organisms. One of the oldest examples of 
human relation with microorganisms is the use of microorganisms to raise the dough 
for bread making, as documented by Egyptian history. Bread of this type was known 
in Egypt at least since 3000 BC, when pharaoh gave beer and bread to his slaves who 
built a pyramid. Besides, it is also known that about 5000 years ago, yeast has also 
been used for making beer and sake. The first written records of brewing are from 
Sumeria about 6,000 years ago. The differences between baking in ancient history 
and today‘s baking is that Saccharomyces cerevisiae does not grow during dough 
raising conditions and therefore, some external sources had to be supplied in the past. 
Despite their limited knowledge about brewing, the bakers did not know anything 
about the active agents of fermentation foam that was used. They only used beer 
mash and fermentation for making bread. However, today, yeast is playing an 
important role as a model organism in biochemistry, genetics, molecular biology and 
biotechnology. It is easy to manipulate and also the most intensively studied 
eukaryotic model organism in molecular and cell biology, much like Escherichia coli 
as the model prokaryote [40]. 
The yeast S. cerevisiae is also closely related with animals and plants. Having 
mitochondria is a common property with animals. S. cerevisiae has a cell wall which 
is hard as  in the other fungi. The cell wall properties show similarities with plant  
cell walls [41,43].  
S. cerevisiae has the ability to grow and reproduce in a simple medium with minimal 
ingredients for growth. Cells are round to ovoid, 5-10 μm in diameter and reproduce 
by a division process known as budding. In this process a small protuberance grows 
and eventually after a nucleus is passed to the daughter cells, separation from the 
parent cells occurs [41,43]. 
The life cycle of S. cerevisiae consists of two forms in which yeast cells can grow 
and survive: haploid and diploid. The haploid cells undergo a simple life cycle of 
mitosis and growth, and under conditions of high stress, they will simply die. The 
diploid cells (the preferential 'form' of yeast) similarly undergo a simple life cycle of 
mitosis and growth, but under stress conditions, they can undergo sporulation, enter 
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meiosis and produce a variety of haploid spores, which can continue to mate 
(conjugate), reforming the diploid [41,42,43]. 
1.2.1 The importance of Saccharomyces cerevisiae in industry 
S. cerevisiae has become increasingly important in biotechnology and development 
of several strains optimized for specific applications has been achieved. Today, 
strains used in the laboratory were derived from industrial strains a long time ago. 
Therefore, it is now a kind of a domesticated microorganism, and thousands years of 
usage has resulted in development of several strains optimized for these specific 
applications [40]. 
There are many reasons for using Saccharomyces cerevisiae in biotechnological 
applications. It is safe and its cultivation is easy and inexpensive compared with 
many other microorganisms. Growth of yeast can be observed very easily and in a 
short time [40,41]. 
A wide range of sugars such as sucrose, glucose, fructose, galactose, inannose, and 
maltose are taken up and used in fermentation processes of Saccharomyces 
cerevisiae and related yeast species. Yeast is widely used in the production of bread 
and alcohol, and is regarded as safe. Genetic and biotechnological applications are 
developing day by day and gene transfer, gene fusion and gene regulation/expression 
have importance in these areas. These techniques have been extensively used in yeast 
strains to make yeast an attractive host organism for heterologous protein production, 
such as human serum albumin and human insulin. However, many heterologous 
proteins are produced at low yields. S. cerevisiae has been becoming an important 
tool to match the requirements of the industry by development of recombinant DNA 
technology and applying modern molecular techniques. Recent research using these 
applications showed that mutagenesis of strains can be used to increase the yield of 
secreted proteins [40]. 
Additionally, yeast can be used for disposal of unutilized products. The search for a 
satisfactory solution for disposal of the unutilized whey produced in the manufacture 
of cheese remains an area of intense concern for the dairy industry. Because of the 
high-cost waste treatment systems, scientists try to find alternative ways for 
recovering the disposal. One approach for that is to ferment the lactose into ethanol 
to use it as a fuel or chemical feedstock. Furthermore, process improvements through 
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engineering are possible; strain improvement can be done and disposal of unutilized 
product can be achieved [40,44]. 
Hybrids construction is possible by using laboratory strains, but not by using most 
industrial strains of S. cerevisiae, such as sake-brewing yeasts and beer-making 
yeasts. This feature of industrial yeast prevents breeding between industrial strains. 
However, by using gene fusion technique, the problem can be solved and hybrids 
that are going to be constructed make it possible to have a progeny with desired 
genetic traits for better beer and sake brewing yeasts [45, 46]. 
Additionally, brewing industry is one of the most important industries where S. 
cerevisiae is used. In this field, there are many types of brewing processes depending 
on the specific type of beer [47]. 
Generally, laboratory strains are suitable for genetic manipulations, because of their 
features such as being isogenic, having sporulation competence when they are 
diploid or being haploid. However, industrial strains have superior ability to make 
tasty food and beverages [48]. 
1.2.2 Oxidative stress 
1.2.2.1 Basics of oxidative stress 
Molecular mechanisms induced upon exposure of cells to adverse conditions are 
commonly designated as stress responses that aim to protect cells against the 
detrimental effects of stress factors and rapid damages. Living cells have adaptive 
responses to oxidative stress, indicating that they sense increased levels of reactive 
oxygen species (ROS) and respond to the signal by increasing the expression of 
defense activities. The mechanisms by which cells sense reactive oxygen species are 
relatively well understood in prokaryotes but not in eukaryotes [49]. 
Oxidative stress, one of the most important and common stresses that activate the 
stress response elements, is caused by an imbalance between the production of 
reactive oxygen and a biological system's ability to readily detoxify the reactive 
intermediates or easily repair the resulting damage. Moreover, cells can be frequently 
exposed to hydrogen peroxide, nitric oxide, peroxynitrite, singlet oxygen, superoxide 
anions and hydroxyl radials and these free radicals such as ROS are formed during a 
variety of biochemical reactions and cellular functions (such as mitochondria 
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metabolism). Under normal, physiological conditions these molecules which are also 
known as ROS are produced in low amounts as a result of metabolism. Therefore, it 
can also be said in another way that ROS form as a natural byproduct of the normal 
metabolism of oxygen and have important roles in cell signaling. The steady-state 
formation of pro-oxidants (free radicals) is normally balanced by a similar rate of 
consumption by antioxidants, but if the production of these reactive molecules 
overwhelms antioxidant defenses, oxidative stress is then generated. [50,51]. 
The main source of ROS is aerobic respiration in vivo, even though ROS are also 
produced by peroxisomal β-oxidation of fatty acids, microsomal cytochrome P450 
metabolism of xenobiotic compounds, stimulation of phagocytosis by pathogens or 
lipopolysaccharides, arginine metabolism, and tissue specific enzymes. These ROS, 
known to cause some degenerative diseases such as atherosclerosis, Parkinson's 
disease and Alzheimer's disease, attack almost all cell components, such as DNA, 
protein and lipid membrane. Unsaturated fatty acyl groups in membranes are a major 
target for the hydroxyl radical and the protonated superoxide anion. Autocatalytic 
lipid peroxidation is initiated as a result of the attack and causes the formation of 
reactive lipid radicals and lipid hydroperoxides. Moreover, damage to lipids involves 
the oxidation of polyunsaturated fatty acid by an autocatalytic process, leading to the 
production of fatty acids hydroperoxides, which undergo fragmentation, generating a 
variety of highly reactive products, such as epoxides, aldehydes and alkanes. Highly 
reactive products can disseminate and increase initial radical events by damaging 
DNA and proteins [52]. 
Increasing the response of defense mechanism against the ROS causes oxidative 
stress response activation. The conditions that are related with this defense 
mechanism are:  
 Changing from anaerobic to aerobic conditions 
 An increase of the mitochondria respiratory chain activity  
 The exposure of the cells to low concentration of oxidants, such as hydrogen 
peroxide or drugs that generate superoxide radicals 
 The decrease of antioxidant defenses [53]. 
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To get over the effects of oxidative stress, cells use complex physiological response 
that encompasses both enzymes such as superoxide dismutase (SOD), catalase, or 
glutathione (GSH) peroxidase  and some protective molecules [50,51]. 
Stress responses that aim to protect cells against the detrimental effects of stress 
factors and rapid damages can occur as an early response and late response. 
Response time is the important parameter to get over the effects of oxidative stress to 
the cell. Early adaptive response provides almost immediate protection against 
sublethal stress conditions while late adaptive response provides a more efficient 
protection against a severe stress and it also allows cells to return to non-stress 
conditions. Early responses that activate some protein kinases or trehalose 
metabolism appear to have two important functions which are providing a minimal 
protection against sudden stress, and initiating late responses, e.g. the synthesis of 
heat shock proteins or enzymes scavenging toxic oxygen radicals. These late 
responses will protect cells permanently and more effectively by allowing adaptation 
to persistent stress [49,50,52]. 
1.2.2.2 Oxidant defense systems 
In chemical terms, oxidative stress is a large rise in the cellular reduction potential or 
a large decrease in the reducing capacity of the cellular redox couples. In other 
words, oxidative stress is the production of reactive oxygen species, which include 
free radicals and peroxides. Some of the less reactive of these species can be 
converted by oxidoreduction reactions into more aggressive radical species that can 
cause extensive cellular damage. Therefore, cells need to protect themselves against 
these factors. Thus, cells possess both enzymatic and non-enzymatic defense systems 
to protect their cellular constituents and maintain cellular redox state. Nonenzymatic 
way to defend the cells is typically done by small molecules which are soluble in 
either an aqueous or, in some instances, a lipid environment. They act in general as 
radical scavengers, being oxidized by ROS and thereby removing oxidants from 
solution. In enzymatic defense systems, however, enzymes can remove oxygen 
radicals and their products and/or repair the damage that happens because of 
oxidative stress. Primary antioxidant defense systems are induced by increased ROS 
production and therefore, there are enzymes and compounds that prevent the 
initiation or propagation of radical/oxidant damage or act as radical chain terminating 
agents (Table 1.2) [54]. 
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Table 1.2: Yeast primary antioxidant defense systems [49] 
 
1.2.2.3 Important elements for reduction of hydrogen peroxide 
Nonenzymatic defense system consists of a variety of different protection elements 
with different functions. Phytochelatins, lipophilic antioxidants, metallothioneins, 
polyamines, ascorbic acid, trehalose, and flavohaemoglobins are some elements of 
non enzymatic defense systems. However, in this part of the defense system against 
hydrogen peroxide stress conditions, glutathione, glutaredoxin and thioredoxin are 
the most important elements that provide some protection against oxidative stress 
and also have some protein repair mechanism against oxidative stress. Moreover, 
recent studies revealed the key roles played by thiol groups, in particular the 
glutathione, glutaredoxin and thioredoxin systems, in maintaining redox homeostasis 
in the cell. 
1.2.2.4 Biosynthesis and regulation of glutathione 
The best known example for the oxidative stress defense mechanism is most 
abundant low-molecular-weight-thiol molecule glutathione (GSH) that act as a 
radical scavenger with redox-active sulphydryl group reacting with oxidants to 
produce reduced glutathione. The biological importance of GSH is dependent on the 
redox-active sulphydryl moiety of its cysteine residue which can act as a free radical 
scavenger. In the reduced state, the thiol group of cysteine is able to donate a 
reducing equivalent (H++ e-) to other unstable molecules, such as reactive oxygen 
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species. In donating an electron, glutathione itself becomes reactive, but it readily 
reacts with another reactive glutathione to form glutathione disulfide (GSSG) [57]. 
Glutathione (GSH) is an abundant cellular thiol which has been implicated in many 
cellular processes including amino acid transport, synthesis of proteins and nucleic 
acids, modulation of enzyme activities and protection against xenobiotics, 
carcinogens, and reactive oxygen species (ROS). Glutathione (GSH) is a tripeptide 
that produces linkage between the amino group of cysteine and the carboxyl group of 
the glutamate side chain and biosynthesis of it is done by GSH1 and GSH2 genes 
respectively encoding γ-glutamylcyteine synthetase and glutathione synthetase. The 
related biochemical pathways are depicted in Figure 1.7.  It is known from the 
mutant GSH1 and GSH2 experiment that glutathione deficient mutant yeast cells are 
hypersensitive to H2O2 and moreover, GSH1 gene is more needed than GSH2 gene 
for the growth of yeast cells in stress conditions [54,55,56]. 
 
Figure 1.7: Outline of biochemistry of GSH: AA, amino acids; X, compounds that 
react with GSH to form conjugates. 1, γ-glutamylcysteine synthetase; 2, 
GSH synthetase; 3, γ -glutamyltranspeptidase; 4, dipeptidases; 5, γ -
glutamylcyclotransferase;6 , 5-oxoprolinase; 7, GSH S-transferases; 8, 
N-acetyltransferase; 9, GSH peroxidases; 10, GSH thiol transferases; 11, 
reaction of free radicals with GSH, 12, glutathione disulfide (GSSG) 
reductase; 13, transport of y-Glu-(Cys)a. GSH functions as a coenzyme 
for formaldehyde dehydrogenase, maleylacetoacetate isomerase, 
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glyoxalase, prostaglandin endoperoxidase isomerases, and 
dichlorodiphenyltrichloroethane (DDT)-dehydrochlorinase and similar 
enzymes. In the glyoxalase reaction, the hemimercaptal formed 
nonenzymatically by reaction of methylglyoxal and GSH is converted by 
glyoxalase I to S-lactyl-GSH, which is split by glyoxalase I1 to D-lactate 
and GSH. In the formaldehyde dehydrogenase reaction, S-formyl GSH is 
formed (GSH + HCHO + NAD+) and hydrolyzed to formate and GSH 
[56]. 
In healthy cells and tissue, more than 90% of the total glutathione pool is in the 
reduced form (GSH) and less than 10% exists in the disulfide form (GSSG). An 
increased GSSG-to-GSH ratio causes a decrease in oxidative stress response. 
Another experiment shows that in rich media with aerobic conditions, cells have a 
high redox ratio (GSH-GSSG) of ≈ 11 – 16:1 indicating that most of the intracellular 
glutathione is maintained in a reduced form. Utilization of glutathione is catalyzed by 
glutathione reductase (GLR, EC 1.6.4.2, NADPH: GSSG oxidoreductase) in order to 
maintain a high intracellular ratio reduced to oxidized glutathione. In fact, 
glutathionylation is a reversible process acting as the more frequent modification of 
protein sulphydryls. The molecular equation for that mechanism is: [57,58,59].  
 GSSG + NAPDH
+
 + H
+
  NADP+ + 2GSH                (1.1) 
The enzyme that takes a role in that pathway is glutathione reductase (GLR) which is 
a member of the FAD-containing pyridine disulphide oxidoreductase family of 
enzymes. It is a flavoprotein and it appears to be a dimer with molecular weight of 
approximately 118,000 and contains 1 FAD per monomer. For each mole of oxidized 
glutathione (GSSG) one mole of NADPH is required to reduce disulphide for GSSG 
to reduced form GSH. NADPH reduces FAD present in GSH to produce a transient 
FADH
-
 anion. This anion then quickly breaks a disulfide bond (Cys58 - Cys63) and 
leads to Cys63 nucleophilically attacking the nearest sulfide unit in the GSSG 
molecule (promoted by His467) which creates a mixed disulfide bond (GS-Cys58) and 
a GS
-
 anion. His467 of GSR then protonates the GS
-
 anion to form the first GSH. 
Next, Cys63 nucleophilically attacks the sulfide of Cys58 releasing a GS
-
 anion which 
in turn picks up a solvent proton and is released from the enzyme, thereby creating 
the second GSH. Thus, for every GSSG and NADPH, two reduced GSH molecules 
that can again act as antioxidants scavenging reactive oxygen species in the cell are 
gained [57,58,59].  
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Some studies on E.coli showed that GSH is not an essential metabolite in this 
organism under normal growth conditions when GLR gene is deleted. As a result, 
mutants more sensitive to oxidative stress conditions were obtained. Grant et al., 
(1996) showed that GLR1 in non-essential under normal growth conditions and 
shares % 49.8 identities with E.coli and human genes. Moreover, of the total 
glutathione detected, most is present in a free form either intracellular (58%) or 
extracellular (39%) [54,57]. 
Little is known about the factors directly involved in defense mechanism of yeast 
cells against oxidative stress. But it is thought that GLR activity is important for this 
stress condition because it maintains the intracellular ratio of GSH: GSSG, but the 
cell is able to maintain normal levels of GSH presumably by de novo synthesis. 
Grant et al., (1996) showed that yeast cells that do not possess the GLR activity were 
sensitive to a range of oxidants such as hydrogen peroxide, tert-butyl hydroperoxide 
and cumene hydroperoxide. This is a good evidence for the importance of GSH in 
detoxification of these various ROS. Additionaly, glr1 gene helps to maintain the 
necessary level of GSH (Figure 1.8). Moreover, it was observed that abnormally high 
GSSG levels in a glr1 mutant may contribute to inability of glr1 cells to survive, as 
oxidant challenge would further increase the GSSG levels and GSSG has been 
shown to be a toxic agent that inhibits protein synthesis [57,58,60]. 
 
Figure 1.8: Yeast glutathione cycle [60] 
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Moreover, the expression of GLR1 is induced by oxidants, and regulation is 
dependent upon the transcriptional activator protein yAP-1. YAP1 (YML007W) - 
Basic leucine zipper (bZIP) transcription factor is required for oxidative stress 
tolerance; is activated by H2O2 through the multistep formation of disulfide bonds 
and transit from the cytoplasm to the nucleus; and mediates resistance to cadmium. 
Yap1p, a member of the AP-1 family of transcription factors, activates the 
transcription of anti-oxidant genes in response to oxidative stress. Yap1p is involved 
in one of three mechanisms that regulate the transcriptional response to oxidative 
stress. The other two involve Hog1p and Skn7p. The preferred Yap1p binding site is 
TTACTAA. The genes regulated by Yap1p include anti-oxidant genes such as 
TRR1, TRX2, GSH1, and GLR1. Although many of the genes regulated by Yap1p 
are also regulated by Skn7p, Yap1p and Skn7p appear to respond to different 
oxidative stresses. Consistent with its primary role in responding to oxidative stress, 
a YAP1 null mutant is sensitive to multiple oxidative stresses, including hydrogen 
peroxide and compounds that alter the redox status in the cell  [57,60,61]. 
All organisms encounter with ROS during normal cellular processes and these 
species are toxic agents that can cause damages on protein, nucleic acid and lipid 
levels. These highly reactive small molecules with unpaired valence shell electrons 
form as a natural byproduct of the normal oxidative metabolism and have important 
roles in cell signaling. Furthermore, during environmental stress, ROS levels can 
increase dramatically, which can result in significant damage to cell structures and 
hence oxidative stress. Catalase, superoxide dismutase, and glutathione reductase and 
these kinds of enzymes take roles on protection of cellular defense mechanisms 
against reactive oxygen species. Yeast cells show an adaptive response to oxidative 
stress induced by hydrogen peroxide and superoxide [57,58,61]. 
1.2.2.5 The Glutaredoxin system 
Glutaredoxins commonly found in most organisms are small heat-stable redox 
proteins of approximately one hundred amino-acid residues which use glutathione as 
a cofactor. It is a class of small proteins with an active site containing two redox 
sensitive cysteines. Glutaredoxins catalyze formation of mixed disulfides 
(glutathionylation), which is an important redox regulatory mechanism, particularly 
in mammalian cells under oxidative stress conditions, to sense cellular redox 
potential. Glutaredoxins may operate as dithiol reductants and are involved as 
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alternative pathways in cellular functions such as formation of deoxyribonucleotides 
for DNA synthesis (by reducing the essential enzyme ribonucleotide reductase), the 
generation of reduced sulfur (via 3'-phosphoadenylylsulfate reductase), signal 
transduction, and the defense against oxidative stress. Moreover, these small proteins 
which are thought to work just like thioredoxin, another important factor, act as a 
source of electrons for ribonucleotide reductase in yeast [54,60,61].  
It is known that S. cerevisiae has two glutaredoxin genes (GRX1 and GRX2). In 
spite of the relatively high degree of similarity between the two proteins, it appears 
that they perform different roles in protecting the cell against H2O2 and superoxide 
anions, respectively (Figure 1.9). Thus, just like thioredoxins, glutaredoxins are 
required for resistance to oxidative stress. Two genes share 40-52% identity and 61-
76% similarity
 
with glutaredoxins from bacterial and mammalian species. Some 
studies showed that upon deletion for both GRX1 and GRX2, yeast cells were viable 
but
 
lacking heat-stable oxidoreductase activity using β-hydroxyethyl disulfide 
(HED) as a model disulfide substrate. Furthermore, mutants lacking Grx1 and Grx2 
were sensitive to oxidative stress conditions and overexpression of Grx1 or Grx2 
increased resistance to various hydroperoxides. Then, related with some experiment 
it can be said that expression of Grx1 and Grx2 is up-regulated in response to stress 
conditions, including exposure to oxidants, with both genes regulated via stress-
responsive elements. Two glutaredoxins may play distinct roles during different 
growth and stress conditions. It was shown by their differences in gene expression 
and also it is known that Grx2 accounts for the majority of its activity in vivo. 
Similarly, Grx2 can directly reduce hydroperoxides, albeit with a
 
lower catalytic 
efficiency than Grx1. Furthermore, the grx1 mutant was sensitive to oxidative stress 
induced by the superoxide anion, whereas the grx2 mutant was sensitive to hydrogen 
peroxide. In addition, the isoforms of Grx2 were detected in the cells that localized to 
the cytosol and mitochondria, respectively. It was also shown that both
 
Grx1 and 
Grx2 had oxidoreductase activity against the mixed
 
disulfide formed between HED 
and GSH, although it remains unclear
 
whether this activity serves a protective 
function against
 
physiological substrates formed during stress conditions. However, 
comparative studies indicated that the TRX system seems to be more important than 
the GRX system in protection against external hydroperoxides in yeast cells [62, 63, 
64].  
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Figure 1.9: The GSH/Glutaredoxin and thioredoxin systems: The latter enzyme 
employs electrons from NADPH to regenerate GSH from oxidized 
glutathione disulphide (GSSG) formed during the GRX reaction [64]. 
The importance of glutaredoxins for protection of cells against ROS shows their 
specific role in the regulation of a cellular antioxidant(s), or also the general role in 
protection against oxidants as a result of their disulfide oxidoreductase activity. For 
instance, glutathione peroxidase is an antioxidant enzyme that can catalyze the 
breakdown of hydroperoxides by using GSH as a reductant. Some studies showed 
how glutaredoxin and thioredoxin systems could serve as electron donors for human 
plasma glutathione peroxidase [63].  
Therefore, the absence of glutaredoxin affects the ability of glutathione peroxidase to 
work properly. In addition, the antioxidant ascorbic acid, which can detoxify 
hydrogen peroxide and other forms of ROS, may require glutaredoxin activity for 
maintenance of its function [63,64]. 
1.2.2.6 The Thioredoxin systems 
Thioredoxin is a small sulphydryl rich protein which can be used as a reductant for 
thioredoxin peroxidase and for ribonucleotide reductase. Thus, it acts as an 
antioxidant by facilitating the reduction of other proteins by cysteine thiol-disulfide 
exchange. It contains a dithiol active site sequence of Cys-Gly-Pro-Cys. 
Thioredoxins are found in nearly all known organisms and are essential for life in 
mammals [54,65,66]. 
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TRX1 and TRX2 are the related genes for encoding the thioredoxin proteins in yeasts. 
Deletion of these genes does not cause the death of yeast cells in stress conditions, 
only extend the S-phase of the cell cycle and increase the level of oxidized 
glutathione but deletion of TRX2 interestingly makes cells hypersensitive to H2O2, 
but paradoxically resistant to diamide. Moreover, genetic studies showed that 
mutation in thioredoxin related genes have effects on cell cycle regulated genes 
especially in G1/S boundary. Interestingly, it was found that hydrogen peroxide 
arrests the cell cycle in G1 and G2 with Rad9 check point protein which is related 
with oxidative stress conditions [54,66]. 
TRX1 and TRX2 gene - Cytoplasmic thioredoxin isoenzyme of the thioredoxin 
system which protects cells against oxidative and reductive stress, forms LMA1 
complex with Pbi2p, acts as a cofactor for Tsa1p, and is required for ER-Golgi 
transport and vacuole inheritance (Yeast Genome Database). 
In addition, yeast TRX1 and TRX2 showed 78% amino acid sequence identity. The 
amino acid sequence of TR-I displayed 47% identity to human thioredoxin, 46% to 
rabbit bone marrow thioredoxin, 31% to spinach chloroplast thioredoxin and 27% to 
E. coli thioredoxin [66]. 
The TRX system is completed by TRX reductase, which reduces oxidized TRX to 
the active thiol form using NADPH. TRXs participate in the reduction of enzymes 
that form a disulphide during their catalytic cycle, such as ribonucleotide reductase 
(RNR, required for maintaining dNTP pools for DNA synthesis), 3′-
phosphoadenosine 5′-phosphosulphate reductase (PAPS reductase, required for 
sulphur assimilation) or TRX peroxidase. Thus, it can be said that they modulate the 
redox state of cell protein sulphydryls and consequently protein folding [54,67]. 
In S. cerevisiae, there are three thioredoxins which are Trx1, Trx2, and Trx3. The 
first two of them are cytosolic, whereas Trx3 is mitochondrial TRX.  Thus, it can be 
concluded that there are two different TRX systems in yeast cells (Figure 1.10).  
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Figure 1.10: Components of the S. cerevisiae thioredoxin and glutaredoxin systems 
in nucleus, mitochondria and cytosol [70] 
The cytosolic TRX molecules of S. cerevisiae are required for the defense against 
externally-added hydroperoxides. At the end of the studies with individual and 
double mutants, it was observed that Trx2 had a more important role than Trx1 in 
this respect, which indicates that the two TRXs did not have exactly overlapping 
functions. Moreover, expression of Trx2 increased when external hydrogen peroxide 
was added. The protective function of Trx2 occurs through its role as reductant of 
cytosolic Tsa1 TRX peroxidase, although studies revealed that TRX system does not 
have a significant protection mechanism against singlet oxygen [54,68,69,70]. 
1.2.2.7 Interplay between glutaredoxin and thioredoxin systems 
The study related with the identification of a glutathione reductase (GLR1) null 
mutant in a genetic screen for mutations that confer a requirement for thioredoxins 
also helped to identify the functional link between the thioredoxin and 
GSH/glutaredoxin systems in yeast. The major redox buffer in eukaryotic cells is 
GSH and the ratio of GSSG/2GSH is an important criterion to measure the redox 
cellular situation. GSH concentration in S. cerevisiae wild type cells may be in the 
range 1–10 mM or even higher. It is considered as an important substrate for GPXs, 
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GRXs, and GSTs and its levels are also affected by TRX system. Different 
experiments revealed the existence of a close relationship between these redox 
systems as indicated below [61,70]. 
i. Glr1 function is required in the absence of Trx1 and Trx2 
ii. GSSG/GSH ratio is influenced by Trx1 and Trx2 
iii. Mutant cells containing trx1 trx2 grx1 grx2 is non viable  
However, a functional asymmetry could be observed between both systems. 
Therefore, the redox state of Grx1 and Grx2 was shifted to a more oxidized form in a 
glr1 mutant, whereas that of Trx1 and Trx2 was not affected in these conditions. The 
same study demonstrated that Trr1 regulates the redox state of cytosolic TRXs. A 
security mechanism for the cell being able to survive in conditions of GSH depletion 
(i.e. oxidative stress) or under defects in the GRX system was related with the 
independent redox regulation of TRXs from the GSH-GRX system. Also some 
relation was found between Grl1 and Trx3 based on their mitochondrial levels. It was 
observed that Trx3 accumulated in the absence of Glr1 [69,70].  
A further overlap between the two systems was evident by observing elevated 
levelsof GSSG in yeast cells mutated in. This result indicated a link between the 
thioredoxin system and the redox status of GSH in the cell [71]. 
The conservation of thioredoxins and glutaredoxins has been achieved through the 
evolution, particularly in the region of their active sites. For instance, considerable 
functional redundancy has been identified between the two systems, including 
activity towards ribonucleotide reductase, PAPS reductase and plasma glutathione 
peroxidase [60]. 
Finally, the reason for the essential requirement for a glutaredoxin or thioredoxin still 
remains unknown today. Finding which of the yeast glutaredoxin or thioredoxin 
isoenzymes can function in the reduction of ribonucleotides should be the first step 
of future research. However, it seems likely that both systems are active, as 
deoxynucleotide triphosphate levels were unaltered in a trx1 trx2 mutant. Similarly, 
the roles for the yeast glutaredoxins or thioredoxins in disulphide bond formation and 
isomerization still remains to be elucidated [60]. 
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1.2.2.8 Enzymatic defense system 
Several enzymes also take place in the cellular antioxidant defense mechanism. 
These enzymes are capable of removing oxygen radicals and their products and/or 
repairing the damage caused by oxidative stress. Catalase, superoxide dismutase, and 
peroxidases are the most important enzymes for this defense system. One group of 
enzymes act directly as ROS detoxifiers, whereas the second group act as redox 
regulators of protein thiols and contribute to maintain the redox balance of the cell. 
However, both types of strategies overlap (Figure 1.11) [60,91]. 
 
Figure 1.11: Enzymatic ROS detoxification and control of redox state of protein 
sulphdryl groups in yeast [70] 
Catalase 
Catalase, one of the most potent catalysts known, is a heme containing redox 
enzyme. Each catalase molecule can decompose millions of hydrogen peroxide 
molecules every second. Catalase is found in high concentrations in a cellular 
compartment called the peroxisome.  Catalase (EC 1.11.1.6), found nearly in the 
peroxisomes of all aerobic cells serves to protect the cell from the toxic effects of 
hydrogen peroxide by breaking it down itself into molecular oxygen and water 
without the production of free radicals. The mechanism of catalysis is not well-
known, but the general reaction is given in Equation 1 [42,54]: 
                                                 2H2O2  2 H2O + O2                                          (1.2) 
Catalase consists of a tetramer of four polypeptide chains, each over 500 amino acids 
long. It contains four porphyrin heme groups that allow the enzyme to react with the 
hydrogen peroxide. Although the optimum pH for catalase is approximately 7.0, 
optimum temperature varies among different species [42]. 
  
30 
Breaking down mechanism of hydrogen peroxide occurs in two stages, where 
hydrogen peroxide alternately oxidizes and reduces the haem iron at the active site.  
In the first step, one hydrogen peroxide molecule oxidizes the haem to an oxyferryl 
species, and then in the second step, a second hydrogen peroxide molecule is used as 
a reductant to regenerate the enzyme. Water and oxygen are produced in the end. 
Catalases may have another role: the generation of ROS, possibly hydroperoxides, 
upon UVB irradiation.  In this way, UVB light can be detoxified through the 
generation of hydrogen peroxide, which can then be degraded by the catalase.  
NADPH may play a role in providing the electrons needed to reduce molecular 
oxygen in the production of ROS [54,72]. 
In S. cerevisiae, two different types of catalase have been found which are 
peroxisomal catalase A encoded by CTA1 and cytosolic catalase T encoded by CTT1 
These two enzymes are localized in different cellular compartments and thus possess 
independent control. The molecular weights of the biologically active, 
homotetrameric enzymes are 170-190 kD and 225-250 kD for catalase A and T, 
respectively. Limited data is available regarding those enzymes in the cell [73,74,75]. 
Acyl-CoA oxidization during fatty acid beta-oxidation at peroxisomes for the 
detoxification of hydrogen peroxide is generated by involvement of CTA1. Even 
though expression of CTA1 is induced in yeast cells growing under fatty acids as the 
only carbon source, mutant yeast cells that do not have the CTA1 are still able to 
grow in these conditions, which shows that peroxisomal catalase activity is 
unimportant. Moreover, Ctt1 at cytosol still is a mystery, because a null ctt1 mutant 
displays wild type exponential growth in aerobic conditions and is not more sensitive 
to hydrogen peroxide than wild type cells. But double deletion of these two genes 
make cells hypersensitive to peroxide in stationary phase which points to a 
cooperative role of both catalases in protecting in such conditions against external 
hydrogen peroxide. Thus, although the catalase genes are only moderately inducible 
by H2O2, both catalases are clearly important for resistance towards H2O2. However, 
oxidative, osmotic, carbon starvation or freeze–thawing stresses trigger the 
expression of CTT1 [54,70]. 
It is known that there is complementation between detoxifying enzymes in the 
oxidative stress response. This is supported by the observation in S. cerevisiae cells 
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that the absence of catalases enhanced the hypersensibility to oxidants of a strain 
unable to synthesize GSH [70]. 
Earlier studies in yeast already suggested that mitochondria possess an independent 
mechanism for decomposing exogenous H2O2 and that endogenous detoxification of 
H2O2 by cytochrome c peroxidase takes place in this organelle. Although so far, 
yeast catalase A has been primarily considered as a peroxisomal protein, it was 
shown that there is catalase activity in yeast mitochondria. Mitochondria and 
peroxisomes are metabolically linked organelles, which are cooperating and cross-
talking. Petrova et al., (2004) showed that catalase activity in yeast mitochondria 
might have a similar important in vivo function by cooperating with mitochondrial 
SODs in the detoxification of H2O2 in this organelle. To sum up, it can be said that 
mitochondria and peroxisomes share a variety of enzymatic reactions and yeast 
catalase A is not only targeted to peroxisomes but also efficiently co-imported into 
mitochondria, especially when under respiratory growth conditions as Cta1p works 
as scavenger of mitochondrially derived H2O2 [70,74]. 
Superoxide Dismutase 
Superoxide dismutase (SOD, EC 1.15.1.1), common in all eukaryotes, catalyzes 
superoxide conversion into oxygen and hydrogen peroxide. Superoxide dismutase is 
widespread in nature. As such, it is an important antioxidant defense in nearly all 
cells exposed to oxygen. Yeast cells possess three types of superoxide dismutase 
which are the extracellular superoxide dismutase (EcSod), the mitochondrially-
located (MnSod (encoded by the SOD2 gene)) and cytoplasmically-located 
Cu/ZnSod (encoded by the SOD1 gene). In addition, a fraction of Sod1 is localized 
at the mitochondrial intermembrane space. The two isoforms of SOD in prokaryotes 
are FeSOD and MnSOD. Cytoplasmically-located type is the major superoxide 
dismutase involved in removing superoxide anions from the cytoplasm and possibly 
also peroxisomes. There are also studies showed that Cu/ZnSod protects cells against 
respiration derived superoxide anions and has some buffering role for intracellular 
copper concentration (unrelated information with protecting cells against oxidative 
stress). Moreover, MnSod protects the mitochondria from superoxide anions that are 
produced during respiration and exposure to ethanol. This superoxide dismutase also 
has a role to counter the toxicity of superoxide anions generated exogenously during 
fermentative growth [60,70,77]. 
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Null mutants of superoxide dismutase (SOD) in Saccharomyces cerevisiae 
are
 
associated with a number of biochemical defects.  Sod1 and sod2 null mutants of 
S. cerevisiae provided information about the functions of these two enzymes. Thus, 
Sod2 seems to be essential for defense against O2
-
 generated at the mitochondrial 
respiratory chain. Mutants without Sod2 gene were hypersensitive to hyperoxia and 
unable to grow under respiratory conditions. Besides, it did not have an important 
effect of externally added oxidants. Mutants in SOD1 exhibited a variety of 
phenotypes including poor growth in respiratory conditions, loss of viability in 
stationary phase and hypersensitivity against externally-added oxidants (such as 
paraquat or menadione). In addition to being hypersensitive to oxygen toxicity, 
strains containing deletions in both SOD1 and SOD2 were defective in sporulation, 
associated with a high mutation rate, and were unable to biosynthesize lysine and 
methionine. It apparently also caused defects in pentose phosphate pathway 
[70,74,77]. 
Peroxidases 
Peroxidases have some differences in activity levels compared to SODs and 
catalases. SODs and catalases detoxify the ROS by the help of their redox properties 
of the metal group associated with the enzyme. However, peroxidases which reduce 
inorganic and organic peroxidases into the corresponding alcohols by using active 
site cysteine thiols work in a different way. Thus, activity of peroxidase depends on 
electron donor for thiols. GSH, an important antioxidant, can directly react with 
radicals and electrophiles. Therefore, it can act as a source of electrons for 
peroxidases [54,70]. 
Two different peroxidases exist which are glutathione peroxidase (GPXs) and TRX 
peroxidases (also known as peroxiredoxin) [70,76]. 
There are two types of GPX which are the classical one, soluble, multimeric and acts 
on inorganic and organic hydroperoxidases; and the other one, phospholipid peroxide 
GPXs (PHGPXs), which are monomeric and membrane associated. This phosholipid 
peroxide GPX class also reduces lipid hydroperoxides in membranes. Thus, it can be 
said that PHGPXs are important for repairing membrane lipid peroxidation. In other 
words, glutathione peroxidases activity can be both selenium dependent and 
independent.  There are three gene products which are GPX1, GPX2, and GPX3 with 
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36% homology significantly. In mammals, the greatest homology was found in 
active site [54,70,79]. 
Deletion of GPX1, GPX2 and GPX3 does not affect the growth of mutant yeast cells. 
They can grow just like the wild type at the same rate under stress conditions. 
Moreover, GPX3 also plays a major role in the oxidative stress in yeast. It was 
shown that the mutation resulted in sensitivity to hydrogen peroxide and tert-butyl 
hydroperoxides and the basal level of it was high compared to the expression of 
GPX1 and GPX2. Therefore, the different isoforms of glutathione peroxidase have 
distinct roles in the yeast cells while the identities of their intracellular targets remain 
unknown [54,87]. 
The other peroxidase type is peroxiredoxins (PRXs) which have received 
considerable attention in recent years as a new and expanding family of thiol-specific 
antioxidant proteins. Generally, these are found in yeast, plant and animal cells, 
including both protozoan and helminth parasites, and in some eubacteria and archaea. 
These peroxidases are also termed as the thioredoxin peroxidases and alkyl-
hydroperoxide-reductase-C22 proteins. PRXs reduce hydrogen peroxide, 
peroxynitrite and a wide range of organic hydroperoxides (ROOH) with TRXs acting 
usually as electron donors, although other reductants including GSH may be 
important in some cases for their activity. Moreover, they are located in the cytosol 
but sometimes also found in mitochondria, chloroplasts and peroxisomes, associated 
with nuclei and membranes [70,80]. 
All peroxiredoxins have a conserved motif, at least one cysteine motif at their active 
center. Many of them also form oligomers [81]. 
1.2.2.9 Regulation in response to oxidative stress condition 
Yeast cells give respond to oxidative stress conditions by upregulating the synthesis 
of a number of protective molecules such as components related with 
GSH/glutaredoxin and thioredoxin systems. Moreover, a number of stress response 
control mechanism have been implicated in these systems including YAP-1 and Skn7 
regulator molecules. Related stress conditions and control sites with genes are shown 
in Table 1.3 [54]. 
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Table 1.3: Regulation of stress response system in stress conditions [54] 
 
yAP-1, a leucine zipper transcription factor, is a very important element for 
regulation of the synthesis and reduction of GSH. The Yap1 protein was purified on 
the basis of its ability to bind to the same sequence as the mammalian Ap-1 (Jun/Fos) 
transcription factor in vitro and in vivo. GSH1, GSH2, and GLR1 have yAP-1 
transcription factor binding sites (ARE) and their expressions are changed with 
respect to ROS. Yap1-mediated regulatory pathways controlling the oxidative stress 
adaptive response are activated by redox sensory mechanisms which detect changes 
in the intracellular redox balance caused by ROS and oxidised thiols. These sensory 
mechanisms involve redox-sensitive cysteine residues that rapidly sense and 
transduce the stress signals to activate regulatory proteins. Such signal transduction 
frequently involves protein conformational changes triggered by the reversible 
formation of disulphide bonds. In addition to Yap1, several other regulatory proteins 
including transcription factors and protein tyrosine phosphatases are also regulated 
via such redox processes. Putative Yap1p-binding sites have been located in the 5‘ 
promoter sequence of a number of yeast genes encoding antioxidant activities. Thus, 
elevation of GSH levels response to oxidative stress can occur by increasing the 
oxidized and reduced forms of GSSG. The whole ARE elements are also increased in 
stress conditions. But the regulation of thioredoxin related genes is done by yAP-1 
and Skn7 transcriptional activators. The in co-operative action induces TRX2 and 
TRR1. Additionally, it can be concluded that GSH pathway and thioredoxin need 
yAP-1 transcription factor but their needs for Skn7 are different. In contrast, the 
expression of both GRX1 and GRX2 is activated by the high-osmolarity glycerol 
pathway (HOG) and negatively regulated by the Ras-protein kinase A pathway 
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(PKA) via stress responsive STRE elements. GRX1 contains one STRE element 
whereas GRX2 contains two. Thus, GRX1 is induced to significantly higher levels 
compared with GRX2 after the heat and osmotic stress [54,70,82,83].  
The role of yAP-1 transcription factor in the regulation of enzymes which protect 
against oxidants was discovered when yap1 mutants of S. cerevisiae were found to 
be hypersensitive to oxidants. Moreover, YAP-1 was found to be essential for drug 
and metal response, too. Also, studies with hydrogen peroxide showed that when the 
gene encoding Yap1p was deleted, S. cerevisiae was sensitive to hydrogen peroxide. 
Moreover, high copy number of this protein resulted in high levels of total 
glutathione [70,82,83]. 
Yap1 is induced by the oxidants by a mechanism which acts on subcellular protein 
localization, specifically by regulating its nuclear export. In non-stressed cells, Yap1 
localizes in the cytoplasm due of rapid nuclear export triggered by the nuclear export 
receptor Crm1. Diamide and hydroperoxides both inhibit Yap1 nuclear export by 
disrupting its interaction with Crm1, thus promoting Yap1 nuclear accumulation 
[83]. 
Sequence of whole yeast genome helps to the identification of open reading frames 
encoding additional bZip transcription factors (Yap3, YHL009c; Yap4 YOR028c; 
Yap5 YIR018w; Yap6 YDR259c; Yap7 YOL028c; Yap8 YPR199c). An analysis of 
the possible functions of these transcription factors has been performed. The 
resulting information (although by no means complete) suggested that all of these 
transcription factors have distinct physiological roles with considerable overlap 
between them, although they have different mechanisms on affecting the oxidative 
stress response mechanisms [70]. 
1.2.3 Metabolic and inverse metabolic engineering 
Cells are complex systems; genetic and regulatory changes can have drastic effects 
on the cells' ability to survive. The practice of optimizing genetic and regulatory 
processes within the cells to improve cellular activities by manipulation of 
enzymatic, transport, and regulatory functions of the cell with the use of recombinant 
DNA technology is the definition of metabolic engineering [44]. In essence, 
metabolic engineering is the application of engineering principles of design and 
analysis to the metabolic pathways in order to achieve a particular goal. Metabolic 
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engineering involves strain improvement by recruitment of heterologous genes and 
redirection of metabolite flow. Metabolic engineers commonly work to reduce 
cellular energy use, for example, the energetic cost of cell reproduction or 
proliferation and to reduce waste production. In order to improve the productivity of 
a desired metabolite of an organism, a wide series of manipulations and experimental 
approaches are applied in metabolic engineering field. This difficulty can be coped 
with new approaches including random, combinatorial approaches, such as 
evolutionary engineering which is an inverse metabolic engineering strategy 
[44,85,86]. 
The application of metabolic engineering strategies for strain development has also 
been successful. However, it is difficult and often inefficient to apply metabolic 
engineering to complex or unknown, not fully investigated cellular systems. The 
classical approach of metabolic engineering requires detailed knowledge of the 
enzyme kinetics, the system network, and intermediate pools involved, and on such 
bases, a genetic manipulation is proposed for some presumed benefits. The inverse 
metabolic engineering strategy is an alternative approach to overcome these 
problems of metabolic engineering. In contrast, inverse metabolic engineering 
approach firstly identifies the desired phenotype, secondly, determines 
environmental or genetic conditions that confer this phenotype, and as a last step, 
alters the phenotype of the selected host by genetic manipulation [44, 87]. 
1.2.4 An Inverse metabolic engineering approach: Evolutionary engineering 
Metabolic engineering of more complex cellular systems or cellular systems that are 
not fully understood remains a challenge. Thus, evolutionary approaches are 
becoming increasingly important for improving complex metabolic phenotypes. For 
those complex phenotypes, evolutionary engineering based on nature's 'engineering' 
principle by variation and selection help to improve and tailor various cellular 
properties towards obtaining a desired phenotype. By mimicking the idea of natural 
evolution, repetitive cycles of variation and selection of improved phenotypes helps 
to define the term of evolutionary engineering. This strategy is used to create a strain 
with specific and desired properties. In evolutionary engineering for strain 
development, three major steps are involved which are synthesis of an improved 
strain, analysis of the strains‘ performance under desired conditions, and designing of 
the next target for further optimization [86,88]. 
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Scientifically, evolutionary engineering can help to increase our knowledge in the 
field of metabolic networks and their regulation. Selected phenotypes are very likely 
to have altered network regulation, rebalanced fluxes, altered transport mechanisms 
and/or increased substrate availability. Different biological methods such as genome 
sequencing, transcriptional profiling, gene-trait mapping could be combined with 
modern tools for flux analysis. Additionaly, bioinformatics would help to analyze 
phenotypes selected under different conditions. With the help of this combinatorial 
approach, data will be provided about the underlying molecular mechanisms of 
metabolic networks [88, 89]. 
1.3 The Aim of the Research  
Ischemia reperfusion damage (IRD) is the most common cause of Acute Kidney 
Failure (AKF). Furthermore, ischemia-reperfusion and related damage is implicated 
in organ transplantation, cardiovascular disorders, and infarcts. However, the 
mechanism of ischemia reperfusion damage based on gene expression is not well 
characterized. Congruent with the multigenic concept of complex diseases, the 
promise of personalized medicine will depend on the detailed understanding of the 
genes and gene variants that contribute to disease susceptibility and progression. 
Because preconditioning has been demonstrated to ameliorate ischemia/reperfusion 
injury in several cells and tissues, we aimed to investigate the effects of ischemia-
reperfusion along with ischemic or heat preconditioning on global gene expression 
profile of rat kidney tissues, by using DNA microarray analysis. 
In the second part of the study, oxidative stress response along with preconditioning 
were studied in a simple eukaryotic model organism, Saccharomyces cerevisiae. 
Evolutionary engineering approach was applied to obtain yeast cells resistant to 
oxidative stress. After obtaining resistant mutant strains, cell survival was 
determined using most probable number-based (MPN) method. Evolutionary 
engineered mutants with increased resistances to oxidative stress could be useful in a 
variety of industrial applications involving yeast, such as baking, brewing, wine 
making and even bioremediation. Additionally, the effect of preconditioning was 
investigated on the oxidative stress resistance levels of the selected yeast mutants and 
different selection strategies were compared and discussed. 
 
  
38 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
39 
 
2. MATERIALS AND METHODS 
2.1 Materials, Equipments and Organisms 
2.1.1 Software and websites 
- Microarray Suite 5.0 (MAS5) Software (Affymetrix, California CA, USA) 
- Eisen Lab‘s Cluster 
- Eisen Lab‘s Treeview 
- Rat Genome Database (http://rgd.mcw.edu/) 
- UCSC Genome Browser (http://genome.ucsc.edu/) 
- GeneCards (http://www.genecards.org/)  
- Saccharomyces Genome Database (http://www.yeastgenome.org/) 
2.1.2 Rat model organism 
96 male, 30 week old - Wistar rats (Rattus norvegicus) were studied. The weights of 
the rats were between 220-358 g (Tektas, 2006) [90]. 
2.1.3 Yeast strain 
Saccharomyces cerevisiae CEN.PK113.7D was kindly provided by Dr. Peter Kötter 
(University of Frankfurt, Germany). Saccharomyces cerevisiae CEN.PK113.7D was 
named as ―905‖ and ethyl methane sulphonate (EMS) mutagenized Saccharomyces 
cerevisiae CEN.PK 113-7D cells were obtained by applying the EMS mutagenesis 
method called as ―906‖ (Lawrence et al., 1991). Then, mutant yeast cell populations 
were treated with continuous oxidative stress with different preconditioning by using 
hydrogen peroxide (H2O2). Throughout this study, wild-type S. cerevisiae and 
mutagenized individuals were investigated. 
2.1.4 Yeast culture media: Composition of yeast minimal medium (YMM) 
Yeast Nitrogen Base without amino acids  6.7 g 
Dextrose      20 g 
Agar (for solid media)    20 g 
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Per liter of distilled water. 
2.1.5 Chemicals, buffers and solutions 
Ethanol (absolute) (J.T.Baker (Holland)). 
Hydrogen peroxide (35%, v/v)  (Merck (Germany)) 
Phosphate Buffer (50mM pH 7.2) 
CoCl2 solution (1 M) (Merck (Germany)) 
Glycerol (Sigma) 
NaCl (Carlo Erba) 
2.1.6 Laboratory equipment 
Microfuge     Eppendorf Microcentrifuge (USA) 
Centrifuge      Allegra 25R Centrifuge Beckman 
UV-Visible Spectrophotometer                     Shimadzu UV-1601 (Japan)   
Micropipettes Eppendorf, 5000µl, 1000µl, 200µl, 
100µl, 20µl.  
Water Bath     Memmert wb-22 (Switzerland) 
Laminar Flow     Biolab Faster BH-EN 2003 
Autoclaves     Tuttnauer 2540 ml (Switzerland)  
Deep Freezers and refrigerators  80˚C Heto ultrafreeze 4410 (Denmark),  
 -20˚C, +4˚C Arçelik (Turkey) 
Vortex      NüveNM 110 (Turkey) 
Orbital Shaker incubators              Certomat S-2 (Germany) 
Thermomixer Compact   Eppendorf 
Microplate Reader    Biorad 
2.2 Methods 
Generally, in kidney-based microarray study, in silico analysis was performed, 
whereas in yeast based study, the experimental evolutionary engineering 
methodology was used to obtain oxidative stress resistant mutant yeast cells. 
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2.2.1 Microarray data analysis of rat kidney study 
2.2.1.1 Wistar rat model for ischemia-reperfusion applications with 
preconditioning 
96 male, 30 week old - Wistar rats (Rattus norvegicus) were studied. The weights of 
the rats were between 220-358 g. Different short and long ischemic periods, 0, 15 
and 60 min were combined (Table 1). Briefly, rats were anesthetized using Atorpin 
(0.05 – 0.1 mg/kg), ketamin (25 – 60 mg/kg) and rompun (2.5 mg/kg) via 
intraperitonoel injection. The experiments with 45 min ischemic time were combined 
with ischemic preconditioning and heat preconditioning. Preconditioning time was 
45 min for each condition. All experimental steps were performed under RNAse-free 
conditions. RNA was isolated using pegGold TM (PEQLAB Biotechnologie GMBH, 
Erlangen Germany). All experimental steps described so far have been performed 
previously [90]. 
Table 2.1: Nomenclature for differently treated samples for ischemia-reperfusion for 
varying time periods, and with or without preconditioning. 
Conditions Explanation for Sample Treatment 
I 45 / R 0 45 min ischemia 
I 45 / R 15 45 min ischemia followed by 15 min reperfusion 
I 45 / R 60 45 min ischemia followed by 60 min reperfusion 
  
IP I 45 / R 0 Ischemic preconditioning followed by 45 min ischemia 
IP I 45 / R 15 
Ischemic preconditioning followed by 45 min ischemia followed by 15 min 
reperfusion 
IP I 45 / R 60 
Ischemic preconditioning followed by 45 min ischemia followed by 15 min 
reperfusion 
  
HP I 45 / R 0 Heat preconditioning followed by 45 min ischemia 
HP I 45 / R 15 
Heat preconditioning followed by 45 min ischemia followed by 15 min 
reperfusion 
HP I 45 / R 60 
Heat preconditioning followed by 45 min ischemia followed by 60 min 
reperfusion 
 
2.2.1.2 Microarray experiments 
Microarray experiments were performed at the Institute for Cell Biology (University 
Klinik in Essen, under the supervision of Prof. Dr. Tarik Möröy und PD Dr. Ludger 
Klein-Hitpaß), as described previously [88]. Gene Chip Rat Chip Expression Set 230 
(Affymetrix, Paulo alto, CA, USA) was used. RNA quality and quantity was of 
isolated RNA assessed by agarose gel electrophoresis and Agilent® Nano 6000 
  
42 
Assay (Agilent, Santa Clara CA, USA). For each experimental group four samples 
with an absorbance ratio (OD260/OD280) over 1.7 were analyzed.  
Two of the samples of 15 µg were combined and each hybridization was represented 
with 30 µg total RNA. Hybridization was carried out according to Affymetrix 
Manuel gene expression monitoring GeneChip® Expression Analysis, Technical 
Manual (Affymetrix, Paulo Alto, CA, USA).  
2.2.1.3 Statistical data analysis 
Data analysis was performed with the Microarray Suite 5.0 (MAS5) Software 
(Affymetrix, California CA, USA).  Cut-off point was set as 2-fold differential 
regulation and genes above and below 2-fold differential regulation with present 
value higher than 300 were chosen for further analysis. 
Gene expression data; i) without preconditioning, ii) with ischemic-preconditioning 
and iii) with heat-preconditioning were formulated as log2 (experiment/control) ratio 
and combined on the same platform.  
Clustering was done using Cluster under K-means-10 setting. Results were 
visualized with Treeview. Gene abbreviations were organized and corrected using 
GeneCards. 
2.2.2 Obtaining oxidative stress resistant mutant yeast Cells 
2.2.2.1 Yeast culture, stock culture preparation and chemical mutagenesis 
Saccharomyces cerevisiae CEN.PK113.7D was used throughout the studies, kindly 
provided by Dr. Laurent Benbadis, INSA-Toulouse. The stock cultures were kept for 
long-term storage at -80°C. 500 μl culture was withdrawn from the culture tubes, 
added to sterile microfuge tubes and washed twice in YMM, using a microfuge at 
12000 rpm for 5 min. The supernatant was then discarded, the pellet was 
resuspended in 500μl YMM and 500μl, 60% (v/v) glycerol solution was added into 
this culture suspension to make the final glycerol concentration 30% (v/v). Finally, 
the stock culture tubes were placed at -80 °C deep freezer.  
Yeast cells were chemically mutagenized by using ethylmethane sulfonate (EMS), as 
described previously described by Lawrence in 1991. 
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2.2.2.2 Continuous oxidative stress with and without preconditioning 
In order to obtain oxidative stress resistant mutant S. cerevisiae, hydrogen peroxide 
was applied continuously in the culture medium. In continuous stress selection 
strategy, the cultures were exposed to hydrogen peroxide from the beginning of the 
inoculation to the end of the incubation. The incubation time was about 24 h. 
To investigate the effects of preconditioning on yeast similar to rat kidney, same 
preconditioning types were applied to yeast. Following preconditioning, continuous 
oxidative stress strategy was applied to yeast cells to obtain mutant yeast cells 
resistant to oxidative stress via evolutionary engineering. 
Thus, the following evolutionary engineering strategies with or without 
proconditioning similar to those applied to rat tissues, were used for obtaining 
oxidative stress resistant mutant yeasts: 
- Selection without preconditioning (OC Generations): Firstly, frozen stock 
culture of EMS-mutagenized wild type S. cerevisiae (906) was inoculated into 10 
ml YMM. Overnight incubation was performed at 30°C and 150 rpm. A 
centrifuge tube that contained only YMM was used as control and another one 
containing hydrogen peroxide was used for stress application. According to the 
optical density (OD600) of the preculture, same amount of cultures (to a final 
OD600 ~ 0,35) were transferred into new tubes. For control sample, centrifugation 
tube contained only YMM, whereas for stress sample, the centrifugation tubes 
contained YMM and hydrogen peroxide. The oxidative stress levels were 
determined according to continuous stress screening results. Stress levels were 
gradually increased in each generation. The growth of the cultures was controlled 
after 24 h incubation by measuring optical density of cultures at 600 nm and 
survival ratio of OC generation was calculated. Generations obtained without any 
preconditioning were labeled as “OC”. 
- Selection with Oxidative Preconditioning (OP Generations): Firstly, frozen 
stock culture of 906 was inoculated into 10 ml YMM. Overnight incubation was 
performed at 30°C and 150 rpm. A centifuge tube that contained only YMM was 
used as control and another one containing hydrogen peroxide was used for stress 
application. Before transferring the culture into the new tubes, stock culture that 
was inoculated in YMM overnight was incubated in 0.3 mM H2O2 for 1 h. To do 
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that, according to the optical density (OD600) of the preculture, same amount of 
cultures (OD600 ~ 0, 35) were transferred into microfuge tubes. Centrifugation 
was applied for 5 minutes at 14000rpm. The supernatant was then discarded and 
YMM without dextrose was added to the control sample and YMM without 
dextrose and 0.3 mM H2O2 were added to the stress sample. Both of them were 
then incubated at 30°C for an hour. Thereafter, they were transferred into the 
centrifugation tubes. Control sample was transferred into the centrifugation tube 
containing only YMM, while stress sample was transferred into the 
centrifugation tubes containing YMM and hydrogen peroxide.  Stress levels were 
gradually increased in each generation. The growth of the cultures was controlled 
after 24 h incubation by measuring optical density of cultures at 600 nm and 
survival ratio of OP generation was calculated. Generations obtained with 
oxidative stress preconditioning were labeled as “OP”.  
- Selection with Heat Preconditioning (HP Generations): Lastly, heat 
preconditioning followed by continuous oxidative stress condition was applied as 
another selection procedure to yeast cells. To do that, frozen stock culture of 906 
was inoculated into 10 ml YMM. Overnight incubation was performed at 30°C 
and 150 rpm. A tube that contained only YMM were labeled as control and 
another one with hydrogen peroxide was labeled for stress application. Before 
transferring the culture into the new tubes, stock culture that was inoculated in 
YMM overnight was incubated at 37°C for 1 h. To do that, according to the 
optical density (OD600) of the preculture, same amount of cultures (OD600 ~ 0, 
35) were transferred into microfuge tubes. Centrifugation was applied for 5 
minutes at 14000 rpm in a benchtop centrifuge. The supernatant was then 
discarded and YMM without dextrose was added to microfuge tubes. Microfuge 
tubes labeled as control were then incubated at 30°C for 1 h, whereas the stress 
samples were incubated at 37°C for an hour. They were then transferred into the 
centrifugation tubes. Control sample was transferred into the centrifugation tube 
containing only YMM, while stress sample was transferred into the 
centrifugation tubes containing YMM and hydrogen peroxide. Stress levels were 
gradually increased in each generation. The growth of the cultures was controlled 
after 24 h incubation by measuring optical density of cultures at 600 nm and 
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survival ratio of HP generation was calculated. Generations obtained with heat 
stress preconditioning were labeled as “HP”. 
For the continuous oxidative stress strategy, frozen stock culture of 906 was 
inoculated into 10 ml YMM. Overnight incubation was performed at 30°C and 150 
rpm. A centrifuge tube that contained only YMM was used as control and another 
one with hydrogen peroxide was used for stress application. According to the optical 
density (OD600) of the preculture, same amounts of cultures were transferred into 
these tubes, which contained only 10 ml YMM and H2O2 with YMM. The oxidative 
stress levels were determined according to continuous stress screening results. The 
incubation time was 24h. The continuous stress strategy with and without 
preconditioning is shown Figure 2.1. 
 
Figure 2.1: Flow charts of evolutionary selection and preconditioning strategies 
2.2.2.3 Screening of mutant populations under oxidative stress conditions 
Saccharomyces cerevisiae CEN.PK 113-7D (also named as 905) and EMS-
mutagenized wild-type (906) stock cultures were obtained from –80°C and 
inoculated to 10 ml YMM in 50 ml test tubes. They were incubated overnight at 
30°C and 150 rpm. Test tubes were taken and prepared for 905 and 906‘s H2O2 stress 
screening applications. The tubes were labeled according to stress levels that were 
applied both for 905 and 906. The stress levels were chosen as 0.1mM H2O2, 0.3mM 
H2O2, 0.5mM H2O2, 0.7mM H2O2, 1mM H2O2, 2mM H2O2, 3mM H2O2, 4mM H2O2, 
5mM H2O2, 7mM H2O2, 10mM H2O2 and 13mM H2O2 in liquid YMM cultures. All 
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tubes were mixed well and placed into the incubator at 30°C and 150 rpm. The 
growth of the cultures was controlled at 24, 48, and 72h of incubation by measuring 
optical density of cultures at 600 nm. 
The screening results (survival ratios) were used for the determination of the initial 
oxidative stress molarities for further experiments.  
2.2.2.4 Obtaining increasing stress generations 
The H2O2 concentrations to be applied in increasing stress level selections were 
decided according to the screening results. 906 was withdrawn from frozen stock and 
inoculated into 10 ml YMM in 50 ml test tubes. After overnight incubation at 30°C 
and 150 rpm, adjusting optical density to 0.35 the pre-culture were inoculated into 
two 50 ml test tubes which contain 10 ml YMM as a control and 0.5 mM H2O2 
containing 10 ml YMM. Test tubes were placed to the incubator under the same 
conditions. Incubation was finished after 24h to measure optical densities (OD600). 
The survival ratios were determined from these values. Three different generations 
were obtained.  
 OC generations were obtained through the continuous oxidative stress 
strategy. 
 OP generations were obtained through the oxidative preconditioning followed 
by the continuous oxidative stress strategy. 
 HP generations were obtained through the heat preconditioning followed by 
the continuous oxidative stress strategy. 
2.2.2.5 Selection of individual mutants 
After obtaining continuous stress generations, selection of individual mutants were 
performed. The last mutant population generations of OC, OP and HP were 
inoculated into Petri-plates. The cultures were incubated at 30°C for 48 h. The yeast 
colonies were then picked randomly from the plates and transferred into 10 ml 
YMM.  
Different H2O2 concentrations were applied to 905 and all the individuals which 
were obtained from continuous stress with and without preconditioning strategies, in 
order to select the most H2O2 resistant mutant individuals by using 5-tube MPN 
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methodology. To the cells which were allowed to grow overnight, the application 
was carried out as follows: 
 Twenty µl of the stressed cells were inoculated into the 5 parallel wells of the 
first row of microtiter plates containing 180 µl YMM.  
 After mixing the cells with yeast minimal medium inside the wells using a 
multipipette, 20µl of the cultures from the first row were transferred to the 
second row of the microtiter plates to make a ten-fold dilution. This was 
repeated until the eighth row of the microtiter plate. For control groups, 
dilution rate was started from 10
-4
, whereas in stress applied groups, dilution 
rate was started from 10
-1
. 
 The microtiter plates were incubated at 30˚C for 72 h and the survival ratios 
were determined. 
2.2.2.6 Determination of resistance to continuously applied oxidative stress 
Different hydrogen peroxide stress levels were also applied continuously to the 
mutant individuals by using 5-tube MPN methodology to determine their oxidative 
stress resistance. 1mM H2O2 and 2mM H2O2 concentrations were applied to wild 
type and all individuals which were obtained from continuous stress strategies with 
different preconditioning approaches. After 24, 48 and 72 h, the mutant individual‘s 
cell numbers per ml values were determined and their survival ratios were calculated.  
2.2.2.7 Determination of resistance to pulse oxidative stress 
Individuals that were selected from OC, OP and HP generations were also tested for 
their resistance to pulse oxidative stress. Here, the stress was applied as H2O2 pulses 
for 90 min only. Frozen stock aliquots of C2, C4, C7, C8, OC-20 Population, P3, P4, 
P5, P-20 Population, H1, H5, H6, H7, H8, H-20 Population and 905 wild type were 
inoculated into 10 ml YMM and incubated at 30°C, 150 rpm. After overnight 
incubation, spectrophotometric measurements were done and the samples were 
inoculated into 10 ml YMM. Inoculation was performed according to OD600 results 
of the preculture, the cells OD600 of initial culture upon inoculation result was 
adjusted to 0.25. When the OD600 values of the culture reached between 0.5-0.6, one 
ml of the culture was transferred into a 1.5 ml microfuge tube. For each individual, 
two tubes were prepared and one of them was used as control, the other one was used 
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for stress application. They were then exposed to oxidative stress, except for the 
control tubes.  Two conditions were applied as stress conditions which were 0.1M 
and 0.3M hydrogen peroxide. After 90 min stress exposure, the cells were washed 
twice with YMM without dextrose and inoculated into 96-well plate. After 24 h, 48 h 
and 72 h of incubation at 30°C, MPN test results were obtained. 
2.2.2.8 Screening of individual mutants under various stress conditions 
905 and all mutant individuals selected were screened by applying different stress 
types to determine their potential cross-resistances to corresponding stresses, using 5-
tube MPN methodology. 
Application of cobalt stress 
By using continuous stress application, different cobalt stress levels were applied to 
the mutant individuals and the wild-type by using 5-tube MPN methodology. CoCl2 
stress application was performed by applying 1 mM CoCl2 and 2 mM CoCl2 stress 
continuously. After 48 and 72 h of incubation at 30°C, viable cell numbers per ml 
were determined and the survival ratios were calculated. 
Application of ethanol stress 
Ethanol stress was applied again by using MPN methodology. Two stress levels 
which were 5 and 7% (v/v) ethanol were tested. After 72 h of incubation at 30°C, the 
survival ratios were calculated. 
Application of heat stress 
Heat stress conditions were defined as the incubation of the cells at 60°C for 10 min. 
For this stress condition, also 5-tube MPN methodology was applied. After 72 h of 
incubation at 30°C, the survival ratios were calculated. 
Application of osmotic stress 
Osmotic stress was also studied under continuous stress conditions, using 5-tube 
MPN method. For that stress condition, 5 and 7% (w/v) NaCl were applied as stress 
levels. After 72 h of incubation at 30°C, the survival ratios were calculated. 
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Application of freezing thawing stress 
One ml cell were suspended in 1.5 ml microfuge tubes. All samples were centrifuged 
at 14000 rpm for 5 min in a benchtop centrifuge. After centrifugation, supernatant 
was discarded and 1 ml dextrose-free yeast minimal medium was added into each 
microfuge tubes. After that, they were centrifuged and washed once with dextrose-
free yeast minimal medium. The ―stress‖ samples were immersed in liquid nitrogen 
for 25 min and controls were kept at room temperature. For thawing, all of the 
samples were place into the 30ºC water bath for 20 min. Finally, for each sample, 5-
tube MPN methodology was applied. After 72 h of incubation at 30°C, the survival 
ratios were calculated. 
2.2.2.9 Growth curve analysis of best individual obtained from different 
continuous oxidative stress conditions 
Four 2L-flasks, each containing 400 ml of YMM were prepared and sterilized. Wild 
type and H7 were cultivated with the initial OD600 value 0.2. Besides control 
samples, 2mM hydrogen peroxide was applied to wild type and H7 individual. Thus, 
four 2L-flasks were used for parallel cultivations of the wild type and H7 with and 
without oxidative stress. Sampling at 0
th
, 8
th
, 10
th
, 12
th
, 14
th
, 16
th
, 18
th
, 20
th
, 22
nd
, 24
th
, 
28
th
, 30
th
 and 32
nd
 hours of incubation was performed. Samples were used for 
spectrophotometric measurements, cell dry weight analysis and catalase activity 
measurements. 
Spectrophotometric analysis 
At each sampling time, from each flask, 500µl samples was withdrawn to measure 
OD600 for growth analysis. By using OD600 values, the growth curves of each culture 
were plotted. 
Dry weight analysis 
Two microfuge tubes were used for dry weight analysis of each culture sample and 
0.75 ml of cultures were transferred into those tubes, which were weighed and placed 
into 80
o
C oven for 24 h before. After centrifugation at 14000 rpm for 5 min in a 
Beckman Coulter Microfuge, supernatants were discarded. The tubes were dried at 
80
o
C oven for 48 h, their weights were measured and finally the dry weights of 
cultures per 1 ml of medium were calculated.  
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Catalase activity 
Spectrophotometric measurements were performed done for determining catalase 
activity. To do that, first of all, precultures of the cells were spun down in microfuge 
tubes. The pellets were washed twice with distilled water. The volume of water was 
the same as the culture volume. The pellets were then resuspended in 200-250 µl 
phosphate buffers (50 mM, pH 7.2). Glass beads (sterile) with 2 mm diameter were 
added to the microfuge tubes up to a final volume of 1 ml. The microfuge tubes were 
wrapped by using parafilm. After that, the tubes were vortexed for 1 min and placed 
to -80˚C for 1 min. This step was repeated 10 times. After this step, the cells extracts 
were taken by using a syringe, and transferred to new microfuge tubes and these 
tubes were centrifuged for 10 min at 12000 rpm (4˚C).  The supernatant was used for 
catalase activity measurements (or 1:10 dilution of the supernatant as necessary). 
During the last step, 680 µl phosphate buffer and 480 µl 40 mM H2O2 were also 
mixed and incubated at 30˚C for 2.5 min.  Lastly, 40 µl cell extracts were added to 
this mixture and the decrease in OD240 was measured by using quartz cuvettes. 
Samples that were withdrawn during the growth experiment were used for catalase 
activity determination 
Determination of the total soluble protein concentration  
For the determination of total soluble protein concentration, Bradford Assay was 
performed. The assay was performed at room temperature, using culture supernatants 
as samples. The measurement was accomplished at 595 nm by using a 96 well plate. 
For the assay, 0.125 mg/ml, 0.25 mg/ml, 0.5 mg/ml, 0.75 mg/ml, 1 mg/ml, 1.5 mg/ml 
and 2 mg/ml standard Bovine serum albumin (BSA) concentrations were used. 5 µl 
of BSA standards and samples were loaded in a 96 well plate. 200 µl of Bradford 
Reagent was added onto each well. After incubation at room temperature for 5 min, 
the absorbance values were measured at 595 nm by a Microplate Reader 3550-UV 
(Biorad). 
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3. RESULTS 
3.1 Microarray Data Analysis for Ischemia-Reperfusion with Preconditioning 
Background in Rat Kidney 
Microarray analysis was applied to RNA samples of rat tissues prepared as described 
in section 2.2.1. For each experimental group, four RNA samples with an absorbance 
ratio (OD260/OD280) over 1.7 were analyzed. Moreover, cut-off point was set as 2-
fold differential regulation and genes above and below 2-fold differential regulation 
with present value higher than 300 were chosen for further analysis. The statistical 
analysis for cut off were done on Excel platform. The results revealed 140 genes as 
related with the ischemia-reperfusion with preconditioning background in rat kidney. 
Thereafter, by using Cluster and Treeview softwares of Eisen Laboratory (Stanford 
University), genes were organized into four groups with respect to their response to 
ischemia and reperfusion as the following: 
i) Genes whose expression level is sensitive to ischemia /reperfusion and whose 
expression is reversible, 
ii) Genes, which are up-regulated constitutively,  
iii) Genes which are down-regulated constitutively, 
iv) A group of genes with a complex chaotic expression pattern 
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Figure 3.1: Global gene expression patterns as a function of ischemia and 
reperfusion. First group of genes were directly responsive to ischemia 
and reperfusion. Their expression was altered with respect to 
reperfusion time after initial ischemic response. The second group of 
genes was constitutively up-regulated as a response to ischemia. 
Reperfusion did not reverse their induction. The third group of genes 
was constitutively down-regulated upon ischemic treatment. Their 
expression was not altered upon reperfusion. The fourth group 
displayed an indirect, chaotic expression pattern, which could not be 
assigned to ischemia reperfusion periods directly. 
3.1.1 First group: Genes reversibly responsive to ischemia and reperfusion 
The largest group with 69 members comprising nearly half of the differentially 
regulated genes was the first group. These genes were sensitive to ischemia and 
reperfusion and their regulation was directly related to the conditions. Identification 
of functionally concordant genes in the same expression group, such as Ras1 and 
Rhob GTPases, Jun and Junb transcriptional factors has mapped conserved signal 
transduction pathways. Well-characterized Ras pathway and its transcriptional 
mediators, Jun-family transcription factors have been implicated in stress response 
and these all are found in the first group of the genes. 
Table 3.1: List of genes identified as reversibly responsive to ischemia and 
reperfusion 
Gene Name Description 
F3 coagulation factor 3 
Sqstm1 Sequestosome 1 
Arl4 ADP-ribosylation factor-like 4 
Gadd45a Growth arrest and DNA-damage-inducible 45 alpha 
  
53 
Table 3.1 (continued): List of genes identified as reversibly responsive to ischemia 
and reperfusion 
Ifrd1 interferon-related developmental regulator 1 
Cebpb CCAAT/enhancer binding protein (C/EBP), beta 
Adamts1 
A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin 
type 1 motif, 1 
Nfil3 Nuclear factor, interleukin 3 regulated 
Gadd45b_predicted Growth arrest and DNA-damage-inducible 45 beta (predicted) 
Snf1lk SNF1-like kinase 
Dusp1 Dual specificity phosphatase 1 
Dusp5 Dual specificity phosphatase 5 
Cxcl1 Chemokine (C-X-C motif) ligand 1 
Cxcl2 Chemokine (C-X-C motif) ligand 2 
Myd116 Myeloid differentiation primary response gene 116 
Rasd1 RAS, dexamethasone-induced 1 
Rhob rhoB gene 
Nr1d1 nuclear receptor subfamily 1, group D, member 1 
Gadd45g_predicted growth arrest and DNA-damage-inducible 45 gamma (predicted) 
Egr2 Early growth response 2 
Comt Catechol-O-methyltransferase 
Nr4a1 nuclear receptor subfamily 4, group A, member 1 
Gdf15 Growth differentiation factor 15 
Dusp6 Dual specificity phosphatase 6 
Egr1 early growth response 1 
Atf3 activating transcription factor 3 
Cyr61 cysteine rich protein 61 
Btg2 B-cell translocation gene 2, anti-proliferative 
Atf4 activating transcription factor 4 
Zfp36 zinc finger protein 36 
Tnfrsf12a tumor necrosis factor receptor superfamily, member 12a 
Rgs2 regulator of G-protein signaling 2 
Junb Jun-B oncogene 
Jun v-jun sarcoma virus 17 oncogene homolog (avian) 
Dusp4 dual specificity phosphatase 4 
Areg Amphiregulin 
Ier3 Immediate early response 3 
Per1 Period homolog 1 (Drosophila) 
Ddit4 DNA-damage-inducible transcript 4 
Nfkbia nuclear factor of kappa light chain gene enhancer in B-cells inhibitor, alpha 
RGD1307599_predicted 
similar to Mitogen-inducible gene 6 protein homolog (Mig-6) (Gene 33 
polypeptide) (predicted) 
Ctgf Connective tissue growth factor 
Mafb v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) 
Igfbp1 Insulin-like growth factor binding protein 1 
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Table 3.1 (continued): List of genes identified as reversibly responsive to ischemia 
and reperfusion 
Bhlhb3 Basic helix-loop-helix domain containing, class B3 
Cxcl10 Chemokine (C-X-C motif) ligand 10 
Cxcl9 Chemokine (C-X-C motif) ligand 9 
HO-1 Heme oxygenase 1 
Cd74 
CD74 antigen (invariant polpypeptide of major histocompatibility class II antigen-
associated) 
Cxcr4 Chemokine (C-X-C motif) receptor 4 
Psmb8 Proteosome (prosome, macropain) subunit, beta type 8 
Dtr diphtheria toxin receptor 
Psmb9 Proteosome (prosome, macropain) subunit, beta type 9 
Ubd ubiquitin D 
Irf1 interferon regulatory factor 1 
Ccnl1 cyclin L1 
Id1 Inhibitor of DNA binding 1, helix-loop-helix protein (splice variation) 
Nr4a3 nuclear receptor subfamily 4, group A, member 3 
Copeb / KLF6 core promoter element binding protein 
Ccl20 Chemokine (C-C motif) ligand 20 
Arhe Ras homolog gene family, member E 
Mx2 Myxovirus (influenza virus) resistance 2 
Grp58 Glucose regulated protein, 58 kDa 
Copeb core promoter element binding protein 
Hspa1a /// Hspa1b heat shock 70kD protein 1A /// heat shock 70kD protein 1B 
Klf4 Kruppel-like factor 4 (gut) 
Hspa1a Heat shock 70kD protein 1A 
Ddit3 DNA-damage inducible transcript 3 
 
Results were obtained from microarray experiments as flouroscent signal intensities. 
They were then processed using Eisen Lab‘s Treeview software for visualization. 
The first group of genes were those found to be sensitive to ischemia and 
reperfusion. There seemed to be a reversible mechanism connected with the 
reperfusion time. 
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Figure 3.2: Expression level changes in genes responsive to ischemia and 
reperfusion based on microarray analysis.  
(Green color indicates down-regulation and red color up-regulation in Figure 3.2.) 
3.1.2 Second group: Genes constitutively up-regulated upon ischemia 
The second group of genes were found to be up-regulated as a response to ischemia 
and they were not responsive to reperfusion, based on microarray analysis results. 
This group was constitutively induced as a response to ischemia and consists of 20 
genes. 
Table 3.2: List of constitutively up-regulated genes 
Gene Name Description 
Nef3 neurofilament 3, medium 
Bpgm 2,3-bisphosphoglycerate mutase 
Slc22a7 solute carrier family 22 (organic anion transporter), member 7 
Hmgcs2 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 
Aldh1a4 Aldehyde dehydrogenase family 1, subfamily A4 
Igh-1a_predicted immunoglobulin heavy chain 1a (serum IgG2a) (predicted) 
Alas2 aminolevulinic acid synthase 2 
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Table 3.2 (continued): List of constitutively up-regulated genes 
S100a8 S100 calcium binding protein A8 (calgranulin A) 
Npy neuropeptide Y 
Hbb hemoglobin beta 
Nritp ion transporter protein 
Cdc25b cell division cycle 25 homolog B 
c-maf v-maf musculoaponeurotic fibrosarcoma (avian) oncogene homolog (c-maf) 
S100a9 S100 calcium binding protein A9 (calgranulin B) 
IgG-2a Gamma-2a immunoglobulin heavy chain 
Hba-a1 hemoglobin alpha, adult chain 1 
Klf2 Kruppel-like factor 
Igha immunoglobulin heavy chain (alpha polypeptide) 
Snca Synuclein, alpha 
Csda cold shock domain protein A 
 
Results were obtained from microarray experiments as flouroscent signal intensities. 
They were then processed using Eisen Lab‘s Treeview software for visualization. 
The second group of genes were constitutively up regulated. 
 
Figure 3.3: Expression level changes in constitutively up-regulated genes based on 
microarray analysis.  
(Green color indicates down-regulation and red color up-regulation in Figure 3.3.) 
3.1.3 Third group: Genes constitutively down-regulated upon ischemia 
The third group of genes consisted of genes which were found to be repressed as a 
response to ischemic treatment. Their repression was not affected by reperfusion. 
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This group consisted of 29 genes. Interestingly, these two groups which consisted of 
up-regulated and down-regulated genes were also irresponsive to two conditions of 
pre-conditioning; heat-preconditioning and ischemic-preconditioning.  
Table 3.3: List of constitutively down-regulated genes 
Gene Name Description 
Cyp2c Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) 
Tagln Transgelin 
Fn1 fibronectin 1 
Aldr1 
Aldehyde reductase 1 (low Km aldose reductase) (5.8 kb PstI fragment, probably the 
functional gene) 
Cktsf1b1 Cysteine knot superfamily 1, BMP antagonist 1 
Alcam Activated leukocyte cell adhesion molecule 
Fxyd4 FXYD domain-containing ion transport regulator 4 
Jund Jun D proto-oncogene 
Aplp2 Amyloid beta (A4) precursor-like protein 2 
Timp3 tissue inhibitor of metalloproteinase 3 (Sorsby fundus dystrophy, pseudoinflammatory) 
Fkbp5_predicted FK506 binding protein 5 (predicted) 
Tpm1 Tropomyosin 1, alpha 
akr1b1 
Aldehyde reductase 1 (low Km aldose reductase) (5.8 kb PstI fragment, probably the 
functional gene) 
Ptn Pleiotrophin 
Slc14a2 solute carrier family 14 (urea transporter), member 2 
Slc25a25 solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 
Cpe carboxypeptidase E 
S100a6 S100 calcium binding protein A6 (calcyclin) 
Aqp4 Aquaporin 4 
Nupr1 Nuclear protein 1 
Pace4 Subtilisin - like endoprotease 
Fabp4 fatty acid binding protein 4, adipocyte 
RT1-S3 RT1 class Ib, locus S3 
Hmgcs1 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 
Thrsp Thyroid hormone responsive protein 
Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 
Usp2 Ubiquitin specific protease 2 
Acox2 acyl-Coenzyme A oxidase 2, branched chain 
Fasn fatty acid synthase 
 
  
58 
 
Figure 3.4: Expression level changes in constitutively down-regulated genes, based 
on microarray analysis. 
(Green color indicates down-regulation and red color up-regulation in Figure 3.4.) 
3.1.4 Fourth group: Genes with a complex expression pattern 
In the last group of genes, regulation was found to be complex. They showed up-
regulation or down-regulation patterns upon different preconditioning. Their 
regulation changed according to the reperfusion time and preconditioning. There was 
no exact pattern for this group that consisted of 22 genes. 
Table 3.4: List of genes with a complex expression pattern 
Gene Name Description 
Slfn3 Schlafen 3 
RGD:621546 tropomyosin 3, gamma 
Ccl2 chemokine (C-C motif) ligand 20 
Dbp D site albumin promoter binding protein 
RT1-Aw2 /// RT1- 
A2 /// RT1-A3 
RT1 class Ib, locus Aw2 /// RT1 class Ia, locus A2 /// RT1 class I, A3 
Pou3f1 POU domain, class 3, transcription factor 1 
Ephx2 epoxide hydrolase 2, cytoplasmic 
Trpv1 transient receptor potential cation channel, subfamily V, member 1 
Ca3 Carbonic anhydrase 3 
Hpgd 15-hydroxyprostaglandin dehydrogenase 
Kng1 /// 
MGC108747 
kininogen 1 /// similar to alpha-1 major acute phase protein prepeptide 
RODH II retinol dehydrogenase type II (RODH II) 
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Table 3.4 (continued): List of genes with a complex expression pattern 
Ptgds prostaglandin D2 synthase 
Slc16a1 solute carrier family 16 (monocarboxylic acid transporters), member 1 
Slc9a3r1 ERM-binding phosphoprotein 
Apoe apolipoprotein E 
Slc5a2 solute carrier family 5 (sodium/glucose cotransporter), member 2 
Dscr1 Down syndrome critical region homolog 1 (human) 
Adh1a alcohol dehydrogenase 1 
G6pc glucose-6-phosphatase, catalytic 
Slc7a7 solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 
Epb4.1l3 erythrocyte protein band 4.1-like 3 
Results wew again processed using Eisen Lab‘s Treeview software for visualization. 
The fourth group of genes that was defined as a complex chaotic group which had a 
different expression pattern. 
 
Figure 3.5: Expression level changes in the fourth gene group with complex chaotic 
expression patterns based on microarray analysis 
(Green color indicates down-regulation and red color indicates up-regulation in 
Figure 3.5) 
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3.2 Evolutionary Engineering of Oxidative Stress Resistant Mutant Yeast Cells 
3.2.1 Screening of the wild-type and the initial culture for determination of 
initial hydrogen peroxide stress levels 
The initial H2O2 stress levels for continuous stress selection were determined after 
applying the screening procedure. OD600 values of wild-type (905) culture and EMS-
mutagenized initial culture (906) under continuous stress conditions at 24 h of 
incubation at 30°C were obtained. After continuous stress screening, 0.5 mM H2O2 
concentration was determined as the starting stress level for the mutant yeast cells. 
Table 3.5: Screening results for 905 and 906 for different hydrogen peroxide 
concentrations after 24 hours 
Concentration 
OD600 
(905) 
OD600 
(906) 
Survival Ratio of Wild 
type (905) 
Survival Ratio of EMS-
Mutant  (906) 
0.1 mM H2O2 4.01 4.10 1.015 1.025 
0.3 mM H2O2 4.21 4.50 1.066 1.125 
0.5 mM H2O2 3.7 3.20 0.937 0.800 
0.7 mM H2O2 3.77 3.22 0.954 0.805 
1 mM H2O2 3.46 3.19 0.876 0.798 
2 mM H2O2 3.10 2.88 0.785 0.72 
3 mM H2O2 3.05 2.61 0.772 0.651 
4 mM H2O2 1.36 2.6 0.343 0.650 
5 mM H2O2 0.79 1.02 0.200 0.255 
7 mM H2O22 0.37 0.57 0.094 0.143 
10 mM H2O2 0.36 0.62 0.091 0.155 
13 mM H2O2 0.35 0.48 0.089 0.120 
Control 3.95 4.00 1.000 1.000 
 
Figure 3.6: Continuous oxidative stress screening results of 905 and 906 upon 
different H2O2 concentrations 
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3.2.2 Obtaining the generations with different continuous oxidative stress 
strategy and determination of oxidative stress resistance 
Three different continuous oxidative stress applications for obtaining oxidative stress 
resistant mutant yeast cells were applied. Initial concentration for continuous 
hydrogen peroxide condition was 0.5 mM H2O2 and the concentration was applied to 
OC, OP and HP generations. 
3.2.2.1 OC generations 
0.5 mM H2O2 was selected as the initial stress condition for obtaining OC 
generations. Increasing levels of continuous oxidative stress were applied to mutant 
yeast cells. The level of stress condition were increased at each generation by 0.5 
mM H2O2 up to 10mM H2O2 at generation 20. To that generation, 10 mM H2O2 was 
applied for 5 times, however, it could not survive in higher hydrogen peroxide 
concentrations. Thus, 24 generations were obtained. The survival results are shown 
in Table 3.6. 
Table 3.6: Survival ratios of OC generations (After 24 h) 
 
Generation Stress Concentration (mM) OD600 (Control) OD600 (Stress) Survival Ratio 
1 0.5 3.766 3.770 1.001 
2 1 3.165 3.755 1.186 
3 1.5 3.655 2.197 0.601 
4 2 5.540 3.750 0.677 
5 2.5 5.912 5.396 0.913 
6 3 4.725 4.046 0.856 
7 3.5 4.321 3.297 0.763 
8 4 4.120 3.075 0.746 
9 4.5 5.310 4.455 0.839 
10 5 4.320 3.012 0.697 
11 5.5 4.770 3.110 0.652 
12 6 4.540 3.760 0.828 
13 6.5 3.650 3.010 0.825 
14 7 3.450 2.560 0.742 
15 7.5 3.760 2.890 0.769 
16 8 4.870 3.594 0.738 
17 8.5 4.430 3.210 0.725 
18 9 4.050 1.905 0.470 
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Table 3.6 (continued): Survival ratio of OC generations (After 24 h) 
 
 
Figure 3.7: Survival ratios of OC Generations after 24 h 
3.2.2.2 OP generations 
For obtaining OP generations, the initial stress level was again chosen as 0.5 mM 
H2O2. The oxidative preconditioning was applied as 0.3 mM H2O2 for 1h for each 
generation. During selections, stress levels were increased at each step by 0.5 mM 
H2O2. The 21
st
 generation was the final population. To that generation, 10.5 mM 
H2O2 was applied. At higher concentrations of hydrogen peroxide, cells could not 
survive at all. The survival results are shown in Table 3.7. 
 
 
 
19 9.5 4.150 2.030 0.489 
20 10 6.040 1.580 0.262 
21 10 4.120 0.760 0.184 
22 10 4.430 0.780 0.176 
23 10 4.250 0.500 0.118 
24 10 4.200 0.542 0.129 
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Table 3.7: Survival ratios of OP generations (After 24 h) 
Generation Stress Concentration (mM) OD600 (Control) OD600 (Stress) Survival Ratio 
1 0.5 3.808 2.800 0.735 
2 1 2.990 2.630 0.880 
3 1.5 5.010 4.740 0.946 
4 2 4.915 5.120 1.042 
5 2.5 5.269 5.372 1.020 
6 3 5.130 5.250 1.023 
7 3.5 4.683 3.556 0.759 
8 4 4.725 3.890 0.823 
9 4.5 5.505 4.305 0.782 
10 5 5.212 3.887 0.746 
11 5.5 5.312 3.980 0.749 
12 6 4.980 3.870 0.777 
13 6.5 4.675 3.424 0.732 
14 7 5.220 3.300 0.632 
15 7.5 5.340 3.580 0.670 
16 8 4.670 3.250 0.696 
17 8.5 4.120 2.900 0.704 
18 9 3.405 1.940 0.570 
19 9.5 4.780 2.390 0.500 
20 10 4.260 0.920 0.216 
21 10.5 5.210 2.300 0.441 
 
 
Figure 3.8: Survival ratios of OP generations after 24 h 
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3.2.2.3 HP generations 
HP generation were also obtained like OP generations as described in Section 3.22.3. 
The only exception was the application of heat preconditioning instead of oxidative 
preconditioning during selections, for each generation. The stress levels were 
increased at each step by 0.5 mM H2O2. The 21
st
 generation was the final generation, 
which survived 11 mM H2O2. No survivors were observed at higher H2O2 
concentrations. The survival results are shown in Table 3.8. 
Table 3.8: Survival ratios of HP generations (After 24 h) 
Generation Stress Concentration (mM) OD600 (Control) 
OD600 
(Stress) 
Survival Ratio 
1 0.5 3.808 4.690 1.232 
2 1 3.258 3.954 1.214 
3 1.5 3.750 4.460 1.189 
4 2 5.100 4.980 0.976 
5 2.5 6.160 5.742 0.932 
6 3 5.625 6.270 1.115 
7 3.5 5.978 4.767 0.797 
8 4 5.890 5.720 0.971 
9 4.5 4.920 4.770 0.970 
10 5 5.361 4.515 0.842 
11 5.5 4.979 4.432 0.890 
12 6 5.100 4.880 0.957 
13 6.5 4.870 4.450 0.914 
14 7 5.820 5.500 0.945 
15 7.5 5.780 5.250 0.908 
16 8 4.870 3.940 0.809 
17 8.5 4.650 3.980 0.856 
18 9 4.305 2.907 0.675 
19 9.5 5.300 4.020 0.758 
20 10 5.756 2.180 0.379 
21 11 5.976 2.480 0.415 
 
  
65 
 
Figure 3.9: Survival ratios of HP generations after 24 h 
3.2.3 Selection of individual mutants from final mutant populations 
After obtaining OC, OP and HP generations, selection of individual mutants were 
performed. The last mutant populations of the three different oxidative stress 
selection strategies were inoculated into Petri-plates. The cultures were incubated at 
30°C for 48 h. The yeast colonies were then chosen randomly and transferred into 10 
ml YMM.  
One mM H2O2 and 2mM H2O2 concentrations were applied to wild type 905 and all 
individuals obtained from continuous stress strategies with different preconditioning 
features, to determine the most H2O2 resistant mutant individuals by using 5-tube 
MPN methodology. Individuals selected from the last OC population were labeled as 
C1, C2, C3, C4, C5, C6, C7, C8, C9, C10 and CP (as the last population). Individuals 
selected from the last OP population were labeled as P1, P2, P3, P4, P5, P6, P7, P8, 
P9, P10 and CP (as the last population). After 24, 48 and 72 hours of incubation, 
survivals were determined. 
3.2.3.1 Continuous oxidative stress eesistance of OC individuals 
Resistance characteristics of individual mutants of the last OC population were 
analyzed using five-tube MPN method and the resistant individuals were determined. 
Individuals were tested at continuously applied 1 mM and 2 mM H2O2 
concentrations. 
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Table 3.9: Survival ratios of OC mutant individuals at 1 mM H2O2 and 2 mM H2O2 
continuous stress levels (After 24 h) 
Individuals 
Number of 
cells/ml 
(Control) 
Number 
of 
cells/ml 
(1mM 
H2O2) 
Number 
of 
cells/ml 
(2mM 
H2O2) 
Survival 
Ratio 
(1mM 
H2O2) 
Survival 
Ratio  
(2mM 
H2O2) 
Survival 
Ratio as fold 
of wild type  
(1mM H2O2) 
Survival 
Ratio as fold 
of wild type  
(2mM H2O2) 
C1 22000000 54000 9200 0.002455 0.000418 26.393 254.545 
C2 35000000 160000 16000 0.004571 0.000457 49.155 278.261 
C3 11000000 54000 5400 0.004909 0.000491 52.786 298.814 
C4 9200000 160000 16000 0.017391 0.001739 187.003 1058.601 
C5 22000000 92000 16000 0.004182 0.000727 44.966 442.688 
C6 35000000 35000 16000 0.001000 0.000457 10.753 278.261 
C7 9200000 160000 9200 0.017391 0.001000 187.003 608.696 
C8 9200000 9200 16000 0.001000 0.001739 10.753 1058.601 
C9 92000000 160000 9200 0.001739 0.000100 18.700 60.870 
C10 22000000 9200 16000 0.000418 0.000727 4.497 442.688 
CP 22000000 92000 5400 0.004182 0.000245 44.966 149.407 
Wild Type 14000000 1300 23 0.000093 0.000002 1.000 1.000 
 
 
Figure 3.10: Survival ratios of OC mutant individuals upon continuous 1 mM H2O2 
and 2 mM H2O2 stress (After 24 h) 
At the end of 24h, there is no obvious growth except C4, C7 individuals upon 
continuous 1 mM H2O2 and 2 mM H2O2 stress. Therefore, the results of 48h and 72h 
were also checked.  
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Table 3.10: Survival ratios of OC mutant individuals at 1 mM H2O2 and 2 mM H2O2 
continuous stress levels (After 48 h) 
Individuals 
Number 
of cells/ml 
(Control) 
Number 
of 
cells/ml 
(1mM 
H2O2) 
Number 
of 
cells/ml 
(2mM 
H2O2) 
Survival 
Ratio 
(1mM 
H2O2) 
Survival 
Ratio  
(2mM H2O2) 
Survival 
Ratio as 
fold of wild 
type  
(1mM 
H2O2) 
Survival 
Ratio as 
fold of wild 
type  
(2mM 
H2O2) 
C1 22000000 920000 540000 0.041818 0.024545 2613.636 24545.455 
C2 11000000 920000 350000 0.083636 0.031818 5227.273 31818.182 
C3 11000000 920000 160000 0.083636 0.014545 5227.273 14545.455 
C4 11000000 3300000 350000 0.300000 0.031818 18750.000 31818.182 
C5 17000000 700000 160000 0.041176 0.009412 2573.529 9411.765 
C6 35000000 2200000 92000 0.062857 0.002629 3928.571 2628.571 
C7 9200000 92000 92000 0.010000 0.010000 625.000 10000.000 
C8 9200000 160000 170000 0.017391 0.018478 1086.957 18478.261 
C9 35000000 1100000 350000 0.031429 0.010000 1964.286 10000.000 
C10 26000000 1100000 92000 0.042308 0.003538 2644.231 3538.462 
CP 26000000 920000 350000 0.035385 0.013462 2211.538 13461.538 
Wild Type 180000000 2800 110 0.000016 0.000001 1.000 1.000 
 
 
Figure 3.11: Survival ratios of OC mutant individuals upon continuous 1 mM H2O2 
and 2 mM H2O2 stress (After 48 h) 
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Table 3.11: Survival ratios of OC mutant individuals at 1 mM H2O2 and 2 mM H2O2 
continuous stress levels (After 72 h) 
Individuals 
Number 
of cells/ml 
(Control) 
Number 
of 
cells/ml 
(1mM 
H2O2) 
Number 
of 
cells/ml 
(2mM 
H2O2) 
Survival 
Ratio 
(1mM 
H2O2) 
Survival 
Ratio  
(2mM 
H2O2) 
Survival 
Ratio as fold 
of wild type  
(1mM H2O2) 
Survival 
Ratio as fold 
of wild type  
(2mM H2O2) 
C1 28000000 1400000 920000 0.050000 0.032857 320.513 2738.095 
C2 7000000 1700000 350000 0.242857 0.050000 1556.777 4166.667 
C3 11000000 1400000 350000 0.127273 0.031818 815.851 2651.515 
C4 11000000 2400000 340000 0.218182 0.030909 1398.601 2575.758 
C5 170000000 1700000 7000000 0.010000 0.041176 64.103 3431.373 
C6 35000000 2400000 1600000 0.068571 0.045714 439.560 3809.524 
C7 92000000 7000000 1600000 0.076087 0.017391 487.737 1449.275 
C8 9200000 2400000 700000 0.260870 0.076087 1672.241 6340.580 
C9 35000000 1700000 540000 0.048571 0.015429 311.355 1285.714 
C10 26000000 2800000 160000 0.107692 0.006154 690.335 512.821 
CP 330000000 2400000 350000 0.007273 0.001061 46.620 88.384 
Wild type 18000000 2800 220 0.000156 0.000012 1.000 1.000 
  
 
Figure 3.12: Survival ratios of OC mutant individuals continuous upon 1 mM H2O2 
and 2 mM H2O2 stress (After 72 h) 
3.2.3.2 Continuous oxidative stress resistance of OP individuals 
Resistance characteristics of individual mutants of the last OP population were 
analyzed with five-tube MPN method and the resistant individuals were determined. 
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Individuals were tested at continuously applied 1 mM and 2 mM H2O2 
concentrations. 
Table 3.12: Survival ratios of OP mutant individuals at 1 mM H2O2 and 2 mM H2O2 
continuous stress levels (After 24 h) 
Individuals 
Number 
of cells/ml 
(Control) 
Number 
of 
cells/ml 
(1mM 
H2O2) 
Number 
of 
cells/ml 
(2mM 
H2O2) 
Survival 
Ratio 
(1mM 
H2O2) 
Survival 
Ratio  
(2mM 
H2O2) 
Survival 
Ratio as 
fold of 
wild type  
(1mM 
H2O2) 
Survival 
Ratio as 
fold of 
wild type  
(2mM 
H2O2) 
P1 22000000 17000 23 0.000773 0.000001 8.309 0.523 
P2 22000000 240 23 0.000011 0.000001 0.117 0.523 
P3 22000000 160000 9200 0.007273 0.000418 78.201 209.091 
P4 28000000 160000 16000 0.005714 0.000571 61.444 285.714 
P5 3500000 52000 1700 0.014857 0.000486 159.754 242.857 
P6 160000000 160000 1600 0.001000 0.000010 10.753 5.000 
P7 220000000 220000 540 0.001000 0.000002 10.753 1.227 
P8 92000000 160000 130 0.001739 0.000001 18.700 0.707 
P9 92000000 170000 540 0.001848 0.000006 19.869 2.935 
P10 220000000 220000 5400 0.001000 0.000025 10.753 12.273 
PP 35000000 22000 540 0.000629 0.000015 6.759 7.714 
Wild type 14000000 1300 23 0.000093 0.000002 1.000 1.000 
 
 
Figure 3.13: Survival ratios of OP mutant individuals upon continuous 1 mM H2O2 
and 2 mM H2O2 stress (After 24 h) 
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At the end of 24h, there is no obvious growth except P5 individual upon continuous 
1 mM H2O2. Therefore, the results of 48h and 72h were also checked.  
Table 3.13: Survival ratios of OP mutant individuals at 1 mM H2O2 and 2 mM H2O2 
continuous stress levels (After 48 h) 
Individuals 
Number 
of cells/ml 
(Control) 
Number 
of 
cells/ml 
(1mM 
H2O2) 
Number of 
cells/ml 
(2mM 
H2O2) 
Survival 
Ratio 
(1mM 
H2O2) 
Survival 
Ratio  
(2mM 
H2O2) 
Survival 
Ratio as 
fold of wild 
type  
(1mM 
H2O2) 
Survival 
Ratio as 
fold of wild 
type  
(2mM 
H2O2) 
P1 26000000 110000 92000 0.004231 0.003538 264.423 3538.462 
P2 17000000 24000 92000 0.001412 0.005412 88.235 5411.765 
P3 22000000 700000 1600000 0.031818 0.072727 1988.636 72727.273 
P4 35000000 24000000 5200000 0.685714 0.148571 42857.143 148571.429 
P5 26000000 170000 3500000 0.006538 0.134615 408.654 134615.385 
P6 35000000 1600000 24000 0.045714 0.000686 2857.143 685.714 
P7 920000000 3300000 160000 0.003587 0.000174 224.185 173.913 
P8 920000000 3500000 24000 0.003804 0.000026 237.772 26.087 
P9 920000000 5400000 2800000 0.005870 0.003043 366.848 3043.478 
P10 920000000 54000000 940000 0.058696 0.001022 3668.478 1021.739 
PP 35000000 1100000 920000 0.031429 0.026286 1964.286 26285.714 
Wild type 180000000 2800 110 0.000016 0.000001 1.000 1.000 
 
 
 
Figure 3.14: Survival ratios of OP mutant individuals upon continuous 1 mM H2O2 
and 2 mM H2O2 stress (After 48 h) 
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Table 3.14: Survival ratios of OP mutant individuals at 1 mM H2O2 and 2 mM H2O2 
continuous stress levels (After 72 h) 
Individuals 
Number 
of cells/ml 
(Control) 
Number 
of 
cells/ml 
(1mM 
H2O2) 
Number 
of 
cells/ml 
(2mM 
H2O2) 
Survival 
Ratio 
(1mM 
H2O2) 
Survival 
Ratio  
(2mM 
H2O2) 
Survival 
Ratio as 
fold of 
wild type  
(1mM 
H2O2) 
Survival 
Ratio as 
fold of 
wild type  
(2mM 
H2O2) 
P1 22000000 170000 92000 0.007727 0.004182 49.534 348.485 
P2 17000000 24000 92000 0.001412 0.005412 9.050 450.980 
P3 22000000 2800000 240000 0.127273 0.010909 815.851 909.091 
P4 35000000 28000000 5400000 0.800000 0.154286 5128.205 12857.143 
P5 17000000 3300000 1700000 0.194118 0.100000 1244.344 8333.333 
P6 350000000 1600000 240000 0.004571 0.000686 29.304 57.143 
P7 1.1E+10 33000000 2800000 0.003000 0.000255 19.231 21.212 
P8 92000000 3500000 24000 0.038043 0.000261 243.868 21.739 
P9 33000000 5400000 280000 0.163636 0.008485 1048.951 707.071 
P10 22000000 7000000 9200000 0.318182 0.418182 2039.627 34848.485 
PP 54000000 5400000 7000000 0.100000 0.129630 641.026 10802.469 
Wild type 18000000 2800 220 0.000156 0.000012 1.000 1.000 
 
 
Figure 3.15: Survival ratios of OP mutant individuals upon continuous 1 mM H2O2 
and 2 mM H2O2 stress (After 72 h) 
3.2.3.3 Continuous oxidative stress resistance of HP individuals 
Resistance characteristics of individual mutants of the last HP population were 
analyzed with five-tube MPN method and the resistant individuals were determined. 
Individuals were tested at continuously applied 1 mM and 2 mM mM H2O2 
concentrations. 
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Table 3.15: Survival ratios of HP mutant individuals at 1 mM H2O2 and 2 mM H2O2 
continuous stress levels (After 24 h) 
Individuals 
Number 
of cells/ml 
(Control) 
Number 
of 
cells/ml 
(1mM 
H2O2) 
Number 
of 
cells/ml 
(2mM 
H2O2) 
Survival 
Ratio 
(1mM 
H2O2) 
Survival 
Ratio  
(2mM 
H2O2) 
Survival 
Ratio as 
fold of 
wild type  
(1mM 
H2O2) 
Survival 
Ratio as 
fold of wild 
type  
(2mM 
H2O2) 
H1 54000000 5400000 3500 0.100000 0.000065 1075.269 32.407 
H2 54000000 5400000 1700 0.100000 0.000031 1075.269 15.741 
H3 17000000 920000 9200 0.054118 0.000541 581.910 270.588 
H4 22000000 1600000 9200 0.072727 0.000418 782.014 209.091 
H5 17000000 5400000 110000 0.317647 0.006471 3415.560 3235.294 
H6 35000000 3500000 54000 0.100000 0.001543 1075.269 771.429 
H7 17000000 1600000 16000 0.094118 0.000941 1012.018 470.588 
H8 35000000 5400000 160000 0.154286 0.004571 1658.986 2285.714 
H9 160000000 2800000 35000 0.017500 0.000219 188.172 109.375 
H10 22000000 1700000 17000 0.077273 0.000773 830.890 386.364 
HP 35000000 1700000 700 0.048571 0.000020 522.273 10.000 
Wild type 14000000 1300 23 0.000093 0.000002 1.000 1.000 
 
 
 
Figure 3.16: Survival ratios of HP mutant individuals upon continuous 1 mM H2O2 
and 2 mM H2O2 stress (After 24 h) 
HP individual survived at the end 24 h. Compared to OP, OC individual, the survival 
ratio of HP individuals were better at the end of 24h. 
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Table 3.16: Survival ratios of HP mutant individuals at 1 mM H2O2 and 2 mM H2O2 
continuous stress levels (After 48 h) 
Individuals 
Number 
of cells/ml 
(Control) 
Number 
of 
cells/ml 
(1mM 
H2O2) 
Number 
of 
cells/ml 
(2mM 
H2O2) 
Survival 
Ratio 
(1mM 
H2O2) 
Survival 
Ratio  
(2mM 
H2O2) 
Survival 
Ratio as 
fold of 
wild type  
(1mM 
H2O2) 
Survival 
Ratio as fold 
of wild type  
(2mM H2O2) 
H1 35000000 3500000 1700000 0.100000 0.048571 6250.000 48571.429 
H2 92000000 11000000 16000000 0.119565 0.173913 7472.826 173913.043 
H3 35000000 5400000 1700000 0.154286 0.048571 9642.857 48571.429 
H4 170000000 22000000 3500000 0.129412 0.020588 8088.235 20588.235 
H5 220000000 92000000 3500000 0.418182 0.015909 26136.364 15909.091 
H6 350000000 35000000 3500000 0.100000 0.010000 6250.000 10000.000 
H7 54000000 3500000 9200000 0.064815 0.170370 4050.926 170370.370 
H8 2200000 240000 540000 0.109091 0.245455 6818.182 245454.545 
H9 240000000 35000000 9200000 0.145833 0.038333 9114.583 38333.333 
H10 170000000 24000000 14000000 0.141176 0.082353 8823.529 82352.941 
HP 350000000 92000000 9200000 0.262857 0.026286 16428.571 26285.714 
Wild type 180000000 2800 110 0.000016 0.000001 1.000 1.000 
 
 
 
Figure 3.17: Survival ratios of HP mutant individuals upon continuous 1 mM H2O2 
and 2 mM H2O2 stress (After 48 h) 
 
 
  
74 
Table 3.17: Survival ratios of HP mutant individuals at 1 mM H2O2 and 2 mM H2O2 
continuous stress levels (After 72 h) 
Individuals 
Number 
of cells/ml 
(Control) 
Number 
of 
cells/ml 
(1mM 
H2O2) 
Number 
of 
cells/ml 
(2mM 
H2O2) 
Survival 
Ratio 
(1mM 
H2O2) 
Survival 
Ratio  
(2mM 
H2O2) 
Survival 
Ratio as 
fold of wild 
type  
(1mM 
H2O2) 
Survival 
Ratio as 
fold of wild 
type  
(2mM 
H2O2) 
H1 35000000 35000000 5400000 1.000000 0.154286 6410.256 12857.143 
H2 92000000 24000000 17000000 0.260870 0.184783 1672.241 15398.551 
H3 35000000 5400000 1700000 0.154286 0.048571 989.011 4047.619 
H4 170000000 22000000 3500000 0.129412 0.020588 829.563 1715.686 
H5 22000000 9200000 5400000 0.418182 0.245455 2680.653 20454.545 
H6 46000000 17000000 7000000 0.369565 0.152174 2369.008 12681.159 
H7 2300000 1600000 920000 0.695652 0.400000 4459.309 33333.333 
H8 22000000 2400000 9200000 0.109091 0.418182 699.301 34848.485 
H9 240000000 35000000 2400000 0.145833 0.010000 934.829 833.333 
H10 170000000 24000000 1700000 0.141176 0.010000 904.977 833.333 
HP 350000000 92000000 17000000 0.262857 0.048571 1684.982 4047.619 
Wild type 18000000 2800 220 0.000156 0.000012 1.000 1.000 
 
 
Figure 3.18: Survival ratios of HP mutant individuals upon continuous 1 mM H2O2 
and 2 mM H2O2 stress (After 72 h) 
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3.2.4 Pulse oxidative stress resistance of mutant individuals obtained from 
different continuous oxidative stress selection strategies 
3.2.4.1 OC individuals 
C2, C4, C7, C8, OC-20 Population and the wild type (905) were used for the pulse 
H2O2 stress tests. After 24, 48 and 72 h of incubation, the survivals were determined. 
At 24
th
 h of incubation, however, there was no growth in any of the individuals. 
Table 3.18: Survival ratios of OC mutant individuals upon 0.1M H2O2 and 0.3M 
H2O2 pulse stress application (After 48 h) 
Individuals 
Number 
of cells 
per ml 
(Control) 
Number 
of cells 
per ml 
(0.1M 
H2O2) 
Number 
of cells 
per ml 
(0.3M 
H2O2) 
Survival 
Ratio 
 (0.1 M H2O2) 
Survival 
Ratio 
 (0.3 M H2O2) 
C2 5400000 54000 17000 0.01000 0.00315 
C4 54000000 70000 3500 0.00130 0.00006 
C7 54000000 350000 92000 0.00648 0.00170 
C8 3500000 35000 22000 0.01000 0.00629 
OC-20 5400000 16000 16000 0.00296 0.00296 
Wild type 3500000 0 0 0.00000 0.00000 
 
 
Figure 3.19: Survival ratios of OC mutant individuals upon 0.1M H2O2 and 0.3M 
H2O2 pulse stress (After 48 h) 
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Table 3.19: Survival ratios of OC mutant individuals upon 0.1M H2O2 and 0.3M 
H2O2 pulse stress application (After 72 h) 
Individuals 
Number of 
cells per 
ml 
(Control) 
Number of 
cells per 
ml 
0.1M H2O2 
Number of 
cells per ml 
0.3M H2O2 
Survival Ratio  
(0.1 M H2O2) 
Survival Ratio 
 (0.3 M H2O2) 
C2 5400000 110000 17000 0.02037 0.00315 
C4 54000000 70000 7000 0.00130 0.00013 
C7 54000000 220000 92000 0.00407 0.00170 
C8 9200000 92000 54000 0.01000 0.00587 
OC-20 9200000 16000 16000 0.00174 0.00174 
Wild type 16000000 0 0 0 0 
 
 
Figure 3.20: Survival ratios of OC mutant individuals upon 0.1M H2O2 and 0.3M 
H2O2 pulse stress (After 72 h) 
3.2.4.2 OP individuals 
P3, P4, P5, and the P-20 Population were used for pulse H2O2 stress tests. After 24, 
48 and 72 h of incubation, the survivals were determined. At 24
th
 hour of incubation, 
there was no growth in any of the individuals. 
Table 3.20: Survival ratios of OP mutant individuals upon 0.1M H2O2 and 0.3M 
H2O2 pulse stress application (After 48 h) 
Individuals 
Number of 
cells per ml 
(Control) 
Number of 
cells per ml 
0.1M H2O2 
Number of 
cells per ml 
0.3M H2O2 
Survival Ratio  
(0.1 M H2O2) 
Survival Ratio  
(0.3 M H2O2) 
P3 9200000 1100000 160000 0.11957 0.01739 
P4 5400000 3500000 350000 0.64815 0.06481 
P5 92000000 920000 350000 0.01000 0.00380 
P-20 3500000 540000 35000 0.15429 0.01000 
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Figure 3.21: Survival ratios of OP mutant individuals upon 0.1M H2O2 and 0.3M 
H2O2 pulse stress (After 48 h) 
Table 3.21: Survival ratios of OP mutant individuals upon 0.1M H2O2 and 0.3M 
H2O2 pulse stress application (After 72 h) 
Individuals 
Number of 
cells per ml 
(Control) 
Number of 
cells per ml 
0.1M H2O2 
Number of 
cells per ml 
0.3M H2O2 
Survival Ratio 
 (0.1 M H2O2) 
Survival Ratio  
(0.3 M H2O2) 
P3 9200000 1100000 170000 0.11957 0.01848 
P4 5400000 3500000 460000 0.64815 0.08519 
P5 92000000 1100000 350000 0.01196 0.00380 
P-20 3500000 350000 92000 0.10000 0.02629 
 
 
Figure 3.22: Survival ratios of OP mutant individuals upon 0.1M H2O2 and 0.3M 
H2O2 pulse stress (After 72 h) 
 
 
 
  
78 
3.2.4.3 HP individuals 
H1, H5, H6, H7, H8 and the H-20 Population were used for the pulse H2O2 stress 
tests After 24, 48 and 72 h of incubation, the survivals were determined. Unlike OC 
and OP mutants, growth was observed in HP individuals and population already at 
24
th
 hour of incubation.  
Table 3.22: Survival ratios of HP mutant individuals upon 0.1M H2O2 and 0.3M 
H2O2 pulse stress application (After 24 h) 
Individuals 
Number of 
cells per 
ml 
(Control) 
Number of 
cells per 
ml 
0.1M H2O2 
Number of 
cells per 
ml 
0.3M H2O2 
Survival Ratio 
 (0.1 M H2O2) 
Survival Ratio 
 (0.3 M H2O2) 
H1 2800000 17000 16000 0.00607 0.00571 
H5 9200000 92000 22000 0.01000 0.00239 
H6 16000000 1600000 920000 0.10000 0.05750 
H7 9200000 920000 350000 0.10000 0.03804 
H8 16000000 350000 35000 0.02188 0.00219 
HP-20 1700000 24000 2400 0.01412 0.00141 
 
Figure 3.23: Survival ratios of HP mutant individuals upon 0.1M H2O2 and 0.3M 
H2O2 pulse stress (After 24 h) 
Table 3.23: Survival ratios of HP mutant individuals upon 0.1M H2O2 and 0.3M 
H2O2 pulse stress application (After 48 h) 
Individuals 
Number of 
cells per 
ml 
(Control) 
Number of 
cells per 
ml 
0.1M H2O2 
Number of 
cells per 
ml 
0.3M H2O2 
Survival Ratio 
 (0.1 M H2O2) 
Survival Ratio  
(0.3 M H2O2) 
H1 16000000 260000 920000 0.01625 0.05750 
H5 24000000 240000 260000 0.01000 0.01083 
H6 16000000 3500000 2200000 0.21875 0.13750 
H7 16000000 9200000 5400000 0.57500 0.33750 
H8 17000000 3500000 350000 0.20588 0.02059 
HP-20 2200000 160000 170000 0.07273 0.07727 
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Figure 3.24: Survival ratios of HP mutant individuals upon 0.1M H2O2 and 0.3M 
H2O2 pulse stress (After 48 h) 
Table 3.24: Survival ratios of HP mutant individuals upon 0.1M H2O2 and 0.3M 
H2O2 pulse stress application (After 72 h) 
Individuals 
Number of 
cells per 
ml 
(Control) 
Number of 
cells per 
ml 
0.1M H2O2 
Number of 
cells per 
ml 
0.3M H2O2 
Survival Ratio 
 (0.1 M H2O2) 
Survival 
Ratio  
(0.3 M H2O2) 
H1 16000000 260000 920000 0.01625 0.05750 
H5 24000000 170000 220000 0.00708 0.00917 
H6 16000000 9200000 4900000 0.57500 0.30625 
H7 9200000 9200000 5400000 1.00000 0.58696 
H8 17000000 16000000 3500000 0.94118 0.20588 
HP-20 2200000 540000 220000 0.24545 0.10000 
 
Figure 3.25: Survival ratios of HP mutant individuals upon 0.1M H2O2 and 0.3M 
H2O2 pulse stress application (After 72 h) 
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3.2.5 Cross-resistance tests of individual mutants to various stress conditions 
3.2.5.1 Cobalt stress 
The resistance to CoCl2 stress was tested in selected mutant individuals by applying 
1 mM CoCl2 stress continuously. After 48 and 72 h of incubation, the survivals were 
determined (Table 3.25 and 3.36, Figures 3.26 and 3.27).  
Table 3.25: Survival ratios of selected mutant individuals upon 1 mM CoCl2 stress 
after 48 h of incubation 
Individuals 
Number of 
cells per ml 
Control 
Number of 
cells per ml 
1mM CoCl2 
Survival Ratio 
(1mM CoCl2) 
Survival As Fold of Wild 
Type 
C2 54000000 31000 0.00057 8.201 
C4 24000000 24000 0.00100 14.286 
C7 17000000 2400 0.00014 2.017 
C8 35000000 1600 0.00005 0.653 
P3 54000000 24000 0.00044 6.349 
P4 17000000 24000 0.00141 20.168 
P5 16000000 24000 0.00150 21.429 
H1 9200000 24000 0.00261 37.267 
H5 14000000 24000 0.00171 24.490 
H6 14000000 16000 0.00114 16.327 
H7 16000000 24000 0.00150 21.429 
H8 11000000 24000 0.00218 31.169 
Wild Type 35000000 2400 0.00007 1.000 
 
 
Figure 3.26: Survival ratios of selected mutant individuals upon 1 mM CoCl2 stress 
(After 48 h) 
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Table 3.26: Survival ratios of selected mutant individuals upon 1 mM CoCl2 stress 
after 72h of incubation 
Individuals 
Number of 
cells per ml 
(Control) 
Number of 
cells per ml 
1mM CoCl2 
Survival Ratio 
(1mM CoCl2) 
Survival As Fold of 
Wild Type 
C2 54000000 350000 0.00648 20.908 
C4 24000000 350000 0.01458 47.043 
C7 17000000 24000 0.00141 4.554 
C8 35000000 35000 0.00100 3.226 
P3 54000000 540000 0.01000 32.258 
P4 26000000 540000 0.02077 66.998 
P5 16000000 540000 0.03375 108.871 
H1 9200000 240000 0.02609 84.151 
H5 14000000 460000 0.03286 105.991 
H6 14000000 920000 0.06571 211.982 
H7 16000000 920000 0.05750 185.484 
H8 60000000 1600000 0.02667 86.022 
Wild Type 160000000 49000 0.00031 1.000 
 
 
Figure 3.27: Survival ratios of selected mutant individuals upon 1 mM CoCl2 stress 
(After 72 h) 
3.2.5.2 Osmotic stress 
Selected individuals after the pulse oxidative stress and the wild type (905) were 
examined under 5% and 7% (w/v) NaCl (osmotic) continuous stress conditions. 
Survivals were determined using five-tube MPN method. Survival results based on 
72h of incubation are shown in Table 3.27 and Figure 3.28. 
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Table 3.27: Survival ratios of selected mutant individuals and the wild type under 
5% and 7% (w/v) continuous NaCl stress (After 72 h) 
Individuals 
Number 
of cells 
per ml 
(Control) 
Number 
of cells 
per ml 
(5% 
NaCl) 
Number 
of cells 
per ml 
(7% 
NaCl) 
Survival 
Ratio 
(5% 
NaCl) 
Survival 
Ratio 
(7% 
NaCl) 
Survival As 
Fold of 
Wild Type 
(5% NaCl) 
Survival 
As Fold of 
Wild Type 
(7% NaCl) 
C2 92000000 920000 240000 0.0100 0.0026 2.6316 10.0334 
C8 11000000 1600000 92000 0.1455 0.0084 38.2775 32.1678 
P3 9200000 2800000 24000 0.3043 0.0026 80.0915 10.0334 
P4 9200000 540000 240000 0.0587 0.0261 15.4462 100.3344 
H6 9200000 5400000 920000 0.5870 0.1000 154.4622 384.6154 
H7 3300000 350000 540000 0.1061 0.1636 27.9107 629.3706 
Wild Type 92000000 350000 24000 0.0038 0.0003 1.0000 1.0000 
 
 
Figure 3.28: Survival ratios of selecetd mutant individuals and the wild type upon 
5% and 7% (w/v) continuous NaCl stress (After 72 h) 
 
3.2.5.3 Ethanol stress 
Selected individuals after the pulse oxidative stress and the wild type 905 were 
examined under continuously applied 5% and 7% (v/v) ethanol stress conditions. 
Survival were determined by using five-tube MPN method. Survival results are 
shown in Table 3.28 and Figure 3.29. 
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Table 3.28: Survival ratios of selected mutant individuals and the wild type upon 5% 
and 7% (v/v) continuous ethanol stress (After 72 h) 
Individuals 
Number 
of cells 
per ml 
(Control) 
Number 
of cells 
per ml 
(5%(v/v) 
Ethanol) 
Number 
of cells 
per ml 
(7%(v/v)  
Ethanol) 
Survival 
Ratio 
(5%(v/v)  
Ethanol) 
Survival 
Ratio 
(7%(v/v)  
Ethanol) 
Survival As 
Fold of 
Wild Type  
(5%(v/v)  
Ethanol) 
Survival As 
Fold of Wild 
Type  
(7%(v/v)  
Ethanol) 
C2 92000000 5400000 3500000 0.05870 0.03804 0.338 6.674 
C8 11000000 3500000 1100000 0.31818 0.10000 1.830 17.544 
P3 9200000 3500000 2400000 0.38043 0.26087 2.188 45.767 
P4 9200000 5400000 2600000 0.58696 0.28261 3.375 49.580 
H6 9200000 5400000 3500000 0.58696 0.38043 3.375 66.743 
H7 3300000 2600000 2400000 0.78788 0.72727 4.530 127.592 
Wild Type 92000000 16000000 520000 0.17391 0.00565 1.000 1.000 
 
 
Figure 3.29: Survival ratios of selected mutant individuals and the wild type upon 
5% and 7% (v/v) continuous ethanol stress (After 72 h) 
 
3.2.5.4 Heat stress 
Selected individuals after the pulse oxidative stress and the wild type (905) were 
examined under pulse heat stress applied at 60°C for 10 min. Upon exposure to pulse 
heat stress, cells were inoculated into 96 well plates, and survivals were determined 
by five tube MPN method after 72 h of incubation at  30°C.  
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Table 3.29: Survival ratios of selected mutant individuals and the wild type upon 
pulse heat stress (60°C, 10 min) (After 72 h) 
Individuals 
Number of cells 
per ml 
(Control) 
Number of cells 
per ml (60°C) 
Survival 
Ratio at 
60°C 
Survival As Fold of Wild 
Type (at 60°C) 
C2 92000000 17000 0.00018 0.154 
C8 11000000 9200 0.00084 0.697 
P3 9200000 54000 0.00587 4.891 
P4 9200000 54000 0.00587 4.891 
H6 9200000 160000 0.01739 14.493 
H7 3300000 180000 0.05455 45.455 
Wild Type 92000000 110000 0.00120 1.000 
 
 
Figure 3.30: Survival ratios of selected mutant individuals and the wild type upon 
pulse heat stress (60°C, 10 min) (After 72 h) 
 
3.2.5.5 Freezing thawing 
Selected individuals after pulse oxidative stress and the wild type (905) were 
examined under -196°C and -20°C freeze thaw stress conditions. Cells were exposed 
to 1x freezing-thawing stress applied as a pulse and after 72 h of incubation at 30°C 
in MPN plates, survivals were determined. Survival based on five tube MPN analysis 
are shown in Tables 3.30 – 3.31 and Figures 3.31 – 3.32. 
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Table 3.30: Survival ratios of selected mutant individuals and the wild type upon 
freeze thaw stress at -196°(After 72h) 
Individuals 
Number of cells per 
ml (Control) 
Number of cells 
per ml (-196°C) 
Survival Ratio 
(-196°C) 
Survival As Fold 
of Wild Type (-
196°C) 
C2 92000000 350000 0.00380 0.645 
C8 11000000 170000 0.01545 2.619 
P3 9200000 54000 0.00587 0.995 
P4 9200000 240000 0.02609 4.422 
H6 9200000 1100000 0.11957 20.265 
H7 3300000 350000 0.10606 17.976 
Wild Type 92000000 540000 0.00587 1.000 
 
Figure 3.31: Survival ratios of selected mutant individuals and the wild type upon 
exposure to 1x freeze-thaw stress at -196°C (After 72 h) 
Table 3.31: Survival ratios of selected mutant individuals and the wild type upon 
freeze thaw stress at -20°C (After 72 h) 
Individuals 
Number of cells 
per ml (Control) 
Number of cells per 
ml 
(-20) 
Survival Ratio 
(-20C) 
Survival As 
Fold of Wild 
Type 
(-20C) 
C2 16000000 1100000 0.06875 0.314 
C8 3500000 920000 0.26286 1.202 
P3 3500000 920000 0.26286 1.202 
P4 5400000 3200000 0.59259 2.709 
H6 17000000 9200000 0.54118 2.474 
H7 7000000 3500000 0.50000 2.286 
Wild Type 16000000 2400000 0.15000 1.000 
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Figure 3.32: Survival ratios of selected mutant individuals and the wild type upon 
exposure to 1x freeze-thaw stress at -20°C (After 72 h) 
 
3.2.6 Growth curve analysis 
3.2.6.1 Spectrophotometric analysis of growth 
In this part of the study, growth physiology of the wild type and the mutant 
individual with the highest resistance, H7, was determined in the presence and 
absence of 2 mM H2O2 in the cultıre medium containing YMM. After sampling at 
0
th
, 3
th
, 6
th
, 12
th
, 15
th
, 18
th
, 24
th
, 27
th
, 30
th
 and 33
th
 hours of incubation, the measured 
OD600 values of wild type (905) and H7 are shown in Table 3.32 and Figure 3.33. 
Table 3.32: OD600 values of wild type (905) and H7 individual in the absence 
(control) and presence of 2mM H2O2 
Time (h) 
OD600 
(905-Control) 
OD600 
(905 - 2mM H2O2) 
OD600 
(H7 - Control) 
OD600 
(H7 - 2mM 
H2O2) 
0 0.20 0.20 0.20 0.20 
3 0.31 0.2 0.27 0.2 
6 0.5 0.21 0.54 0.21 
12 3.56 0.29 0.99 0.24 
15 5.40 0.65 1.70 0.70 
18 5.96 0.69 4.09 1.55 
24 5.93 1.03 6.31 4.80 
27 6.04 1.43 6.34 5.00 
30 5.56 1.60 6.56 5.18 
33 5.87 1.65 6.48 5.24 
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Figure 3.33: Growth curves of wild type and H7 individual in the absence and 
presence of 2mM H2O2 continuous stress condition, based on OD600 
measurements. 
 
3.2.6.2 Dry weight results of the wild type and H7 individual in the absence and 
presence of 2mM H2O2 continuous stress conditions 
The tubes were dried at 80°C oven for 48 h and the dry weight analysis was then 
performed. 
Table 3.33 Dry weight (cdw) results of the wild type and H7 individual grown in 
YMM in the absence and presence of  2mM H2O2. 
Time (h) 
Wild Type -
Control 
(mg/ml) 
Wild Type - 
2mM H2O2 
(mg/ml) 
H7 - Control 
(mg/ml) 
H7 - 2mM H2O2 
(mg/ml) 
0 1.25 1.05 1.15 0.8 
3 1.35 1.1 1.2 0.95 
6 1.4 1.1 1.4 1.05 
12 2.7 1.05 1.6 0.95 
15 3.3 1.4 1.9 1.5 
18 3.5 1.45 2.6 1.75 
24 3.4 1.55 3.7 3.55 
27 3.8 1.6 3.8 4.15 
30 4.1 1.65 4.2 4.1 
33 3.9 1.7 4.35 4.15 
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3.2.6.3 Catalase activity results of the wild type and H7 individual in the absence 
and presence of 2mM H2O2 continuous stress conditions 
Catalase activity was determined spectrophotometrically by measuring the decrease 
in OD240 per unit time. Bradford Assay was also performed to determine total soluble 
protein concetrations of samples and specific catalase activities were represented as 
∆A240/min/mg protein (Table 3.35 and Figure 3.34). 
Table 3.34 Total soluble protein concentrations mg/ml) of the wild type and H7 
individual in the absence and presence of 2mM H2O2 continuous stress 
conditions 
Table 3.35 Specific catalase activity (∆A240/min/mg protein) of the wild type and H7 
individual in the absence and presence of 2mM H2O2 continuous stress 
conditions 
Time (h) 905-Control 905 - 2mM H2O2 H7 - Control H7 - 2mM H2O2 
12 0.0352 0.0082 0.0433 0.0300 
18 0.0441 0.1410 0.3574 0.3828 
24 0.0571 0.1172 0.3767 0.3026 
27 0.0390 0.0621 0.3569 0.2958 
 
 
Figure 3.34 Specific catalase activty (∆A240/min/mg protein) of the wild type and H7 
individual in the absence and presence of 2mM H2O2 continuous stress 
conditions 
Time (h) 905-Control 905 - 2mM H2O2 H7 - Control H7 - 2mM H2O2 
12 0.105 1.091 0.867 1.393 
18 0.109 0.349 0.293 0.193 
24 0.065 0.366 0.675 0.469 
27 0.122 0.095 0.147 0.491 
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4. DISCUSSION & CONCLUSION 
4.1 Investigation of Preconditioning Effect on Ischemia-Reperfusion Conditions 
in Rat Kidneys via cDNA Microarray   
DNA microarray technology is crucial for molecular biology and has countless 
potential applications for basic and applied biological research. It allows analysis of 
the differential expression of hundreds to thousands of genes simultaneously. 
Moreover, high-density microarrays are also promising as clinical tools to measure 
gene expression profiles related with kidney transplantation, to test several 
hypotheses that will directly impact clinical practice. Thus, this technology also 
allowed us to identify gene clusters in experiments of ischemia and reperfusion 
coupled to ischemic- and heat-preconditioning, where 140 differentially expressed 
genes were mapped as genes related with ischemia-reperfusion with preconditioning 
background in rat kidney tissues. 
Our microarray results seem to imply two different regulation mechanisms: short 
term regulation and long term regulation. These are further classified as up-regulated, 
down-regulated, sensitive to ischemia-reperfusion and complex regulation. 
4.1.1 Short Term Regulation 
Upon microarray experiment, the data were clustered by using Clustering software of 
Eisen lab. By clustering 140 genes via K-Means-10 settings, 10 separate groups were 
obtained. More generally, however, 4 different groups were identified, which are 
sensitive to ischemia and reperfusion, up-regulated, down-regulated and complex-
chaotic gene expression group.  
In this experimental setup, an immediate early gene regulation was observed. 
Seventy genes of the 140 differentially regulated genes which constitute the first 
group changed their expression level as a response to ischemia. These genes 
exhibited differential regulation with respect to reperfusion in the 15 min and 60 min 
time intervals we have observed. One can expect to find immediate early genes in 
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this group mainly as initiators of the early response. The expression patterns of no-
preconditioning and heat-preconditioning were closer to each other, where 
reperfusion induced drastic changes in expression. Ischemic preconditioning mimics 
gene expression patterns of early reperfusion, ahead of time. First group of genes 
were directly responsive to ischemia and reperfusion. Their expression was altered 
with respect to reperfusion time after initial ischemic response. This is not surprising, 
because these genes are regulated as a combined response to ischemia and 
reperfusion. Among those are conserved stress pathway signal transducers (Ras, 
Rho) as well as conserved downstream mediators of stress response (Jun family 
transcription factors, Hsp1a and Hsp1b). The following are well characterized 
immediate early genes: Myc (Myelocytomatosis viral oncogene homolog (avian), 
ras1 (RAS1 dexometaxone-induced 1), Rhob (rhoB gene), Egr2 (Early growth 
response 2), Egr1 (Immediate Early response 1), Atf3 and Atf4 (Activating 
transcription factor 3 and 4), Junb (Jun-B oncogene) and Jun (v-jun sarcoma virus 17 
oncogene homolog (avian)), Ccln1 (CyclinL1) and lastly Arhe (Ras homolog gene 
family, member E).   
Proinflammatory genes Dusp1, Dusp6 and Egr1 were also within this expression 
response profile. These genes were repressed upon ischemia and induced following 
reperfusion. Moreover, well-characterized Ras pathway and its transcriptional 
mediators (Jun-family transcription factors) have been implicated in stress response 
[91]. 
Moreover, identified groups of genes as being differentially regulated as a function 
of reperfusion and ischemia and their further in silico characterization has shown that 
ischemic-preconditioning mimics early reperfusion. Apparently, ischemic-
preconditioning seems to serve as a protective mechanism for early ischemic 
damage. 
 
4.1.2 Long Term Regulation 
In this regulation type, three different patterns were observed, which are up-
regulated, down-regulated and complex chaotic gene expression pattern. They 
generally showed a response to ischemia, but they were not responsive to 
reperfusion. 
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In the ―constitutively up-regulated upon ischemia‖ group, genes were up-regulated as 
a response to ischemia and they were not responsive to reperfusion. The genes in this 
group were constitutively induced as a response to ischemia. No matter which 
preconditioning was applied to ischemia-reperfusion condition, over expression 
pattern was never changing. Within the one hour time interval of analysis, induction 
of these genes did not change and was not altered by reperfusion or with 
preconditioning background. Apparently, these groups of genes were directly 
induced as a response to ischemia. Among those genes are two hemoglobin genes: 
Hba-a1 (hemoglobin alpha, adult chain 1) and Hbb (hemoglobin beta). It is not 
surprising that the two building blocks of hemoglobin were constitutively induced 
beyond one hour following ischemia. Apparently, this is a direct long term response 
to ischemia, which possibly leads to hemoglobin synthesis for improved oxygen 
transfer after ischemia. Another gene regulating oxygen transfer mechanics, BPGM 
(2, 3-bisphosphoglycerate mutase) has been implicated in the treatment of ischemia 
[92]. This erythroid-expressed enzyme has been shown to ameliorate oxygen release 
from adult haemoglobin. The first and rate-limiting step of heme biosynthesis is 
catalyzed by ALA synthase (ALAS) [93]. These regulators of oxygen transfer were 
also up-regulated as a response to ischemia. Furthermore, their regulation was 
constitutive and apparently aiming to ameliorate long term oxygen release as a direct 
response to ischemia.  
Besides these, other genes in this group, such as Hmgcs2 (3-hydroxy-3-
methylglutaryl-Coenzyme A synthase 2), Npy (neuropeptide y), S100a8 (S100 
calcium binding protein A8) and S100a9 (S100 calcium binding protein A9) are 
important and critical determinant of organ transplantation success. They have redox 
related events, control on blood pressure, and have highly prognostic effect on acute 
rejections [94,95]. 
The third group of genes were those constitutively repressed as a response to 
ischemic treatment. Their repression was not affected by reperfusion. In this group, 
there were some important genes which are more important than the other such as 
Ptn, Fasn, Acox2, Aqp4, Fkbp5, Aldr1 and Cypc2. Pleiotrophin (PTN) is a heparin-
binding protein, which induces growth, angiogenesis, differentiation, and 
transformation of cells and helps to signal new blood vessel formation [96,97]. 
Besides, it is known that Aldr1 is known that its inhibition is related to the treatment 
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of retinal ischemic injury often observed in diabetic patients [99]. Thus, it is not 
surprising that this gene was down regulated as a response to ischemia. Moreover, 
Cyp2c (Cytochrome p450 2C) is a direct player of redox events and has been 
reported to play an important role in cardiovascular physiology. It also contributes to 
the pathogenesis of various cardiovascular diseases, especially ischemia and 
reperfusion injury [98]. 
The last gene group displayed an indirect, chaotic gene expression pattern, which 
could not be assigned to ischemia reperfusion periods directly. Thus, the results in 
this group should be discussed carefully. In this group, gene expression changed 
according to reperfusion time and preconditioning. However, based on the type of  
preconditioning, different patterns of up-regulation or down-regulation were 
observed. Moreover, at the end of reperfusion time, expression levels of genes were 
generally increased in the former groups. For this group, no such conclusion could be 
made. 
4.2 Evolutionary Engineering of Oxidative Stress Resistant S. cerevisiae and 
Effects of Oxidative and Heat Preconditioning during Selection on General 
Stress Resistance 
In this part of the study, mutant yeast cells resistant to oxidative stress were selected 
by evolutionary engineering approach. Additionally, the effects of oxidative and heat 
preconditioning during selection on oxidative stress resistance of the mutant yeasts 
was studied. The aim was to study and compare the oxidative stress response in two 
different eukaryotic model organisms. During selection in the presence of continuous 
hydrogen peroxide stress, also heat and pulse oxidative stress preconditioning were 
applied to yeast cells. Thus, three different evolutionary engineered mutant yeast 
generations which were named as OC (oxidative continuous selection without any 
preconditioning), OP (pulse oxidative preconditioning) and HP (heat stress 
preconditioning) were obtained. Preconditioning is important for early adaptive 
response. Early adaptive response provides almost immediate protection against 
sublethal stress conditions by activating preexisting defenses, while late adaptive 
response provides a more efficient protection against a severe stress and also allows 
cells to return non-stress conditions [53]. The stress resistance analyses of the 
mutants revealed that oxidative stress selection with heat preconditioning seems to be 
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more effective than the other selection conditions. Final HP generation could resist 
up to 11 mM H2O2 while OC and OP could resist up to only 10 mM H2O2 and 10.5 
mM H2O2, respectively. The observed positive effect of heat preconditioning could 
be explained by the effects on cell wall proteins: the gene SED1 encodes a protein 
called Sed1p which is very rich in threonine and serine, and like other structural cell 
wall proteins, contains a putative signal sequence for the addition of a 
glycosylphosphatidylinositol anchor. Interestingly, SED1 is also strongly up-
regulated under different stress conditions such as cell wall stress, heat stress, 
oxidative stress and hyperosmotic stress, suggesting that Sed1p has a general stress-
protective function [100,101]. Additionally, successive application of heat and 
oxidative stress in our selection strategy might have increased the expression level of 
SED1 and provided higher resistance to oxidative stress. 
The analysis of the stress resistance results of individual mutants selected from 
different strategies could be summerized as follows: C2, C8, P3, P4, H6 and H7 had 
higher resistance. They were thus selected for cross resistance tests. Osmotic, 
ethanol, heat, freeze-thaw (both at -196°C and -20°C) stresses were applied to these 
individuals along with the wild-type. Interestingly, under each stress condition tested, 
individuals obtained from continuous oxidative stress with heat preconditioning 
generally had more resistance compared to the other individuals and the wild-type.  
Under cobalt cross resistance, it was observed that also oxidative preconditioning 
along with heat preconditioning seems to have provided advantage to yeast cells. The 
same observation was also made for osmotic stress that was applied in the presence 
of NaCl. Under ethanol stress conditions, there was no pronounced effect of 
preconditioning, except from the H7 individual, selected from heat preconditioning. 
However, in the presence of heat stress, the highest resistance levels were observed 
in heat preconditioning individuals, as expected, H7 individual being the most  
resistant one. It is known that heat stress can induce some genes which are also 
involved in the protection of cells against oxidative stress and that oxygen is linked 
with heat induced death of yeast cells [102,103]. Moreover, the freeze-thaw cross 
resistance results also revealed that H7 was the most resistant individual also under 
that stress condition. 
Upon identification of H7 as the mutant individual with the highest resistance, its 
growth physiology was investigated along with that of the wild-type, in the presence 
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and absence of 2mM hydrogen peroxide in YMM medium. Catalase activities of the 
cultures were determined. Interestingly, the H7 individual was found to have 
significantly higher specific catalase activity than the wild type, both in the presence 
and absebce of oxidative stress conditions. Apparently, the mutant may be 
eliminating the detrimental effects of hydrogen peroxide by high catalase activity.  
In conclusion, the results of this part of the study show that preconditioning, 
especially heat preconditioning has an importance for obtaining S. cerevisiae mutants 
highly resistant to oxidative stress. Additionally, there seems to be a correlation 
between oxidative stress and freeze thawing stress in heat preconditioning 
individuals. Detailed proteomic and transcriptomic analysis are necessary to 
understand these mechanisms. 
4.3. General Conclusion 
The results revealed by the two parts of this study, based on two different eukaryotic 
model organisms rat and yeast, clearly indicated that oxidative stress response has a 
very complex genetic mechanism and can vary significantly among different 
organisms.  Preconditioning definitely has important effects on gene expression and 
stress protection. However, in different organisms, the type of preconditioning to be 
applied may also be different, depending on the physiology of the organism. To 
summarize, the short-term and long-term effects of preconditioning on stress 
resistance and gene expression has to be investigated in more detail, using different 
model organisms. This would possibly provide us with more comprehensive 
information on stress response mechanism.  
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APPENDIX A: List of Genes Identified as Reversibly Responsive to Ischemia and  
Reperfusion 
Gene Name 25_IP_I45_R0_A_vs_ShamA_Signal 
Log Ratio 
25_IP_I45_R0_A_vs_ShamB_Signal 
Log Ratio 
F3 0.45 0.64 
Sqstm1 0 0.2 
Arl4 0.57 0.5 
Gadd45a 0.37 0.32 
Myc 1.54 1.37 
Ifrd1 -0.06 -0.11 
Cebpb 0.92 0.71 
Adamts1 -0.29 0.05 
Nfil3 -0.28 0.18 
Gadd45b_predicted 1.58 1.12 
Snf1lk 0.14 0.1 
Dusp1 1.35 1.21 
Dusp5 1.67 1.78 
Cxcl1 1.52 1.21 
Cxcl2 1.3 1.29 
Myd116 1.06 0.77 
Rasd1 1.22 1.33 
Rhob 1.01 0.61 
Nr1d1 1.43 1.29 
Gadd45g_predicted 1.1 1.28 
Egr2 1.2 1.17 
Comt 0.68 1.16 
Nr4a1 1.56 1.3 
Gdf15 2.8 2.16 
Dusp6 0.47 0.31 
Egr1 1.45 1.37 
Atf3 2.9 2.1 
Cyr61 1.8 1.05 
Btg2 1.75 1.46 
Atf4 0.69 0.42 
Zfp36 1.33 1.43 
Tnfrsf12a 0.43 0.33 
Rgs2 0.52 0.91 
Junb 2.23 2.15 
Jun 1.46 1.28 
Dusp4 0.28 1.06 
Areg 0.66 0.83 
Ier3 0.24 0.15 
Per1 0.57 0.34 
Ddit4 0.22 0.35 
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Nfkbia 0.2 0.05 
RGD1307599_predicted -0.05 0.19 
Ctgf 0.66 0.27 
Mafb 0.52 1.01 
Igfbp1 0.81 0.93 
Bhlhb3 1.25 0.88 
Cxcl10 0.99 0.67 
Cxcl9 0.5 0.86 
HO-1 0.77 0.8 
Cd74 0.78 1.12 
Cxcr4 1.26 1.03 
Psmb8 0.84 0.81 
Dtr 1.5 0.57 
Psmb9 1.15 0.95 
Ubd 0.83 1.05 
Irf1 0.85 0.77 
Ccnl1 -0.58 -0.7 
Id1 0.51 0.23 
Nr4a3 0.27 -0.22 
Copeb / KLF6 1.17 0.58 
Ccl20 0.08 -0.03 
Arhe -0.37 -0.1 
Mx2 0.14 0.14 
Grp58 -0.61 -0.38 
Copeb 1.17 0.58 
Hspa1a /// Hspa1b 1 -0.07 
Klf4 0.56 0.45 
Hspa1a 0.66 -0.03 
Ddit3 0.43 0.25 
 
 
Gene Name 26_IP_I45_R0_B_vs_ShamA_Signal 
Log Ratio 
26_IP_I45_R0_B_vs_ShamB_Signal 
Log Ratio 
F3 0.81 1 
Sqstm1 0.18 0.47 
Arl4 0.49 0.47 
Gadd45a 0.65 0.68 
Myc 1.5 1.38 
Ifrd1 0.88 0.79 
Cebpb 0.79 0.57 
Adamts1 0.58 0.93 
Nfil3 0.82 1.25 
Gadd45b_predicted 1.5 1.02 
Snf1lk 0.61 0.59 
Dusp1 1.06 1.19 
Dusp5 1.65 1.71 
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Cxcl1 1.7 1.46 
Cxcl2 1.49 1.53 
Myd116 0.98 0.54 
Rasd1 1.25 1.18 
Rhob 0.87 0.57 
Nr1d1 0.88 0.7 
Gadd45g_predicted 1.01 1.22 
Egr2 1.02 1.13 
Comt -0.01 0.53 
Nr4a1 1.32 1.14 
Gdf15 2.35 1.69 
Dusp6 0.71 0.45 
Egr1 1.23 1.14 
Atf3 3.07 2.31 
Cyr61 1.48 0.75 
Btg2 1.53 1.36 
Atf4 0.78 0.46 
Zfp36 1.04 0.99 
Tnfrsf12a 0.95 0.83 
Rgs2 1.02 1.05 
Junb 1.8 1.73 
Jun 1.38 1.11 
Dusp4 0.46 1.08 
Areg -0.23 -0.15 
Ier3 0.15 0.02 
Per1 0.6 0.32 
Ddit4 -0.35 -0.12 
Nfkbia 0.1 -0.01 
RGD1307599_predicted -0.07 0.24 
Ctgf 0.42 0.13 
Mafb 0.46 0.83 
Igfbp1 0.73 0.9 
Bhlhb3 0.7 0.36 
Cxcl10 0.83 0.68 
Cxcl9 0.27 0.67 
HO-1 1.04 0.89 
Cd74 0.56 1.08 
Cxcr4 1.18 1.01 
Psmb8 0.77 0.78 
Dtr 1.83 1.07 
Psmb9 0.76 0.64 
Ubd -0.03 0.22 
Irf1 0.8 0.6 
Ccnl1 0.24 0.13 
Id1 0.1 -0.08 
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Nr4a3 0.6 0.39 
Copeb / KLF6 1.53 0.88 
Ccl20 0.71 0.64 
Arhe 0.13 0.03 
Mx2 -0.15 0.24 
Grp58 -0.24 -0.05 
Copeb 1.53 0.88 
Hspa1a /// Hspa1b 1.77 0.61 
Klf4 0.59 0.53 
Hspa1a 0.93 0.12 
Ddit3 0.32 0.26 
 
Gene Name 27_IP_I45_R15_A_vs_ShamA_Signal 
Log Ratio 
27_IP_I45_R15_A_vs_ShamB_Signal 
Log Ratio 
F3 1.35 1.39 
Sqstm1 0.27 0.71 
Arl4 0.23 0.08 
Gadd45a 0.82 0.69 
Myc 1.26 1.07 
Ifrd1 1.08 0.94 
Cebpb 0.67 0.4 
Adamts1 0.35 0.76 
Nfil3 0.99 1.26 
Gadd45b_predicted 1.47 1.01 
Snf1lk 0.45 0.61 
Dusp1 1.56 1.44 
Dusp5 1.11 1.18 
Cxcl1 0.59 0.45 
Cxcl2 0.51 0.75 
Myd116 1.06 0.77 
Rasd1 1.38 1.36 
Rhob 0.88 0.46 
Nr1d1 0.39 0.44 
Gadd45g_predicted 0.51 0.85 
Egr2 1.1 0.98 
Comt 0.07 0.53 
Nr4a1 1.39 1.14 
Gdf15 0.91 0.29 
Dusp6 0.43 0.26 
Egr1 1.04 0.92 
Atf3 3.23 2.45 
Cyr61 1.75 1.11 
Btg2 1.72 1.34 
Atf4 0.63 0.35 
Zfp36 0.91 0.97 
Tnfrsf12a 0.61 0.51 
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Rgs2 1.19 1.06 
Junb 1.45 1.48 
Jun 1.4 1.21 
Dusp4 0.36 0.95 
Areg -0.54 -0.31 
Ier3 -0.32 -0.41 
Per1 0.48 0.2 
Ddit4 -0.54 -0.3 
Nfkbia 0.14 -0.06 
RGD1307599_predicted -0.05 0.1 
Ctgf 0.28 -0.03 
Mafb 0.66 1.05 
Igfbp1 0.94 1.05 
Bhlhb3 0.55 0.27 
Cxcl10 1.25 0.98 
Cxcl9 0.91 0.92 
HO-1 0.94 0.78 
Cd74 0.96 1.43 
Cxcr4 1.41 1 
Psmb8 1.12 1.14 
Dtr 2.49 1.49 
Psmb9 1.34 1.39 
Ubd 1.13 1.38 
Irf1 1.49 1.4 
Ccnl1 0.9 0.63 
Id1 0.2 -0.07 
Nr4a3 1.13 0.82 
Copeb / KLF6 1.48 1.02 
Ccl20 0.44 0.36 
Arhe 0.48 0.43 
Mx2 0.35 0.66 
Grp58 0.02 0.2 
Copeb 1.48 1.02 
Hspa1a /// Hspa1b 1.54 0.39 
Klf4 0.42 0.35 
Hspa1a 1 0.28 
Ddit3 0.51 0.34 
 
 
Gene Name 28_IP_I45_R15_B_vs_ShamA_Signal 
Log Ratio 
28_IP_I45_R15_B_vs_ShamB_Signal 
Log Ratio 
F3 0.31 0.45 
Sqstm1 0.01 0.28 
Arl4 0.37 0.34 
Gadd45a 0.19 0.28 
Myc 0.99 0.75 
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Ifrd1 0.16 0.05 
Cebpb 0.75 0.51 
Adamts1 -0.01 0.3 
Nfil3 0.43 0.74 
Gadd45b_predicted 1.44 1.07 
Snf1lk -0.28 -0.23 
Dusp1 1.2 1.1 
Dusp5 1.35 1.41 
Cxcl1 1.48 1.42 
Cxcl2 0.91 1.01 
Myd116 0.97 0.71 
Rasd1 1.23 1.16 
Rhob 0.83 0.43 
Nr1d1 1.41 1.11 
Gadd45g_predicted 0.94 1.19 
Egr2 1.01 1.08 
Comt -0.18 0.34 
Nr4a1 1.21 1.2 
Gdf15 2.55 1.94 
Dusp6 0.57 0.36 
Egr1 1.48 1.36 
Atf3 2.4 1.63 
Cyr61 1.35 0.63 
Btg2 1.6 1.29 
Atf4 0.61 0.2 
Zfp36 1.43 1.4 
Tnfrsf12a 0.35 0.36 
Rgs2 0.58 0.78 
Junb 1.78 1.87 
Jun 1.3 1.14 
Dusp4 0.9 1.36 
Areg -0.17 0.07 
Ier3 0.13 -0.01 
Per1 0.27 0.28 
Ddit4 0.52 0.67 
Nfkbia 0.35 0.15 
RGD1307599_predicted -0.01 0.08 
Ctgf 0.27 0.02 
Mafb 0.62 0.9 
Igfbp1 0.96 1.1 
Bhlhb3 0.38 0.01 
Cxcl10 0.84 0.62 
Cxcl9 0.16 0.54 
HO-1 0.82 0.79 
Cd74 0.76 1.24 
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Cxcr4 1.52 1.2 
Psmb8 0.47 0.47 
Dtr 1.46 0.64 
Psmb9 0.72 0.48 
Ubd 1.07 1.24 
Irf1 0.56 0.6 
Ccnl1 0.2 -0.08 
Id1 -0.03 -0.3 
Nr4a3 0.66 0.38 
Copeb / KLF6 0.68 0.3 
Ccl20 0.03 0.09 
Arhe 0.08 0.1 
Mx2 0.08 0.14 
Grp58 -0.44 -0.21 
Copeb 0.68 0.3 
Hspa1a /// Hspa1b 0.35 -0.83 
Klf4 0.27 0.21 
Hspa1a 0.27 -0.47 
Ddit3 0.24 0.14 
 
 
Gene Name 29_IP_I45_R60_A_vs_ShamA_Signal 
Log Ratio 
29_IP_I45_R60_A_vs_ShamB_Signal 
Log Ratio 
F3 1.28 1.5 
Sqstm1 1.14 1.46 
Arl4 1.35 1.37 
Gadd45a 1.41 1.47 
Myc 2.78 2.78 
Ifrd1 2.06 1.91 
Cebpb 1.13 0.93 
Adamts1 1.43 1.79 
Nfil3 0.83 1.16 
Gadd45b_predicted 1.96 1.5 
Snf1lk 0.46 0.57 
Dusp1 1.05 1 
Dusp5 2.71 2.75 
Cxcl1 2.37 1.97 
Cxcl2 1.44 1.52 
Myd116 1.9 1.64 
Rasd1 1.86 1.9 
Rhob 1.69 1.31 
Nr1d1 1.63 1.44 
Gadd45g_predicted 1.52 1.69 
Egr2 1.65 1.14 
Comt -0.37 0.17 
Nr4a1 2.18 2 
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Gdf15 2.08 1.57 
Dusp6 1.37 1.06 
Egr1 2.05 1.84 
Atf3 4.54 3.65 
Cyr61 2.32 1.6 
Btg2 2.3 2.05 
Atf4 1.32 1.03 
Zfp36 1.26 1.19 
Tnfrsf12a 1.64 1.63 
Rgs2 1.52 1.57 
Junb 1.89 1.73 
Jun 2.29 2.07 
Dusp4 0.36 1.05 
Areg 2.35 2.77 
Ier3 0.49 0.33 
Per1 1.25 1.11 
Ddit4 0.14 0.33 
Nfkbia 1.02 0.85 
RGD1307599_predicted 0.44 0.6 
Ctgf 1.09 0.68 
Mafb 1.15 1.57 
Igfbp1 1.7 1.76 
Bhlhb3 2.01 1.66 
Cxcl10 1.97 1.79 
Cxcl9 1.38 1.69 
HO-1 1.01 0.82 
Cd74 1.23 1.55 
Cxcr4 1.85 1.43 
Psmb8 1.08 1.19 
Dtr 3.27 2.41 
Psmb9 1.65 1.55 
Ubd 2.65 2.82 
Irf1 1.35 1.12 
Ccnl1 1.64 1.27 
Id1 1.31 0.84 
Nr4a3 1.18 1.17 
Copeb / KLF6 3.47 3.04 
Ccl20 1.07 0.76 
Arhe 1.44 1.47 
Mx2 0.12 0.23 
Grp58 -0.25 0.06 
Copeb 3.47 3.04 
Hspa1a /// Hspa1b 2.75 1.63 
Klf4 2.28 2.27 
Hspa1a 2.3 1.67 
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Ddit3 2.05 2.04 
 
Gene Name 30_IP_I45_R60_B_vs_ShamA_Signal 
Log Ratio 
30_IP_I45_R60_B_vs_ShamB_Signal 
Log Ratio 
F3 1.32 1.41 
Sqstm1 0.91 1.34 
Arl4 1.04 0.81 
Gadd45a 1.26 1.18 
Myc 2.11 2 
Ifrd1 1.43 1.23 
Cebpb 1.38 1.18 
Adamts1 0.95 1.43 
Nfil3 1.44 1.89 
Gadd45b_predicted 2.05 1.68 
Snf1lk 1.46 1.42 
Dusp1 1.38 1.24 
Dusp5 2.23 2.36 
Cxcl1 2.73 2.39 
Cxcl2 1.99 2.03 
Myd116 1.67 1.42 
Rasd1 1.78 1.73 
Rhob 1.37 1.08 
Nr1d1 0.81 0.74 
Gadd45g_predicted 1.2 1.45 
Egr2 1.48 1.07 
Comt 0.04 0.54 
Nr4a1 1.92 1.71 
Gdf15 2.04 1.48 
Dusp6 0.87 0.79 
Egr1 1.95 1.82 
Atf3 4.22 3.33 
Cyr61 2.08 1.28 
Btg2 2.32 2.1 
Atf4 1.26 0.92 
Zfp36 1.38 1.33 
Tnfrsf12a 1.34 1.25 
Rgs2 0.45 0.61 
Junb 1.71 1.94 
Jun 2.02 1.9 
Dusp4 0.87 1.12 
Areg 0.85 1.44 
Ier3 0.43 0.28 
Per1 0.98 0.71 
Ddit4 0.36 0.55 
Nfkbia 1.06 0.87 
RGD1307599_predicted 0.29 0.42 
  
113 
Ctgf 0.5 0.24 
Mafb 1.16 1.45 
Igfbp1 1.63 1.82 
Bhlhb3 0.81 0.41 
Cxcl10 1.44 1.24 
Cxcl9 0.68 1.2 
HO-1 1.21 1.18 
Cd74 1.49 1.89 
Cxcr4 1.89 1.72 
Psmb8 1.19 1.19 
Dtr 2.77 1.83 
Psmb9 1.45 1.17 
Ubd 0.91 1.17 
Irf1 1.5 1.36 
Ccnl1 1.27 0.96 
Id1 1.28 0.93 
Nr4a3 0.8 0.59 
Copeb / KLF6 2.42 1.83 
Ccl20 1.16 1.03 
Arhe 0.52 0.51 
Mx2 0.6 0.39 
Grp58 -0.06 0.18 
Copeb 2.42 1.83 
Hspa1a /// Hspa1b 2.37 1.17 
Klf4 1.62 1.58 
Hspa1a 1.67 0.95 
Ddit3 1.25 0.96 
 
 
 
 
 
 
 
 
 
Gene Name 13_I45_R0_A_vs_ShamA_Signal Log 
Ratio 
13_I45_R0_A_vs_ShamB_Signal Log 
Ratio 
F3 0.28 0.45 
Sqstm1 -0.55 -0.33 
Arl4 -0.36 -0.29 
Gadd45a 0.11 0.16 
Myc -0.11 -0.2 
Ifrd1 -0.28 -0.29 
Cebpb -0.53 -0.53 
Adamts1 -0.29 0.05 
Nfil3 -0.52 -0.06 
Gadd45b_predicted -0.18 -0.69 
  
114 
Snf1lk 0.08 0.36 
Dusp1 -0.41 -0.61 
Dusp5 0.1 0.21 
Cxcl1 0.69 0.68 
Cxcl2 0.15 0.57 
Myd116 -0.11 -0.33 
Rasd1 -0.15 -0.26 
Rhob 0.41 0.07 
Nr1d1 -0.48 -0.39 
Gadd45g_predicted 0.31 0.57 
Egr2 0.38 0.32 
Comt -3.12 -2.63 
Nr4a1 0.02 -0.13 
Gdf15 0.56 -0.14 
Dusp6 0.29 0.09 
Egr1 0.04 -0.05 
Atf3 1.04 0.41 
Cyr61 0.45 -0.21 
Btg2 0.09 -0.33 
Atf4 0.3 -0.09 
Zfp36 -0.03 0.04 
Tnfrsf12a 0.28 0.11 
Rgs2 -0.02 0 
Junb 0.32 0.34 
Jun 0.75 0.61 
Dusp4 0.27 0.62 
Areg -1.35 -1.26 
Ier3 -1.26 -1.18 
Per1 -0.57 -0.54 
Ddit4 -0.28 -0.09 
Nfkbia -0.39 -0.55 
RGD1307599_predicted -0.29 -0.21 
Ctgf -0.21 -0.54 
Mafb 0.2 0.57 
Igfbp1 0.08 0.3 
Bhlhb3 0.06 -0.05 
Cxcl10 0.34 0.04 
Cxcl9 0.1 0.39 
HO-1 0.27 -0.02 
Cd74 0.26 0.64 
Cxcr4 0.34 0.17 
Psmb8 0.5 0.57 
Dtr 0.67 -0.12 
Psmb9 0.4 0.16 
Ubd -0.35 -0.08 
  
115 
Irf1 0.79 0.57 
Ccnl1 -0.15 -0.38 
Id1 -0.35 -0.72 
Nr4a3 0.48 0.49 
Copeb / KLF6 0.57 -0.3 
Ccl20 0.3 -0.07 
Arhe 0.27 0.13 
Mx2 0.15 0.37 
Grp58 -0.17 0.1 
Copeb 0.57 -0.3 
Hspa1a /// Hspa1b 1.02 -0.04 
Klf4 -0.22 -0.48 
Hspa1a 0.46 -0.2 
Ddit3 0.27 0.13 
 
 
Gene Name 14_I45_R0_B_vs_ShamA_Signal Log 
Ratio 
14_I45_R0_B_vs_ShamB_Signal Log 
Ratio 
F3 -0.06 -0.11 
Sqstm1 -0.59 -0.31 
Arl4 -0.36 -0.41 
Gadd45a -0.64 -0.58 
Myc -0.97 -1.15 
Ifrd1 -0.34 -0.32 
Cebpb -0.73 -0.85 
Adamts1 -0.32 -0.01 
Nfil3 -1.27 -1.25 
Gadd45b_predicted -1.52 -1.72 
Snf1lk -0.4 -0.46 
Dusp1 -0.97 -1.24 
Dusp5 0.15 0.21 
Cxcl1 0.33 -0.02 
Cxcl2 0.03 -0.04 
Myd116 -0.4 -0.7 
Rasd1 -0.3 -0.52 
Rhob 0.07 -0.29 
Nr1d1 0.54 0.38 
Gadd45g_predicted -0.01 0.31 
Egr2 -0.25 -0.39 
Comt -2.55 -1.99 
Nr4a1 -0.6 -0.76 
Gdf15 -0.54 -1.13 
Dusp6 0.45 0.2 
Egr1 -0.62 -0.72 
Atf3 -0.75 -1.22 
Cyr61 -0.21 -0.81 
  
116 
Btg2 -0.56 -0.82 
Atf4 -0.13 -0.49 
Zfp36 -0.01 -0.09 
Tnfrsf12a -0.34 -0.34 
Rgs2 0.06 0.13 
Junb -0.01 0.05 
Jun 0.01 -0.23 
Dusp4 0.03 0.47 
Areg -0.99 -0.41 
Ier3 -1.07 -1.19 
Per1 -0.26 -0.25 
Ddit4 -0.5 -0.22 
Nfkbia -0.67 -0.84 
RGD1307599_predicted -0.11 -0.13 
Ctgf -0.39 -0.78 
Mafb -0.19 0.3 
Igfbp1 -0.3 -0.26 
Bhlhb3 0.65 0.25 
Cxcl10 -0.47 -0.3 
Cxcl9 -0.03 0.28 
HO-1 0.29 0.2 
Cd74 0.13 0.39 
Cxcr4 0.41 0.19 
Psmb8 -0.09 -0.19 
Dtr 0.64 -0.06 
Psmb9 -0.15 -0.17 
Ubd -0.42 -0.11 
Irf1 -0.08 -0.16 
Ccnl1 -0.66 -0.71 
Id1 -0.46 -0.69 
Nr4a3 0.16 0.18 
Copeb / KLF6 -0.29 -0.56 
Ccl20 0.4 0.2 
Arhe 0.49 0.73 
Mx2 -0.06 0.08 
Grp58 -0.34 -0.07 
Copeb -0.29 -0.56 
Hspa1a /// Hspa1b 0.31 -0.85 
Klf4 -0.25 -0.24 
Hspa1a -0.21 -0.87 
Ddit3 -0.42 -0.47 
 
 
Gene Name 15_I45_R15_A_vs_ShamA_Signal Log 
Ratio 
15_I45_R15_A_vs_ShamB_Signal Log 
Ratio 
F3 -1.17 -0.88 
  
117 
Sqstm1 -0.13 0.12 
Arl4 -0.56 -0.38 
Gadd45a -0.58 -0.44 
Myc -0.64 -0.98 
Ifrd1 -0.42 -0.53 
Cebpb -0.8 -1.02 
Adamts1 -0.51 -0.05 
Nfil3 -0.25 0.26 
Gadd45b_predicted -0.89 -1.36 
Snf1lk -0.79 -0.83 
Dusp1 -0.63 -0.83 
Dusp5 0.1 0.07 
Cxcl1 0.63 0.32 
Cxcl2 0.78 0.86 
Myd116 0.12 -0.26 
Rasd1 0.46 0.43 
Rhob 0.4 0.06 
Nr1d1 -0.4 -0.43 
Gadd45g_predicted -0.39 -0.14 
Egr2 0.49 0.58 
Comt 0.02 0.56 
Nr4a1 0.14 0 
Gdf15 0.16 -0.62 
Dusp6 0.51 0.49 
Egr1 0.85 0.71 
Atf3 1.13 0.13 
Cyr61 1.03 0.39 
Btg2 0.65 0.41 
Atf4 0.08 -0.37 
Zfp36 0.17 0.05 
Tnfrsf12a 0.31 0.19 
Rgs2 0.03 -0.07 
Junb 1.02 1.06 
Jun 0.58 0.33 
Dusp4 -0.08 0.44 
Areg -3.39 -3.25 
Ier3 -0.69 -0.69 
Per1 -1.19 -1.24 
Ddit4 -0.69 -0.35 
Nfkbia -0.77 -0.87 
RGD1307599_predicted -1.66 -1.45 
Ctgf -0.33 -0.63 
Mafb -0.03 0.26 
Igfbp1 1.2 1.31 
Bhlhb3 -0.27 -0.63 
  
118 
Cxcl10 1 0.99 
Cxcl9 1.25 1.57 
HO-1 0.86 0.7 
Cd74 1.1 1.57 
Cxcr4 1.13 0.76 
Psmb8 0.92 0.89 
Dtr 1.45 0.47 
Psmb9 1.16 1.1 
Ubd 1.58 1.95 
Irf1 1.39 1.42 
Ccnl1 -0.26 -0.21 
Id1 -0.16 -0.43 
Nr4a3 0.8 0.69 
Copeb / KLF6 0.9 0.33 
Ccl20 0.22 -0.03 
Arhe 0.23 0.2 
Mx2 0.09 0.45 
Grp58 -0.12 0.04 
Copeb 0.9 0.33 
Hspa1a /// Hspa1b 1.14 0.14 
Klf4 -0.03 0.09 
Hspa1a 0.83 0.13 
Ddit3 0.07 -0.23 
 
 
Gene Name 16_I45_R15_B_vs_ShamA_Signal Log 
Ratio 
16_I45_R15_B_vs_ShamB_Signal Log 
Ratio 
F3 -1.08 -0.88 
Sqstm1 -0.51 -0.15 
Arl4 -0.51 -0.51 
Gadd45a -0.1 -0.04 
Myc -0.22 -0.49 
Ifrd1 -0.44 -0.48 
Cebpb -1.06 -1.07 
Adamts1 -0.86 -0.35 
Nfil3 -1.28 -1.11 
Gadd45b_predicted -0.52 -1.01 
Snf1lk -0.26 -0.12 
Dusp1 -0.79 -1.01 
Dusp5 0.43 0.48 
Cxcl1 -0.77 -1.04 
Cxcl2 -0.35 -0.16 
Myd116 -0.03 -0.37 
Rasd1 0.1 -0.01 
Rhob 0.04 -0.26 
Nr1d1 0.89 0.65 
  
119 
Gadd45g_predicted -0.09 0.17 
Egr2 0.05 0.12 
Comt -1.4 -0.95 
Nr4a1 -0.12 -0.28 
Gdf15 0.36 -0.39 
Dusp6 -0.02 -0.06 
Egr1 0.42 0.42 
Atf3 0.37 -0.5 
Cyr61 -0.32 -0.93 
Btg2 0.11 -0.2 
Atf4 0.12 -0.2 
Zfp36 -0.04 -0.08 
Tnfrsf12a 0.2 0 
Rgs2 0.57 0.51 
Junb 0.79 0.78 
Jun 0.41 0.29 
Dusp4 -0.19 0.39 
Areg 0.56 0.98 
Ier3 -0.49 -0.65 
Per1 -0.8 -0.87 
Ddit4 -0.27 -0.06 
Nfkbia -0.79 -0.88 
RGD1307599_predicted -0.85 -0.73 
Ctgf -0.59 -0.97 
Mafb 0.17 0.45 
Igfbp1 0.05 0.14 
Bhlhb3 0.57 0.45 
Cxcl10 -0.28 -0.16 
Cxcl9 -0.23 0.25 
HO-1 -0.08 -0.39 
Cd74 -0.33 -0.05 
Cxcr4 0.22 -0.15 
Psmb8 -0.09 0.02 
Dtr 0.88 0.11 
Psmb9 -0.37 -0.51 
Ubd -0.56 -0.26 
Irf1 0.14 0 
Ccnl1 -0.02 -0.34 
Id1 -0.21 -0.38 
Nr4a3 0.23 0.56 
Copeb / KLF6 0.51 -0.12 
Ccl20 0.42 0.1 
Arhe -0.11 0.33 
Mx2 -0.22 0 
Grp58 -0.3 -0.07 
  
120 
Copeb 0.51 -0.12 
Hspa1a /// Hspa1b 1.47 0.31 
Klf4 -0.1 -0.36 
Hspa1a 0.92 0.19 
Ddit3 0.05 -0.08 
 
 
Gene Name 17_I45_R60_A_vs_ShamA_Signal Log 
Ratio 
17_I45_R60_A_vs_ShamB_Signal Log 
Ratio 
F3 -0.1 0.04 
Sqstm1 -0.18 0.02 
Arl4 0.16 0.1 
Gadd45a 0.27 0.29 
Myc 0.61 0.4 
Ifrd1 0.09 -0.07 
Cebpb 0.14 -0.01 
Adamts1 -0.1 0.29 
Nfil3 -0.48 -0.01 
Gadd45b_predicted 0.66 0.35 
Snf1lk -0.47 -0.19 
Dusp1 1.42 1.37 
Dusp5 1.33 1.37 
Cxcl1 1.75 1.5 
Cxcl2 1.38 1.41 
Myd116 1.36 1.02 
Rasd1 1.47 1.45 
Rhob 1.6 1.27 
Nr1d1 0.97 0.77 
Gadd45g_predicted 0.59 0.98 
Egr2 0.59 0.61 
Comt -0.47 0.03 
Nr4a1 1.42 1.16 
Gdf15 1.14 0.52 
Dusp6 0.74 0.65 
Egr1 1.37 1.38 
Atf3 3.73 2.74 
Cyr61 1.16 0.62 
Btg2 1.72 1.42 
Atf4 0.88 0.51 
Zfp36 1.21 1.25 
Tnfrsf12a 0.73 0.57 
Rgs2 1.02 1.19 
Junb 1.98 1.94 
Jun 2.1 1.82 
Dusp4 0.4 1.02 
Areg -0.35 -0.2 
  
121 
Ier3 0.26 0.07 
Per1 -0.05 -0.22 
Ddit4 0.44 0.74 
Nfkbia 0.22 0.18 
RGD1307599_predicted -0.55 -0.45 
Ctgf 0.06 -0.21 
Mafb 0.44 0.72 
Igfbp1 0.68 0.87 
Bhlhb3 1.02 0.82 
Cxcl10 0.84 0.54 
Cxcl9 0.65 0.67 
HO-1 0.7 0.61 
Cd74 1.2 1.63 
Cxcr4 1.5 1.21 
Psmb8 1.06 1.28 
Dtr 1.27 0.6 
Psmb9 1.34 1.23 
Ubd 0.85 1.07 
Irf1 1.12 1.16 
Ccnl1 0.21 -0.03 
Id1 1.41 0.92 
Nr4a3 0.5 0.57 
Copeb / KLF6 1.92 1.38 
Ccl20 0.15 0.09 
Arhe 0.34 0.34 
Mx2 -0.65 -0.72 
Grp58 -0.49 -0.31 
Copeb 1.92 1.38 
Hspa1a /// Hspa1b 2.87 1.85 
Klf4 1.76 1.61 
Hspa1a 2.91 2.27 
Ddit3 0.72 0.55 
 
 
Gene Name 18_I45_R60_B_vs_ShamA_Signal Log 
Ratio 
18_I45_R60_B_vs_ShamB_Signal Log 
Ratio 
F3 0.27 0.53 
Sqstm1 0.49 0.83 
Arl4 0.52 0.33 
Gadd45a 0.67 0.66 
Myc 1.33 1.26 
Ifrd1 1.08 1.01 
Cebpb 0.22 0.04 
Adamts1 0.53 0.68 
Nfil3 0.68 1.05 
Gadd45b_predicted 1.38 0.96 
  
122 
Snf1lk 0.78 0.89 
Dusp1 1.14 1.18 
Dusp5 1.81 2.01 
Cxcl1 2.02 1.85 
Cxcl2 1.92 1.94 
Myd116 1.3 0.99 
Rasd1 1.36 1.43 
Rhob 1.62 1.25 
Nr1d1 0.79 0.61 
Gadd45g_predicted 0.88 1.13 
Egr2 1.17 1.13 
Comt -0.99 -0.49 
Nr4a1 1.97 1.75 
Gdf15 1.8 1.13 
Dusp6 0.64 0.49 
Egr1 1.76 1.64 
Atf3 3.96 3.24 
Cyr61 1.11 0.56 
Btg2 2.01 1.79 
Atf4 0.93 0.5 
Zfp36 1.35 1.31 
Tnfrsf12a 0.58 0.54 
Rgs2 1.41 1.43 
Junb 2.4 2.36 
Jun 2.19 1.99 
Dusp4 1.42 1.56 
Areg 0.8 1.01 
Ier3 0.13 0.12 
Per1 0.15 -0.07 
Ddit4 0.36 0.47 
Nfkbia 0.48 0.3 
RGD1307599_predicted -0.3 -0.18 
Ctgf 0.15 -0.12 
Mafb 0.4 0.42 
Igfbp1 0.55 0.71 
Bhlhb3 0.9 0.41 
Cxcl10 0.84 0.6 
Cxcl9 -0.16 -0.04 
HO-1 0.64 0.65 
Cd74 -0.2 0.09 
Cxcr4 0.81 0.41 
Psmb8 -0.13 -0.21 
Dtr 1.89 1.19 
Psmb9 -0.49 -0.57 
Ubd 0.57 0.84 
  
123 
Irf1 0.34 0.43 
Ccnl1 0.94 0.88 
Id1 1 0.61 
Nr4a3 1.95 1.77 
Copeb / KLF6 2.34 2.01 
Ccl20 1.06 0.85 
Arhe 1.26 1.35 
Mx2 0.23 -0.2 
Grp58 -0.14 0.1 
Copeb 2.34 2.01 
Hspa1a /// Hspa1b 2.85 1.82 
Klf4 1.74 1.6 
Hspa1a 2.53 1.81 
Ddit3 1.01 0.77 
 
 
 
 
 
 
 
Gene Name 01_HP_I45_R0_A_vs_ShamA_Signal 
Log Ratio 
01_HP_I45_R0_A_vs_ShamB_Signal 
Log Ratio 
F3 -0.82 -0.74 
Sqstm1 -0.71 -0.38 
Arl4 -0.67 -0.45 
Gadd45a -0.92 -0.81 
Myc -1.02 -1.32 
Ifrd1 -0.67 -0.72 
Cebpb -0.95 -0.99 
Adamts1 -0.72 -0.57 
Nfil3 -1.1 -1.04 
Gadd45b_predicted -0.87 -1.22 
Snf1lk -1.03 -1.28 
Dusp1 -1.27 -1.51 
Dusp5 -0.27 0.04 
Cxcl1 0.28 0.04 
Cxcl2 -0.18 0.14 
Myd116 -0.33 -0.65 
Rasd1 -0.29 -0.47 
Rhob 0.14 -0.2 
Nr1d1 0 0.07 
Gadd45g_predicted -0.57 -0.43 
Egr2 -0.75 -0.43 
Comt 0.32 0.86 
Nr4a1 -1.06 -1.14 
Gdf15 0.48 -0.22 
Dusp6 0.13 0 
  
124 
Egr1 -0.3 -0.42 
Atf3 -1.18 -1.98 
Cyr61 -0.03 -0.64 
Btg2 -0.72 -1.23 
Atf4 -0.12 -0.46 
Zfp36 -0.43 -0.57 
Tnfrsf12a -0.09 -0.16 
Rgs2 -0.01 0.12 
Junb 0.14 0.15 
Jun -0.46 -0.72 
Dusp4 -0.25 0.36 
Areg -0.46 -0.37 
Ier3 -1.33 -1.24 
Per1 -1.21 -1.35 
Ddit4 -0.86 -0.65 
Nfkbia -1.15 -1.29 
RGD1307599_predicted -1.06 -1 
Ctgf -1.13 -1.54 
Mafb 0.22 0.59 
Igfbp1 0.17 0.32 
Bhlhb3 0.24 -0.15 
Cxcl10 0.41 0.26 
Cxcl9 0.82 1.16 
HO-1 0.44 0.47 
Cd74 0.69 1.28 
Cxcr4 0.62 0.3 
Psmb8 0.92 0.86 
Dtr 0.75 -0.04 
Psmb9 1.21 0.98 
Ubd 0.68 0.99 
Irf1 1.21 1.16 
Ccnl1 -0.65 -0.77 
Id1 -0.11 -0.52 
Nr4a3 0.77 0.24 
Copeb / KLF6 -0.01 -0.63 
Ccl20 0.31 -0.1 
Arhe 0.29 0.46 
Mx2 -1.03 -0.84 
Grp58 -0.06 -0.52 
Copeb -0.01 -0.63 
Hspa1a /// Hspa1b 0.05 -1 
Klf4 -0.4 -0.47 
Hspa1a -0.01 -0.7 
Ddit3 -0.27 -0.33 
 
  
125 
 
Gene Name 02_HP_I45_R0_B_vs_ShamA_Signal 
Log Ratio 
02_HP_I45_R0_B_vs_ShamB_Signal 
Log Ratio 
F3 -0.6 -0.53 
Sqstm1 -0.11 0.27 
Arl4 -0.82 -0.75 
Gadd45a -0.67 -0.62 
Myc -2.31 -2.7 
Ifrd1 -0.59 -0.59 
Cebpb -1.13 -1.33 
Adamts1 -0.86 -0.41 
Nfil3 -1.22 -0.97 
Gadd45b_predicted -1.52 -2 
Snf1lk -0.8 -0.99 
Dusp1 -1.48 -1.73 
Dusp5 -0.68 -0.55 
Cxcl1 -2.37 -2.62 
Cxcl2 -0.24 -0.05 
Myd116 -0.27 -0.71 
Rasd1 -0.62 -0.62 
Rhob -0.14 -0.5 
Nr1d1 0.06 0.32 
Gadd45g_predicted -0.91 -0.6 
Egr2 0.04 0.22 
Comt 0.46 0.99 
Nr4a1 -0.64 -0.56 
Gdf15 0.41 -0.32 
Dusp6 0.16 -0.02 
Egr1 -0.32 -0.47 
Atf3 -1.11 -1.8 
Cyr61 0.48 -0.23 
Btg2 -0.71 -0.84 
Atf4 -0.04 -0.34 
Zfp36 -0.52 -0.73 
Tnfrsf12a -0.6 -0.83 
Rgs2 0.07 0.22 
Junb -0.15 -0.11 
Jun -0.61 -0.74 
Dusp4 0.02 0.65 
Areg -4.67 -4.26 
Ier3 -1.58 -1.49 
Per1 -3.34 -2.61 
Ddit4 -1.39 -1.17 
Nfkbia -1.1 -1.42 
RGD1307599_predicted -1.16 -1.12 
Ctgf -1.01 -1.31 
  
126 
Mafb -0.02 0.46 
Igfbp1 0.39 0.48 
Bhlhb3 0.19 0.04 
Cxcl10 0.13 0.38 
Cxcl9 0.49 0.97 
HO-1 0.76 0.7 
Cd74 0.68 0.95 
Cxcr4 0.76 0.54 
Psmb8 0.68 0.6 
Dtr 0.87 0.11 
Psmb9 0.81 0.72 
Ubd 0.61 1.01 
Irf1 0.88 0.86 
Ccnl1 0 -0.07 
Id1 -0.32 -0.62 
Nr4a3 0.61 0.65 
Copeb / KLF6 0.55 -0.11 
Ccl20 0.58 0.44 
Arhe 0.71 0.74 
Mx2 -0.01 0.23 
Grp58 0.51 0.44 
Copeb 0.55 -0.11 
Hspa1a /// Hspa1b -0.28 -1.49 
Klf4 -0.5 -0.57 
Hspa1a -0.25 -1.01 
Ddit3 0 0.08 
 
 
Gene Name 03_HP_I45_R15_A_vs_ShamA_Signal 
Log Ratio 
03_HP_I45_R15_A_vs_ShamB_Signal 
Log Ratio 
F3 -0.42 -0.27 
Sqstm1 -0.21 0.14 
Arl4 -0.41 -0.36 
Gadd45a -0.57 -0.56 
Myc -0.46 -0.66 
Ifrd1 -0.13 -0.31 
Cebpb -1.01 -1.11 
Adamts1 -0.32 0.11 
Nfil3 -1.07 -0.48 
Gadd45b_predicted -0.87 -1.15 
Snf1lk -0.69 -0.72 
Dusp1 -1.15 -1.2 
Dusp5 0.03 0.02 
Cxcl1 -0.45 -0.65 
Cxcl2 -0.31 0.24 
Myd116 -0.26 -0.68 
  
127 
Rasd1 0.23 0.06 
Rhob 0.04 -0.26 
Nr1d1 -0.13 -0.04 
Gadd45g_predicted 0.41 0.6 
Egr2 0.44 0.49 
Comt 0.25 0.76 
Nr4a1 -0.05 -0.18 
Gdf15 -0.67 -1.21 
Dusp6 0.14 0.06 
Egr1 0.42 0.29 
Atf3 0.08 -0.78 
Cyr61 1 0.37 
Btg2 -0.22 -0.55 
Atf4 -0.17 -0.43 
Zfp36 -0.23 -0.28 
Tnfrsf12a -0.18 -0.25 
Rgs2 0.62 0.56 
Junb 0.38 0.3 
Jun -0.18 -0.33 
Dusp4 0.26 0.66 
Areg -3.2 -2.8 
Ier3 -1.16 -1.12 
Per1 -0.58 -0.85 
Ddit4 -0.59 -0.44 
Nfkbia -0.67 -0.84 
RGD1307599_predicted -0.62 -0.6 
Ctgf -0.32 -0.69 
Mafb 0.24 0.56 
Igfbp1 0.16 0.37 
Bhlhb3 0.36 0.03 
Cxcl10 -0.31 -0.28 
Cxcl9 -0.17 0.2 
HO-1 0.03 -0.04 
Cd74 -0.66 -0.44 
Cxcr4 0.48 0.18 
Psmb8 -0.31 -0.38 
Dtr 0.64 -0.09 
Psmb9 -0.26 -0.63 
Ubd -0.09 0.23 
Irf1 -0.07 -0.1 
Ccnl1 0.21 0.16 
Id1 0.04 -0.48 
Nr4a3 0.32 0.42 
Copeb / KLF6 0.66 -0.24 
Ccl20 0.42 0.11 
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Arhe 0.6 0.68 
Mx2 -0.08 0.07 
Grp58 0.81 0.3 
Copeb 0.66 -0.24 
Hspa1a /// Hspa1b 0.52 -0.61 
Klf4 -0.24 -0.45 
Hspa1a 0.12 -0.54 
Ddit3 -0.11 -0.17 
 
 
Gene Name 04_HP_I45_R15_B_vs_ShamA_Signal 
Log Ratio 
04_HP_I45_R15_B_vs_ShamB_Signal 
Log Ratio 
F3 -0.89 -0.65 
Sqstm1 0.13 0.28 
Arl4 -0.46 -0.64 
Gadd45a -0.6 -0.53 
Myc -4.07 -4.22 
Ifrd1 -0.41 -0.57 
Cebpb -1.18 -1.26 
Adamts1 -0.84 -0.44 
Nfil3 -0.92 -0.67 
Gadd45b_predicted -0.95 -1.38 
Snf1lk -0.74 -0.61 
Dusp1 -1.31 -1.56 
Dusp5 -0.44 -0.36 
Cxcl1 1.19 0.99 
Cxcl2 0.61 0.71 
Myd116 0.15 -0.08 
Rasd1 0.29 0.37 
Rhob -0.05 -0.49 
Nr1d1 0.91 0.79 
Gadd45g_predicted 0.52 0.71 
Egr2 0.07 0.03 
Comt 0.72 1.21 
Nr4a1 0.31 0.04 
Gdf15 -0.2 -0.89 
Dusp6 0.16 0 
Egr1 0.4 0.29 
Atf3 0.66 -0.2 
Cyr61 0.96 0.22 
Btg2 0.07 -0.4 
Atf4 0.12 -0.18 
Zfp36 -0.13 -0.39 
Tnfrsf12a -0.2 -0.32 
Rgs2 0.9 1.08 
Junb 0.63 0.71 
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Jun 0.12 -0.02 
Dusp4 -0.18 0.39 
Areg -0.8 -0.8 
Ier3 -0.73 -0.7 
Per1 -1.23 -1.26 
Ddit4 -1.51 -1.36 
Nfkbia -1.07 -1.19 
RGD1307599_predicted -1.26 -1.09 
Ctgf -0.8 -1.1 
Mafb 0.25 0.55 
Igfbp1 0.09 0.05 
Bhlhb3 0.47 0.23 
Cxcl10 0.06 -0.02 
Cxcl9 0.15 0.54 
HO-1 0.16 0.23 
Cd74 0.31 0.62 
Cxcr4 0.63 0.29 
Psmb8 0.14 0.07 
Dtr 0.76 -0.08 
Psmb9 0.27 0.17 
Ubd 0.09 0.33 
Irf1 0.25 0.11 
Ccnl1 0.59 0.07 
Id1 0.15 -0.2 
Nr4a3 1.17 1.34 
Copeb / KLF6 0.54 0.03 
Ccl20 -0.13 -0.45 
Arhe 0.88 0.75 
Mx2 0.26 0.5 
Grp58 0.77 0.19 
Copeb 0.54 0.03 
Hspa1a /// Hspa1b 1.57 0.53 
Klf4 0.14 0 
Hspa1a 1.08 0.43 
Ddit3 0.18 0.09 
 
Gene Name 05_HP_I45_R60_A_vs_ShamA_Signal 
Log Ratio 
05_HP_I45_R60_A_vs_ShamB_Signal 
Log Ratio 
F3 -0.16 -0.1 
Sqstm1 -0.01 0.35 
Arl4 0.44 0.41 
Gadd45a 0.54 0.63 
Myc 1.27 1.17 
Ifrd1 0.64 0.54 
Cebpb 0.34 0.24 
Adamts1 0.18 0.41 
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Nfil3 0.65 0.98 
Gadd45b_predicted 1.14 0.85 
Snf1lk -0.17 0.05 
Dusp1 1.6 1.47 
Dusp5 1.59 1.7 
Cxcl1 2 1.7 
Cxcl2 1.66 1.52 
Myd116 1.75 1.38 
Rasd1 1.65 1.53 
Rhob 1.86 1.59 
Nr1d1 0.46 0.42 
Gadd45g_predicted 1.02 1.28 
Egr2 1.52 1.44 
Comt 0.72 1.18 
Nr4a1 1.76 1.58 
Gdf15 2.04 1.21 
Dusp6 0.94 0.85 
Egr1 2.04 1.93 
Atf3 4.08 3.29 
Cyr61 2.34 1.57 
Btg2 2.05 1.87 
Atf4 0.94 0.59 
Zfp36 1.3 1.33 
Tnfrsf12a 0.42 0.28 
Rgs2 0.67 0.3 
Junb 2.49 2.49 
Jun 2.3 2.19 
Dusp4 1.26 1.3 
Areg 0.26 0.45 
Ier3 0.33 0.36 
Per1 -0.11 -0.17 
Ddit4 0.66 0.88 
Nfkbia 0.7 0.53 
RGD1307599_predicted -0.37 -0.33 
Ctgf 0.26 0.07 
Mafb 0.42 0.81 
Igfbp1 0.9 0.97 
Bhlhb3 0 -0.36 
Cxcl10 0.29 0.2 
Cxcl9 0.26 0.66 
HO-1 0.23 0.26 
Cd74 0.08 0.31 
Cxcr4 1.05 0.74 
Psmb8 0.24 0.21 
Dtr 1.85 1.02 
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Psmb9 0.2 0.19 
Ubd 0.47 0.82 
Irf1 0.67 0.5 
Ccnl1 0.46 0.41 
Id1 1.52 1.02 
Nr4a3 1.25 1.01 
Copeb / KLF6 2.54 2.21 
Ccl20 0.8 0.67 
Arhe 0.98 0.99 
Mx2 0.64 0.53 
Grp58 0.93 0.42 
Copeb 2.54 2.21 
Hspa1a /// Hspa1b 3.3 2.24 
Klf4 2.09 2.08 
Hspa1a 3.2 2.49 
Ddit3 0.96 0.95 
 
 
Gene Name 
06_HP_I45_R60_B_vs_ShamA_Signal 
Log Ratio 
06_HP_I45_R60_B_vs_ShamB_Signal 
Log Ratio 
F3 0.5 0.67 
Sqstm1 0.54 0.97 
Arl4 0.21 0.3 
Gadd45a 0.22 0.31 
Myc 1.14 1.02 
Ifrd1 0.71 0.59 
Cebpb -0.06 -0.17 
Adamts1 0.23 0.49 
Nfil3 0.35 0.75 
Gadd45b_predicted 1.04 0.62 
Snf1lk -0.2 -0.05 
Dusp1 0.71 0.49 
Dusp5 1.36 1.52 
Cxcl1 1.53 1.46 
Cxcl2 1.16 1.28 
Myd116 1.38 1.07 
Rasd1 1.43 1.42 
Rhob 1.42 1.02 
Nr1d1 1.16 1.04 
Gadd45g_predicted 0.84 1.06 
Egr2 1.04 1 
Comt 0.54 1.04 
Nr4a1 1.61 1.34 
Gdf15 1.2 0.44 
Dusp6 0.49 0.36 
Egr1 1.6 1.51 
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Atf3 3.8 3.07 
Cyr61 2.02 1.28 
Btg2 1.78 1.59 
Atf4 0.58 0.24 
Zfp36 0.89 0.83 
Tnfrsf12a 0.21 0.1 
Rgs2 1.07 1.17 
Junb 1.95 1.87 
Jun 1.9 1.74 
Dusp4 0.74 0.96 
Areg -0.34 -0.15 
Ier3 -0.15 -0.06 
Per1 0.51 0.22 
Ddit4 0.23 0.31 
Nfkbia 0.61 0.47 
RGD1307599_predicted -0.44 -0.27 
Ctgf -0.02 -0.23 
Mafb 0.15 0.73 
Igfbp1 0.52 0.73 
Bhlhb3 0.4 0.04 
Cxcl10 0.38 0.4 
Cxcl9 0.31 0.53 
HO-1 0.39 0.26 
Cd74 -0.07 0.18 
Cxcr4 0.67 0.44 
Psmb8 0.29 0.31 
Dtr 1.6 0.82 
Psmb9 0.48 0.42 
Ubd 0.44 0.62 
Irf1 0.76 0.71 
Ccnl1 1.42 1.12 
Id1 0.6 0.22 
Nr4a3 1.41 1.57 
Copeb / KLF6 2.39 2.15 
Ccl20 0.83 0.48 
Arhe 1.06 1.24 
Mx2 0.86 0.93 
Grp58 1.73 1.2 
Copeb 2.39 2.15 
Hspa1a /// Hspa1b 2.45 1.26 
Klf4 1.81 1.61 
Hspa1a 2.42 1.79 
Ddit3 0.81 0.88 
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APPENDIX B: List of Constitutively Up-regulated Genes 
Gene Name 
25_IP_I45_R0_A_vs_ShamA_Signal Log 
Ratio 
25_IP_I45_R0_A_vs_ShamB_Signal Log 
Ratio 
Nef3 0.44 0.56 
Bpgm 1.3 1.36 
Slc22a7 0.6 0.52 
Hmgcs2 0.97 -1.81 
Aldh1a4 1.94 0.99 
Igh-1a_predicted 2.01 1.76 
Alas2 2.78 3 
S100a8 3.38 4.96 
Npy 1.24 1.87 
Hbb 1.69 1.52 
Nritp 1.01 0.84 
Cdc25b 2.07 1.9 
c-maf 0.73 0.82 
S100a9 2.29 4.47 
IgG-2a 2.01 1.76 
Hba-a1 0.56 0.64 
Klf2 1 1 
Igha 0.85 1.06 
Snca 0.86 0.62 
Csda 1.88 1.63 
 
Gene Name 
26_IP_I45_R0_B_vs_ShamA_Signal Log 
Ratio 
26_IP_I45_R0_B_vs_ShamB_Signal Log 
Ratio 
Nef3 0.19 0.43 
Bpgm 0.61 0.32 
Slc22a7 0.66 0.72 
Hmgcs2 1.05 -1.35 
Aldh1a4 0.67 0.41 
Igh-1a_predicted 3.55 3.41 
Alas2 1.9 1.76 
S100a8 4.47 5.69 
Npy 0.38 0.78 
Hbb 1.39 1.22 
Nritp 0.89 0.75 
Cdc25b 1.17 0.93 
c-maf 0.64 0.89 
S100a9 4.04 6.81 
IgG-2a 3.55 3.41 
Hba-a1 0.64 0.67 
Klf2 1 1 
Igha 1.64 1.82 
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Snca 0.99 1.13 
Csda 1.02 0.72 
 
Gene Name 
27_IP_I45_R15_A_vs_ShamA_Signal Log 
Ratio 
27_IP_I45_R15_A_vs_ShamB_Signal Log 
Ratio 
Nef3 -0.2 0.07 
Bpgm 0.08 -0.03 
Slc22a7 0.57 0.42 
Hmgcs2 2.19 0.5 
Aldh1a4 0.56 0.25 
Igh-1a_predicted 1.28 1.11 
Alas2 0.46 0.59 
S100a8 0.94 1.34 
Npy -0.14 0.24 
Hbb 0.74 0.5 
Nritp 1.63 1.52 
Cdc25b 0.46 0.32 
c-maf 0.75 0.9 
S100a9 0.95 3.22 
IgG-2a 1.28 1.11 
Hba-a1 0.08 0.15 
Klf2 1 1 
Igha 0.53 0.72 
Snca 1.07 1.08 
Csda 0.4 0.38 
 
Gene Name 
28_IP_I45_R15_B_vs_ShamA_Signal Log 
Ratio 
28_IP_I45_R15_B_vs_ShamB_Signal Log 
Ratio 
Nef3 0.33 0.55 
Bpgm 0.66 0.43 
Slc22a7 0.45 0.34 
Hmgcs2 1.77 -0.48 
Aldh1a4 0.96 0.85 
Igh-1a_predicted 5.14 4.86 
Alas2 1.77 1.7 
S100a8 2.68 4.87 
Npy 1.24 2.07 
Hbb 1.72 1.48 
Nritp 0.92 0.77 
Cdc25b 1.21 1.03 
c-maf 0.71 0.9 
S100a9 1.8 4.27 
IgG-2a 5.14 4.86 
Hba-a1 0.89 0.92 
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Klf2 1 1 
Igha 2.94 3.17 
Snca 0.37 0.08 
Csda 1.08 0.68 
 
Gene Name 
29_IP_I45_R60_A_vs_ShamA_Signal Log 
Ratio 
29_IP_I45_R60_A_vs_ShamB_Signal Log 
Ratio 
Nef3 0.37 0.35 
Bpgm 0.44 0.25 
Slc22a7 0.3 0.26 
Hmgcs2 -0.31 -1.95 
Aldh1a4 1.97 1.03 
Igh-1a_predicted 4.26 3.99 
Alas2 0.69 0.69 
S100a8 2.28 3.42 
Npy 0.36 0.51 
Hbb 0.69 0.48 
Nritp 0.45 0.21 
Cdc25b 0.68 0.45 
c-maf 0.28 0.39 
S100a9 1.67 4.67 
IgG-2a 4.26 3.99 
Hba-a1 0.66 0.63 
Klf2 1 1 
Igha 2.53 2.72 
Snca 0.44 0.26 
Csda 0.25 0.03 
 
Gene Name 
30_IP_I45_R60_B_vs_ShamA_Signal Log 
Ratio 
30_IP_I45_R60_B_vs_ShamB_Signal Log 
Ratio 
Nef3 -0.03 0.07 
Bpgm 0.42 0.32 
Slc22a7 0.18 0.15 
Hmgcs2 0.89 -0.89 
Aldh1a4 0.87 0.44 
Igh-1a_predicted 4.75 4.52 
Alas2 1.11 0.95 
S100a8 2.86 4.13 
Npy 0.38 0.7 
Hbb 1.52 1.3 
Nritp 0.91 0.74 
Cdc25b 0.81 0.38 
c-maf 0.67 0.78 
S100a9 1.92 4.06 
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IgG-2a 4.75 4.52 
Hba-a1 1.16 1.17 
Klf2 1 1 
Igha 1.58 1.77 
Snca 1.2 1.17 
Csda 0.68 0.37 
 
Gene Name 
13_I45_R0_A_vs_ShamA_Signal Log 
Ratio 
13_I45_R0_A_vs_ShamB_Signal Log 
Ratio 
Nef3 0.48 0.56 
Bpgm 0.48 0.16 
Slc22a7 0.62 0.43 
Hmgcs2 1.56 -0.65 
Aldh1a4 -0.62 -1.13 
Igh-1a_predicted 0.81 0.66 
Alas2 1.5 1.47 
S100a8 1.74 3.28 
Npy 0.43 0.67 
Hbb 1.41 1.19 
Nritp 1.13 1.07 
Cdc25b 1.02 0.62 
c-maf 1.69 0.49 
S100a9 2.1 4.74 
IgG-2a 0.81 0.66 
Hba-a1 0.66 0.69 
Klf2 1 1 
Igha 0.29 0.45 
Snca 1.76 1.79 
Csda 0.93 0.6 
 
Gene Name 
14_I45_R0_B_vs_ShamA_Signal Log 
Ratio 
14_I45_R0_B_vs_ShamB_Signal Log 
Ratio 
Nef3 0.32 0.44 
Bpgm 0.94 0.91 
Slc22a7 0.73 0.71 
Hmgcs2 1.79 0.27 
Aldh1a4 1.07 0.5 
Igh-1a_predicted -0.55 -0.65 
Alas2 2.33 2.49 
S100a8 1.4 1.79 
Npy 0.74 1.27 
Hbb 1.8 1.53 
Nritp 1.45 1.16 
Cdc25b 1.82 1.5 
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c-maf 1.66 0.57 
S100a9 0.27 3.3 
IgG-2a -0.55 -0.65 
Hba-a1 0.95 0.97 
Klf2 1 1 
Igha -0.81 -0.52 
Snca 1.6 1.67 
Csda 1.66 1.33 
 
Gene Name 
15_I45_R15_A_vs_ShamA_Signal Log 
Ratio 
15_I45_R15_A_vs_ShamB_Signal Log 
Ratio 
Nef3 0.76 0.98 
Bpgm 1.06 0.86 
Slc22a7 0.88 0.79 
Hmgcs2 1.52 -0.99 
Aldh1a4 2.15 1.64 
Igh-1a_predicted 2.75 2.49 
Alas2 2.25 2.34 
S100a8 3.72 5.38 
Npy 1.96 2.68 
Hbb 1.87 1.64 
Nritp 0.76 0.68 
Cdc25b 1.56 1.2 
c-maf 2.14 0.72 
S100a9 3.36 6.04 
IgG-2a 2.75 2.49 
Hba-a1 1.04 1.08 
Klf2 1 1 
Igha 1 1.18 
Snca 0.66 0.42 
Csda 1.58 1.11 
 
Gene Name 
16_I45_R15_B_vs_ShamA_Signal Log 
Ratio 
16_I45_R15_B_vs_ShamB_Signal Log 
Ratio 
Nef3 -0.37 -0.02 
Bpgm 0.61 0.42 
Slc22a7 0.32 0.22 
Hmgcs2 1.14 -1.49 
Aldh1a4 1.38 0.67 
Igh-1a_predicted -0.88 -1.2 
Alas2 1.48 1.36 
S100a8 1.8 3.2 
Npy 0.74 1.18 
Hbb 1.37 1.15 
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Nritp 0.76 0.69 
Cdc25b 1.04 0.68 
c-maf 0.39 -0.81 
S100a9 0.99 3.54 
IgG-2a -0.88 -1.2 
Hba-a1 0.83 0.84 
Klf2 1 1 
Igha -0.03 0.27 
Snca 1.08 0.98 
Csda 0.91 0.57 
 
Gene Name 
17_I45_R60_A_vs_ShamA_Signal Log 
Ratio 
17_I45_R60_A_vs_ShamB_Signal Log 
Ratio 
Nef3 0.14 0.56 
Bpgm 0.2 0.04 
Slc22a7 0.74 0.61 
Hmgcs2 1.85 -0.7 
Aldh1a4 1.41 0.47 
Igh-1a_predicted 2.24 2.02 
Alas2 1.06 1.19 
S100a8 -0.52 0.52 
Npy 0.24 0.55 
Hbb 1.35 1.16 
Nritp 1.58 1.43 
Cdc25b 0.62 0.21 
c-maf 1.17 0.02 
S100a9 1.48 3.71 
IgG-2a 2.24 2.02 
Hba-a1 0.63 0.72 
Klf2 1 1 
Igha 2 2.2 
Snca 0.55 0.29 
Csda 0.45 0.23 
 
Gene Name 
18_I45_R60_B_vs_ShamA_Signal Log 
Ratio 
18_I45_R60_B_vs_ShamB_Signal Log 
Ratio 
Nef3 0.26 0.57 
Bpgm 0.05 -0.13 
Slc22a7 0.09 0.02 
Hmgcs2 1.04 -1.2 
Aldh1a4 1.11 0.63 
Igh-1a_predicted 2.79 2.49 
Alas2 0.29 0.44 
S100a8 0.23 0.68 
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Npy -0.03 0.58 
Hbb 0.75 0.5 
Nritp 0.83 0.86 
Cdc25b 0.54 0.15 
c-maf 1.24 0.35 
S100a9 1.26 3.51 
IgG-2a 2.79 2.49 
Hba-a1 0.45 0.5 
Klf2 1 1 
Igha 1.12 1.35 
Snca 0.87 0.61 
Csda 0.09 -0.09 
 
Gene Name 
01_HP_I45_R0_A_vs_ShamA_Signal Log 
Ratio 
01_HP_I45_R0_A_vs_ShamB_Signal Log 
Ratio 
Nef3 0.42 0.56 
Bpgm 0.99 0.76 
Slc22a7 0.84 0.77 
Hmgcs2 2.97 1.3 
Aldh1a4 1.62 0.66 
Igh-1a_predicted 2.92 2.59 
Alas2 2.31 2.43 
S100a8 2.24 3.35 
Npy 0.94 1.46 
Hbb 1.53 1.25 
Nritp 1.03 1.03 
Cdc25b 1.79 1.54 
c-maf 1.08 1.22 
S100a9 0.64 2.81 
IgG-2a 2.92 2.59 
Hba-a1 0.53 0.55 
Klf2 1 1 
Igha 1.96 2.17 
Snca 0.53 0.39 
Csda 1.65 1.29 
 
Gene Name 
02_HP_I45_R0_B_vs_ShamA_Signal Log 
Ratio 
02_HP_I45_R0_B_vs_ShamB_Signal Log 
Ratio 
Nef3 0.53 0.73 
Bpgm 1.22 1.06 
Slc22a7 1.21 1.22 
Hmgcs2 2.5 0.65 
Aldh1a4 1.49 1.59 
Igh-1a_predicted 4.34 4.14 
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Alas2 2.6 2.73 
S100a8 2.76 4 
Npy 0.9 1.38 
Hbb 1.85 1.62 
Nritp 1.25 0.7 
Cdc25b 2.12 1.88 
c-maf 0.98 0.99 
S100a9 0.94 2.75 
IgG-2a 4.34 4.14 
Hba-a1 0.89 0.91 
Klf2 1 1 
Igha 1.9 2.13 
Snca 0.44 0.43 
Csda 1.58 1.28 
 
Gene Name 
03_HP_I45_R15_A_vs_ShamA_Signal Log 
Ratio 
03_HP_I45_R15_A_vs_ShamB_Signal Log 
Ratio 
Nef3 0.85 0.94 
Bpgm 0.54 0.37 
Slc22a7 0.72 0.67 
Hmgcs2 3 1.05 
Aldh1a4 1.22 0.69 
Igh-1a_predicted 2.51 2.2 
Alas2 1.35 1.1 
S100a8 2.89 4.41 
Npy 0.92 1.56 
Hbb 1.36 1.1 
Nritp 0.15 0.42 
Cdc25b 0.75 0.42 
c-maf 0.27 0.38 
S100a9 1.76 4.07 
IgG-2a 2.51 2.2 
Hba-a1 0.66 0.66 
Klf2 1 1 
Igha 1.45 1.69 
Snca 0.32 0.29 
Csda 0.77 0.39 
 
Gene Name 
04_HP_I45_R15_B_vs_ShamA_Signal Log 
Ratio 
04_HP_I45_R15_B_vs_ShamB_Signal Log 
Ratio 
Nef3 1.23 1.23 
Bpgm 0.41 0.34 
Slc22a7 0.64 0.65 
Hmgcs2 3.78 1.5 
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Aldh1a4 2.84 2.34 
Igh-1a_predicted 3.51 3.15 
Alas2 0.97 0.92 
S100a8 0.85 1.87 
Npy 0.48 0.91 
Hbb 1.33 1.1 
Nritp 0.56 0.37 
Cdc25b 1.13 0.55 
c-maf 0.79 0.84 
S100a9 -0.71 1.25 
IgG-2a 3.51 3.15 
Hba-a1 0.98 0.9 
Klf2 1 1 
Igha 0.93 1.28 
Snca 0.26 -0.13 
Csda 0.47 0.17 
 
Gene Name 
05_HP_I45_R60_A_vs_ShamA_Signal Log 
Ratio 
05_HP_I45_R60_A_vs_ShamB_Signal Log 
Ratio 
Nef3 0.54 0.66 
Bpgm 0.04 -0.08 
Slc22a7 0.38 0.4 
Hmgcs2 2.36 -0.02 
Aldh1a4 1.73 1.08 
Igh-1a_predicted 1.59 1.37 
Alas2 0.22 0.36 
S100a8 2.88 4.64 
Npy 0.46 0.78 
Hbb 0.48 0.27 
Nritp -0.08 -0.49 
Cdc25b 0.34 -0.1 
c-maf 0.44 0.67 
S100a9 1.39 3.91 
IgG-2a 1.59 1.37 
Hba-a1 0.44 0.39 
Klf2 1 1 
Igha 0.93 1.11 
Snca 0.28 0.09 
Csda -0.14 -0.25 
 
Gene Name 
06_HP_I45_R60_B_vs_ShamA_Signal Log 
Ratio 
06_HP_I45_R60_B_vs_ShamB_Signal Log 
Ratio 
Nef3 0.72 0.9 
Bpgm -0.03 -0.17 
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Slc22a7 0.48 0.43 
Hmgcs2 2.95 0.91 
Aldh1a4 2.15 1.18 
Igh-1a_predicted 1.92 1.72 
Alas2 -0.03 0.05 
S100a8 3.77 4.41 
Npy 0.23 0.6 
Hbb 0.55 0.37 
Nritp 0.47 0.39 
Cdc25b 0.25 -0.26 
c-maf 0.88 1.12 
S100a9 1.13 3.08 
IgG-2a 1.92 1.72 
Hba-a1 0.39 0.4 
Klf2 1 1 
Igha 0.2 0.43 
Snca 0.28 0.4 
Csda -0.04 -0.17 
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APPENDIX C: List of Constitutively Down-regulated Genes 
Gene Name 
26_IP_I45_R0_B_vs_ShamA_Signal Log 
Ratio 
26_IP_I45_R0_B_vs_ShamB_Signal Log 
Ratio 
Cyp2c -1.13 -0.9 
Tagln 0.74 0.43 
Fn1 0.14 -0.6 
Aldr1 -1.9 -2.09 
Cktsf1b1 -1.28 -1.24 
Alcam -0.8 -0.84 
Fxyd4 -0.81 -1.63 
Jund -1.42 -0.74 
Aplp2 0.4 -0.11 
Timp3 0.22 -0.52 
Fkbp5_predicted -0.18 -0.65 
Tpm1 -0.04 -0.2 
akr1b1 -1.9 -2.09 
Ptn 0.17 -0.16 
Slc14a2 -0.53 -1.54 
Slc25a25 -0.45 -0.43 
Cpe -1.13 -0.66 
S100a6 -0.47 -1.26 
Aqp4 -0.73 -1.9 
Nupr1 -0.29 -1.02 
Pace4 -0.17 -0.97 
Fabp4 0.27 -0.57 
RT1-S3 -0.41 -0.63 
Hmgcs1 -0.16 -0.16 
Thrsp -2.56 -3.64 
Cyp1a1 -1.67 -1.72 
Usp2 -0.49 -0.94 
Acox2 0.86 0.83 
Fasn -0.91 -0.93 
 
Gene Name 
27_IP_I45_R15_A_vs_ShamA_Signal Log 
Ratio 
27_IP_I45_R15_A_vs_ShamB_Signal Log 
Ratio 
Cyp2c -0.86 -0.76 
Tagln 0.29 0.12 
Fn1 -0.12 -0.94 
Aldr1 -1.17 -1.4 
Cktsf1b1 -0.84 -0.9 
Alcam -0.33 -0.46 
Fxyd4 -0.04 -1 
Jund -2.05 -1.12 
Aplp2 0.25 -0.3 
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Timp3 0.99 0.32 
Fkbp5_predicted 0.01 -0.41 
Tpm1 0.15 -0.14 
akr1b1 -1.17 -1.4 
Ptn -0.11 -0.26 
Slc14a2 -0.35 -1.59 
Slc25a25 -0.57 -0.55 
Cpe -1.91 -1.33 
S100a6 -0.57 -1.34 
Aqp4 0.41 -0.76 
Nupr1 -0.79 -1.49 
Pace4 -0.22 -0.92 
Fabp4 0.3 -0.53 
RT1-S3 0.32 -0.09 
Hmgcs1 0.08 0.01 
Thrsp -1.94 -2.91 
Cyp1a1 -1.66 -1.67 
Usp2 -0.46 -0.84 
Acox2 -0.72 -0.76 
Fasn -0.5 -0.86 
 
 
Gene Name 
25_IP_I45_R0_A_vs_ShamA_Signal Log 
Ratio 
25_IP_I45_R0_A_vs_ShamB_Signal Log 
Ratio 
Cyp2c -1.03 -0.92 
Tagln 0 -0.21 
Fn1 -0.03 -0.69 
Aldr1 -1.18 -1.39 
Cktsf1b1 -0.92 -0.94 
Alcam -1.27 -1.24 
Fxyd4 0.09 -0.73 
Jund -2.21 -1.7 
Aplp2 0.24 -0.3 
Timp3 0.35 -0.42 
Fkbp5_predicted -0.01 -0.47 
Tpm1 -0.15 -0.26 
akr1b1 -1.18 -1.39 
Ptn -0.84 -0.83 
Slc14a2 -0.1 -1.42 
Slc25a25 -0.07 0.01 
Cpe -1.14 -0.74 
S100a6 0.24 -0.61 
Aqp4 -0.16 -1.51 
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Gene Name 
29_IP_I45_R60_A_vs_ShamA_Signal Log 
Ratio 
29_IP_I45_R60_A_vs_ShamB_Signal Log 
Ratio 
Cyp2c 0.37 0.5 
Tagln -0.69 -0.96 
Fn1 -0.72 -1.49 
Aldr1 -2.69 -2.81 
Cktsf1b1 -0.77 -0.84 
Alcam 0.03 -0.05 
Fxyd4 -0.57 -1.34 
Jund -1.74 -1.15 
Aplp2 -0.96 -1.44 
Timp3 -0.6 -1.22 
Fkbp5_predicted 0.12 -0.28 
Tpm1 -0.12 -0.19 
akr1b1 -2.69 -2.81 
Ptn -0.49 -0.73 
Slc14a2 -3 -3.76 
Slc25a25 0.48 0.49 
Cpe -0.55 -0.25 
S100a6 -0.89 -1.65 
Aqp4 0.02 -1.19 
Nupr1 -0.36 -1.12 
Pace4 -0.53 -1.28 
Fabp4 -1.93 -2.99 
RT1-S3 -0.45 -0.68 
Hmgcs1 0.03 -0.03 
Thrsp -2.35 -3.7 
Cyp1a1 0.46 0.4 
Usp2 0.66 0.21 
Acox2 0.24 0.39 
Fasn -0.81 -0.92 
 
Gene Name 30_IP_I45_R60_B_vs_ShamA_Signal Log 
Ratio 
30_IP_I45_R60_B_vs_ShamB_Signal Log 
Ratio 
Cyp2c -0.55 -0.53 
Tagln 0.26 -0.08 
Fn1 -0.16 -0.78 
Aldr1 0.35 -0.01 
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Cktsf1b1 -0.35 -0.58 
Alcam -0.25 -0.35 
Fxyd4 0.33 -0.58 
Jund -1.26 -0.58 
Aplp2 -0.46 -1 
Timp3 0.07 -0.58 
Fkbp5_predicted -0.1 -0.47 
Tpm1 0.03 -0.16 
akr1b1 0.35 -0.01 
Ptn -0.48 -0.47 
Slc14a2 0.57 -0.72 
Slc25a25 0.25 0.2 
Cpe -0.97 -0.57 
S100a6 0.58 -0.06 
Aqp4 0.2 -1.19 
Nupr1 -0.11 -0.74 
Pace4 -0.54 -1.25 
Fabp4 0.55 -0.04 
RT1-S3 -0.09 -0.4 
Hmgcs1 -0.04 -0.08 
Thrsp -0.27 -1.37 
Cyp1a1 -0.97 -1.04 
Usp2 0.3 -0.17 
Acox2 -1.41 -1.35 
Fasn -0.23 -0.57 
 
Gene Name 
13_I45_R0_A_vs_ShamA_Signal 
Log Ratio 
13_I45_R0_A_vs_ShamB_Signal 
Log Ratio 
Cyp2c 0.39 0.55 
Tagln -0.36 -0.43 
Fn1 -0.18 -1 
Aldr1 -0.52 -0.73 
Cktsf1b1 -0.45 -0.5 
Alcam -0.54 -0.61 
Fxyd4 -0.14 -1.08 
Jund 0.07 0.45 
Aplp2 0.27 -0.34 
Timp3 0.76 0.02 
Fkbp5_predicted -0.37 -0.78 
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Tpm1 -0.27 -0.36 
akr1b1 -0.52 -0.73 
Ptn -0.46 -0.75 
Slc14a2 -0.18 -1.43 
Slc25a25 -0.92 -0.91 
Cpe -1.28 -1 
S100a6 -0.41 -1.21 
Aqp4 -0.62 -2.04 
Nupr1 -0.21 -1.01 
Pace4 -0.53 -1.23 
Fabp4 -0.23 -0.73 
RT1-S3 -0.49 -0.88 
Hmgcs1 -0.88 -1.03 
Thrsp -1.92 -3.15 
Cyp1a1 -1.47 -1.47 
Usp2 -0.27 -0.79 
Acox2 -0.57 -0.39 
Fasn -0.2 -0.55 
 
Gene Name 14_I45_R0_B_vs_ShamA_Signal 
Log Ratio 
14_I45_R0_B_vs_ShamB_Signal 
Log Ratio 
Cyp2c 0.36 0.41 
Tagln -0.7 -0.78 
Fn1 -0.16 -0.93 
Aldr1 -1.4 -1.64 
Cktsf1b1 -1.07 -1.07 
Alcam -0.98 -0.97 
Fxyd4 -0.51 -1.38 
Jund 0.19 0.5 
Aplp2 0.29 -0.29 
Timp3 0.39 -0.27 
Fkbp5_predicted -0.26 -0.76 
Tpm1 -0.57 -0.54 
akr1b1 -1.4 -1.64 
Ptn -0.23 -0.47 
Slc14a2 -0.81 -2.06 
Slc25a25 -1.03 -1.07 
Cpe -1.02 -0.63 
S100a6 -0.87 -1.63 
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Aqp4 -0.63 -1.85 
Nupr1 -1.13 -1.83 
Pace4 -0.78 -1.43 
Fabp4 0.3 -0.33 
RT1-S3 -0.58 -1.01 
Hmgcs1 -1.03 -1.04 
Thrsp -1.8 -2.72 
Cyp1a1 -0.68 -0.76 
Usp2 -0.57 -1.06 
Acox2 -0.86 -0.72 
Fasn -0.59 -0.85 
 
 
 
Gene Name 15_I45_R15_A_vs_ShamA_Signal 
Log Ratio 
15_I45_R15_A_vs_ShamB_Signal 
Log Ratio 
Cyp2c -1.3 -1.21 
Tagln -0.13 -0.27 
Fn1 0.18 -0.73 
Aldr1 -1.73 -1.78 
Cktsf1b1 -0.51 -0.48 
Alcam -0.61 -0.69 
Fxyd4 -0.56 -1.47 
Jund -3.11 -2.54 
Aplp2 0.3 -0.31 
Timp3 -0.28 -0.91 
Fkbp5_predicted -1.21 -1.71 
Tpm1 0.03 -0.24 
akr1b1 -1.73 -1.78 
Ptn -1.03 -0.71 
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Slc14a2 -0.27 -1.34 
Slc25a25 -2.76 -2.76 
Cpe -1.35 -1.02 
S100a6 -0.38 -1.15 
Aqp4 -0.49 -1.71 
Nupr1 -0.1 -0.77 
Pace4 0.68 0 
Fabp4 -0.74 -1.52 
RT1-S3 0.09 -0.27 
Hmgcs1 -0.59 -0.54 
Thrsp -2.23 -3.44 
Cyp1a1 -1.88 -1.8 
Usp2 -1.52 -2.01 
Acox2 -0.7 -0.51 
Fasn -0.58 -0.72 
 
Gene Name 16_I45_R15_B_vs_ShamA_Signal 
Log Ratio 
16_I45_R15_B_vs_ShamB_Signal 
Log Ratio 
Cyp2c 0.54 0.58 
Tagln -1.09 -1.31 
Fn1 -0.5 -1.35 
Aldr1 -2.3 -2.35 
Cktsf1b1 -0.07 -0.13 
Alcam -0.27 -0.35 
Fxyd4 0.36 -0.46 
Jund 0.25 0.74 
Aplp2 0.11 -0.29 
Timp3 0 -0.76 
Fkbp5_predicted -0.78 -1.15 
Tpm1 -0.03 -0.09 
akr1b1 -2.3 -2.35 
Ptn -1.02 -1.16 
Slc14a2 -0.46 -1.5 
Slc25a25 -0.92 -0.75 
Cpe -0.2 0.14 
S100a6 -0.55 -1.35 
Aqp4 0.36 -0.97 
Nupr1 -0.31 -0.94 
Pace4 -0.11 -0.78 
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Fabp4 -1.02 -1.86 
RT1-S3 -0.71 -0.9 
Hmgcs1 -0.69 -0.76 
Thrsp -2.78 -3.82 
Cyp1a1 -0.4 -0.47 
Usp2 -0.6 -1.12 
Acox2 -0.66 -0.58 
Fasn -0.7 -0.82 
 
Gene Name 17_I45_R60_A_vs_ShamA_Signal Log 
Ratio 
17_I45_R60_A_vs_ShamB_Signal Log 
Ratio 
Cyp2c -0.95 -0.82 
Tagln -0.56 -0.67 
Fn1 -0.09 -0.78 
Aldr1 -0.27 -0.47 
Cktsf1b1 -0.6 -0.7 
Alcam -1.05 -1.12 
Fxyd4 0.4 -0.55 
Jund 1.3 1.78 
Aplp2 0.23 -0.32 
Timp3 0.49 -0.3 
Fkbp5_predicted -0.4 -1.01 
Tpm1 -0.53 -0.64 
akr1b1 -0.27 -0.47 
Ptn -0.95 -1.07 
Slc14a2 0.38 -1.11 
Slc25a25 -1.33 -1.39 
Cpe -0.81 -0.54 
S100a6 0.45 -0.1 
Aqp4 0.16 -1.02 
Nupr1 0.2 -0.38 
Pace4 -0.09 -0.72 
Fabp4 -0.35 -1.04 
RT1-S3 0.31 -0.19 
Hmgcs1 -0.84 -0.86 
Thrsp -1.44 -2.51 
Cyp1a1 -0.16 -0.1 
Usp2 -0.33 -0.8 
Acox2 -0.62 -0.53 
  
151 
Fasn -0.67 -0.93 
Gene Name 18_I45_R60_B_vs_ShamA_Signal Log 
Ratio 
18_I45_R60_B_vs_ShamB_Signal Log 
Ratio 
Cyp2c -0.08 0.03 
Tagln -1.26 -1.65 
Fn1 -0.7 -1.51 
Aldr1 -2.46 -2.51 
Cktsf1b1 -0.47 -0.58 
Alcam -0.39 -0.45 
Fxyd4 -0.58 -1.38 
Jund 0.66 1.12 
Aplp2 0.05 -0.72 
Timp3 -0.04 -0.76 
Fkbp5_predicted -0.49 -0.9 
Tpm1 -0.2 -0.37 
akr1b1 -2.46 -2.51 
Ptn -0.52 -0.75 
Slc14a2 -1.13 -2.25 
Slc25a25 -0.84 -0.78 
Cpe -0.6 -0.22 
S100a6 -0.87 -1.67 
Aqp4 -0.32 -1.63 
Nupr1 -0.32 -0.99 
Pace4 -0.38 -1.12 
Fabp4 -1.02 -1.64 
RT1-S3 -0.78 -1.09 
Hmgcs1 -0.1 -0.25 
Thrsp -2.45 -3.77 
 
Gene Name 01_HP_I45_R0_A_vs_ShamA_Signal Log 
Ratio 
01_HP_I45_R0_A_vs_ShamB_Signal 
Log Ratio 
Cyp2c -2.02 -1.87 
Tagln -1.12 -1.31 
Fn1 0.03 -0.75 
Aldr1 -0.52 -0.66 
Cktsf1b1 -0.43 -0.47 
Alcam -0.69 -0.71 
Fxyd4 -0.31 -1.24 
Jund -3.05 -2.42 
Aplp2 0.19 -0.38 
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Timp3 0.14 -0.71 
Fkbp5_predicted -0.96 -1.5 
Tpm1 -0.3 -0.3 
akr1b1 -0.52 -0.66 
Ptn -0.4 -0.56 
Slc14a2 0.62 -0.56 
Slc25a25 -1.98 -2 
Cpe -1.09 -0.79 
S100a6 -0.16 -0.98 
Aqp4 0.15 -1.08 
Nupr1 0.1 -0.54 
Pace4 0.27 -0.3 
Fabp4 -0.52 -1.02 
RT1-S3 0.37 -0.03 
Hmgcs1 -0.77 -0.93 
Thrsp -0.59 -1.63 
Cyp1a1 -1.31 -1.3 
Usp2 -1.23 -1.74 
Acox2 0.58 0.63 
Fasn -0.52 -0.87 
 
Gene Name 02_HP_I45_R0_B_vs_ShamA_Signal Log 
Ratio 
02_HP_I45_R0_B_vs_ShamB_Signal 
Log Ratio 
Cyp2c -1.73 -1.65 
Tagln -0.8 -0.91 
Fn1 -0.11 -0.93 
Aldr1 -2.17 -2.19 
Cktsf1b1 -0.16 -0.27 
Alcam -0.27 -0.21 
Fxyd4 -0.89 -1.64 
Jund -4.08 -3.56 
Aplp2 -0.47 -1.15 
Timp3 -1.02 -1.65 
Fkbp5_predicted -0.72 -1.14 
Tpm1 -0.42 -0.33 
akr1b1 -2.17 -2.19 
Ptn -0.41 -0.51 
Slc14a2 -0.67 -1.85 
Slc25a25 -1.94 -1.97 
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Cpe -1.05 -0.73 
S100a6 -0.73 -1.45 
Aqp4 -0.88 -2.17 
Nupr1 -0.57 -1.27 
Pace4 -0.43 -1.25 
Fabp4 -1.62 -2.34 
RT1-S3 -0.48 -0.55 
Hmgcs1 -0.82 -0.79 
Thrsp -2.38 -3.51 
Cyp1a1 -1.32 -1.24 
Usp2 -1.47 -2.04 
Acox2 0.31 0.27 
Fasn -0.67 -0.73 
 
Gene Name 03_HP_I45_R15_A_vs_ShamA_Signal Log 
Ratio 
03_HP_I45_R15_A_vs_ShamB_Signal 
Log Ratio 
Cyp2c -0.34 -0.32 
Tagln -0.53 -0.69 
Fn1 -0.23 -1 
Aldr1 -0.85 -0.99 
Cktsf1b1 0.36 0.28 
Alcam -0.13 -0.26 
Fxyd4 -0.45 -1.28 
Jund -3.84 -3.23 
Aplp2 -0.81 -1.32 
Timp3 -0.47 -1.19 
Fkbp5_predicted -1.02 -1.57 
Tpm1 0.08 0 
akr1b1 -0.85 -0.99 
Ptn -0.7 -0.69 
Slc14a2 -0.37 -1.56 
Slc25a25 -1.02 -1.05 
Cpe -0.61 -0.26 
S100a6 -0.11 -0.78 
Aqp4 0.08 -1.18 
Nupr1 0.33 -0.3 
Pace4 -0.19 -0.95 
Fabp4 0.38 -0.26 
RT1-S3 -0.73 -1.02 
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Hmgcs1 -0.15 -0.24 
Thrsp 0.57 -0.82 
Cyp1a1 0.31 0.25 
Usp2 -0.95 -1.42 
Acox2 1.02 1 
Fasn 0.08 -0.28 
 
Gene Name 04_HP_I45_R15_B_vs_ShamA_Signal Log 
Ratio 
04_HP_I45_R15_B_vs_ShamB_Signal 
Log Ratio 
Cyp2c -0.94 -0.71 
Tagln -0.81 -0.98 
Fn1 -0.31 -1.07 
Aldr1 -0.36 -0.52 
Cktsf1b1 -0.74 -0.69 
Alcam -0.12 -0.19 
Fxyd4 -0.45 -1.43 
Jund -3.95 -3.36 
Aplp2 -1.01 -1.45 
Timp3 -0.85 -1.72 
Fkbp5_predicted -0.9 -1.21 
Tpm1 0.03 -0.13 
akr1b1 -0.36 -0.52 
Ptn -0.95 -0.94 
Slc14a2 -0.06 -1.24 
Slc25a25 -1.78 -1.81 
Cpe -0.12 0.16 
S100a6 0.17 -0.5 
Aqp4 -0.11 -1.33 
Nupr1 -0.56 -1.15 
Pace4 -1.21 -1.96 
Fabp4 -0.05 -0.46 
RT1-S3 -0.76 -0.72 
Hmgcs1 -0.71 -0.86 
Thrsp -1.91 -2.69 
Cyp1a1 -1.11 -1.06 
Usp2 -1.27 -1.77 
Acox2 -0.85 -0.5 
Fasn -0.34 -0.6 
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Gene Name 05_HP_I45_R60_A_vs_ShamA_Signal Log 
Ratio 
05_HP_I45_R60_A_vs_ShamB_Signal 
Log Ratio 
Cyp2c -1.52 -1.52 
Tagln -0.64 -0.76 
Fn1 -0.53 -1.38 
Aldr1 -1.42 -1.53 
Cktsf1b1 -0.08 -0.15 
Alcam -0.86 -0.96 
Fxyd4 0.45 -0.47 
Jund -1.49 -0.56 
Aplp2 -0.05 -0.56 
Timp3 -0.16 -0.88 
Fkbp5_predicted -0.67 -1.13 
Tpm1 -0.03 -0.2 
akr1b1 -1.42 -1.53 
Ptn -0.91 -1.12 
Slc14a2 0.32 -0.83 
Slc25a25 -0.49 -0.54 
Cpe -1.39 -0.98 
S100a6 0.28 -0.44 
Aqp4 0.27 -1.19 
Nupr1 0.17 -0.36 
Pace4 0.34 -0.39 
Fabp4 -0.7 -1.49 
RT1-S3 -0.41 -0.39 
Hmgcs1 -0.02 -0.08 
Thrsp -0.83 -2.12 
Cyp1a1 -1.26 -1.25 
Usp2 -1.06 -1.51 
Acox2 0.22 0.27 
Fasn 0.17 -0.17 
 
Gene Name 06_HP_I45_R60_B_vs_ShamA_Signal Log 
Ratio 
06_HP_I45_R60_B_vs_ShamB_Signal 
Log Ratio 
Cyp2c -0.5 -0.45 
Tagln -0.82 -1.06 
Fn1 -0.7 -1.44 
Aldr1 -2.25 -2.42 
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Cktsf1b1 0.24 0.13 
Alcam 0.13 0.1 
Fxyd4 -0.02 -0.88 
Jund -1.93 -0.62 
Aplp2 -0.94 -1.52 
Timp3 -0.65 -1.32 
Fkbp5_predicted -1.07 -1.55 
Tpm1 0 -0.21 
akr1b1 -2.25 -2.42 
Ptn -0.15 -0.14 
Slc14a2 -0.36 -1.58 
Slc25a25 -1.07 -1.06 
Cpe -0.96 -0.57 
S100a6 -0.29 -1.01 
Aqp4 0.34 -0.96 
Nupr1 -0.38 -0.97 
Pace4 -0.35 -1.05 
Fabp4 -1.35 -1.86 
RT1-S3 -0.15 -0.58 
Hmgcs1 -0.05 -0.06 
Thrsp -1.79 -3.22 
Cyp1a1 -0.69 -0.71 
Usp2 -1.14 -1.65 
Acox2 -0.82 -0.57 
Fasn -0.47 -0.68 
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APPENDIX D: List of Genes with a Complex Expression Pattern 
Gene Name 25_IP_I45_R0_A_vs_ShamA_Signal 
Log Ratio 
25_IP_I45_R0_A_vs_ShamB_Signal 
Log Ratio 
Slfn3 -0.6 -0.53 
RGD:621546 -1.22 -2.6 
Ccl2 -0.32 -0.29 
Dbp 0.9 0.43 
RT1-Aw2 /// RT1-A2 
/// RT1-A3 
0.48 0.65 
Pou3f1 1.03 0.34 
Ephx2 0.31 1.05 
Trpv1 -0.65 0.66 
Ca3 -0.09 0.37 
Hpgd -0.34 -0.07 
Kng1 /// MGC108747 -0.19 0.85 
RODH II 0.08 0.31 
Ptgds 0.87 0.68 
Slc16a1 0.02 0.54 
Slc9a3r1 0.61 0.3 
Apoe 0.16 0.27 
Slc5a2 0.55 0.77 
Dscr1 0.87 0.76 
Adh1a 0.49 0.59 
G6pc -0.1 0.39 
Slc7a7 0.63 0.74 
Epb4.1l3 0.13 0.64 
 
Gene Name 26_IP_I45_R0_B_vs_ShamA_Signal Log 
Ratio 
26_IP_I45_R0_B_vs_ShamB_Signal 
Log Ratio 
Slfn3 0.01 -0.08 
RGD:621546 -0.83 -1.16 
Ccl2 0.35 0.31 
Dbp -0.28 -0.98 
RT1-Aw2 /// RT1-
A2 /// RT1-A3 
-0.43 -0.3 
Pou3f1 0.43 -0.21 
Ephx2 -0.59 0.22 
Trpv1 -0.56 0.92 
Ca3 -0.33 0.15 
Hpgd -1.8 -1.99 
Kng1 /// 
MGC108747 
0.34 1.38 
RODH II 0.3 0.42 
Ptgds 1.14 0.89 
  
158 
Slc16a1 0.71 1.09 
Slc9a3r1 0.78 0.53 
Apoe -0.01 0.15 
Slc5a2 0.58 0.72 
Dscr1 1.07 0.99 
Adh1a 0.55 0.63 
G6pc -0.16 0.29 
Slc7a7 0.87 0.97 
Epb4.1l3 0.3 0.86 
 
Gene Name 27_IP_I45_R15_A_vs_ShamA_Signal 
Log Ratio 
27_IP_I45_R15_A_vs_ShamB_Signal 
Log Ratio 
Slfn3 -0.02 -0.01 
RGD:621546 0.14 -0.21 
Ccl2 -0.4 -0.27 
Dbp 0.03 -0.56 
RT1-Aw2 /// RT1-
A2 /// RT1-A3 
-0.82 -0.76 
Pou3f1 -0.97 -1.6 
Ephx2 -2.82 -2.04 
Trpv1 -0.09 1.41 
Ca3 -0.29 0.06 
Hpgd -0.54 -0.3 
Kng1 /// 
MGC108747 
-1.81 0.17 
RODH II 0.3 0.66 
Ptgds 1.39 1.18 
Slc16a1 1.4 2.08 
Slc9a3r1 1.09 0.72 
Apoe 0.63 0.7 
Slc5a2 0.76 1.17 
Dscr1 1.41 1.35 
Adh1a 1.21 1.27 
G6pc 0.24 0.75 
Slc7a7 1.33 1.28 
Epb4.1l3 1.14 1.65 
 
 
Gene Name 28_IP_I45_R15_B_vs_ShamA_Signal 
Log Ratio 
28_IP_I45_R15_B_vs_ShamB_Signal 
Log Ratio 
Slfn3 -0.18 -0.11 
RGD:621546 1.11 0.53 
Ccl2 0.97 0.87 
Dbp -0.4 -1.24 
RT1-Aw2 /// RT1-
A2 /// RT1-A3 
0.66 0.79 
  
159 
Pou3f1 0.46 -0.25 
Ephx2 -1.54 -0.92 
Trpv1 -3.23 -1.3 
Ca3 -2.37 -2.15 
Hpgd 0.02 0.44 
Kng1 /// 
MGC108747 
-1.17 0.03 
RODH II -0.12 0.18 
Ptgds 1.35 0.96 
Slc16a1 0.65 1.21 
Slc9a3r1 0.6 0.32 
Apoe 0.02 0.26 
Slc5a2 0.45 0.61 
Dscr1 0.68 0.49 
Adh1a -0.25 -0.18 
G6pc -0.06 0.37 
Slc7a7 0.16 0.24 
Epb4.1l3 0.02 0.55 
 
Gene Name 29_IP_I45_R60_A_vs_ShamA_Signal 
Log Ratio 
29_IP_I45_R60_A_vs_ShamB_Signal 
Log Ratio 
Slfn3 0.62 0.53 
RGD:621546 0.94 0.44 
Ccl2 -0.53 -0.42 
Dbp 1.45 0.88 
RT1-Aw2 /// RT1-
A2 /// RT1-A3 
0.77 0.92 
Pou3f1 1 0.21 
Ephx2 -0.24 0.47 
Trpv1 -0.6 0.58 
Ca3 -0.84 -0.57 
Hpgd 0.02 0.46 
Kng1 /// 
MGC108747 
-0.26 0.38 
RODH II -0.23 0.1 
Ptgds -0.16 -0.48 
Slc16a1 -0.83 -0.55 
Slc9a3r1 -0.17 -0.35 
Apoe -1.67 -1.49 
Slc5a2 -0.29 -0.17 
Dscr1 0.85 0.6 
Adh1a -0.77 -0.79 
G6pc -1.13 -0.68 
Slc7a7 -1.01 -0.94 
Epb4.1l3 -1.04 -0.61 
 
  
160 
 
 
Gene Name 
30_IP_I45_R60_B_vs_ShamA_Signal 
Log Ratio 
30_IP_I45_R60_B_vs_ShamB_Signal 
Log Ratio 
Slfn3 -0.04 0.15 
RGD:621546 0.49 0.31 
Ccl2 0.91 0.93 
Dbp -0.43 -1.07 
RT1-Aw2 /// RT1-A2 
/// RT1-A3 -1.4 -1.18 
Pou3f1 0.85 0.24 
Ephx2 -0.29 0.39 
Trpv1 -0.52 0.42 
Ca3 0.39 0.88 
Hpgd -0.98 -1.02 
Kng1 /// MGC108747 1.35 4.71 
RODH II -0.07 0.24 
Ptgds 0.69 0.42 
Slc16a1 0.55 1.01 
Slc9a3r1 0.4 0.27 
Apoe -0.13 -0.02 
Slc5a2 0.48 0.57 
Dscr1 0.92 0.85 
Adh1a 0.1 0.31 
G6pc -0.51 -0.01 
Slc7a7 0.17 0.14 
Epb4.1l3 -0.05 0.49 
 
 
Gene Name 13_I45_R0_A_vs_ShamA_Signal 
Log Ratio 
13_I45_R0_A_vs_ShamB_Signal 
Log Ratio 
Slfn3 -0.14 -0.13 
RGD:621546 0.49 0.03 
Ccl2 0.08 0.16 
Dbp 0.17 -0.39 
RT1-Aw2 /// RT1-A2 
/// RT1-A3 
-1.72 -1.64 
Pou3f1 -0.7 -1.4 
Ephx2 -0.81 0.01 
Trpv1 -0.73 0.4 
Ca3 -0.09 0.29 
Hpgd 0.08 0.51 
Kng1 /// MGC108747 -2.11 0.27 
RODH II 1.37 1.85 
Ptgds 1.41 1.25 
  
161 
Slc16a1 0.87 1.25 
Slc9a3r1 1.04 0.71 
Apoe 0.48 0.48 
Slc5a2 0.95 1.15 
Dscr1 1.05 0.94 
Adh1a 0.7 0.75 
G6pc 0.52 1.03 
Slc7a7 0.89 0.89 
Epb4.1l3 0.81 1.3 
 
 
Gene Name 
14_I45_R0_B_vs_ShamA_Signal 
Log Ratio 
14_I45_R0_B_vs_ShamB_Signal 
Log Ratio 
Slfn3 -0.94 -0.87 
RGD:621546 -0.7 -1.04 
Ccl2 -1.26 -1.04 
Dbp 0.84 0.3 
RT1-Aw2 /// RT1-A2 
/// RT1-A3 -0.16 -0.01 
Pou3f1 -0.93 -1.72 
Ephx2 0.16 0.95 
Trpv1 -0.58 0.5 
Ca3 0.8 1.39 
Hpgd 0.3 0.53 
Kng1 /// MGC108747 0.55 3.5 
RODH II 1.61 1.9 
Ptgds 1.13 0.98 
Slc16a1 0.31 0.84 
Slc9a3r1 1.18 0.98 
Apoe 0.42 0.62 
Slc5a2 0.89 1.08 
Dscr1 0.83 0.8 
Adh1a -1.32 -1.25 
G6pc 0.01 0.47 
Slc7a7 0.78 0.92 
Epb4.1l3 0.59 1.28 
 
Gene Name 15_I45_R15_A_vs_ShamA_Signal 
Log Ratio 
15_I45_R15_A_vs_ShamB_Signal 
Log Ratio 
Slfn3 0.67 0.72 
RGD:621546 1.04 0.69 
Ccl2 -0.22 -0.01 
Dbp -1.14 -1.86 
RT1-Aw2 /// RT1-A2 
/// RT1-A3 
0.84 1.12 
  
162 
Pou3f1 -0.78 -1.3 
Ephx2 -0.73 0.07 
Trpv1 -0.8 0.92 
Ca3 -0.57 -0.18 
Hpgd 0.18 0.61 
Kng1 /// MGC108747 -1.68 0.8 
RODH II 0.22 0.62 
Ptgds 0.48 -0.25 
Slc16a1 -0.13 0.53 
Slc9a3r1 0.48 0.32 
Apoe -0.78 -0.59 
Slc5a2 -0.45 -0.45 
Dscr1 0.21 0.23 
Adh1a -1.16 -0.82 
G6pc -0.3 0.08 
Slc7a7 -0.85 -0.69 
Epb4.1l3 -0.15 0.24 
 
Gene Name 
16_I45_R15_B_vs_ShamA_Signal 
Log Ratio 
16_I45_R15_B_vs_ShamB_Signal 
Log Ratio 
Slfn3 -0.03 -0.13 
RGD:621546 -2.31 -2.55 
Ccl2 -0.98 -0.91 
Dbp 0.92 0.43 
RT1-Aw2 /// RT1-
A2 /// RT1-A3 -0.82 -0.69 
Pou3f1 0.04 -0.78 
Ephx2 0.03 0.73 
Trpv1 -1.6 -0.34 
Ca3 -1.48 -1.63 
Hpgd 0.46 0.67 
Kng1 /// 
MGC108747 0.41 3.26 
RODH II 1.14 1.45 
Ptgds -1.08 -1.24 
Slc16a1 -0.68 -0.41 
Slc9a3r1 0.94 0.59 
Apoe -1.41 -1.24 
Slc5a2 -1.58 -1.66 
Dscr1 -0.31 -0.37 
Adh1a -2 -1.87 
G6pc -0.9 -0.55 
Slc7a7 -1.6 -1.5 
Epb4.1l3 -0.82 -0.4 
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Gene name 
17_I45_R60_A_vs_ShamA_Signal 
Log Ratio 
17_I45_R60_A_vs_ShamB_Signal 
Log Ratio 
Slfn3 -0.07 0.09 
RGD:621546 -0.38 -0.7 
Ccl2 0.03 -0.02 
Dbp 0.85 0.3 
RT1-Aw2 /// RT1-A2 /// 
RT1-A3 0.73 0.99 
Pou3f1 -0.98 -1.66 
Ephx2 -0.37 0.36 
Trpv1 -0.27 1.09 
Ca3 -0.91 -0.64 
Hpgd 1.33 1.56 
Kng1 /// MGC108747 0.7 3.46 
RODH II 0.43 0.6 
Ptgds 1.13 0.99 
Slc16a1 0.79 1.21 
Slc9a3r1 0.97 0.74 
Apoe 0.76 0.87 
Slc5a2 0.97 1.22 
Dscr1 1.05 0.99 
Adh1a -0.78 -0.58 
G6pc -0.07 0.43 
Slc7a7 1.26 1.27 
Epb4.1l3 0.5 1.09 
 
 
Gene Name 18_I45_R60_B_vs_ShamA_Signal 
Log Ratio 
18_I45_R60_B_vs_ShamB_Signal 
Log Ratio 
Slfn3 -0.4 -0.39 
RGD:621546 0.46 0.11 
Ccl2 -0.98 -0.87 
Dbp 0.16 -0.48 
RT1-Aw2 /// RT1-A2 
/// RT1-A3 
-0.44 -0.3 
Pou3f1 -0.62 -1.33 
Ephx2 -0.3 0.39 
Trpv1 -0.56 0.37 
Ca3 -0.15 0.34 
Hpgd 1 1.24 
Kng1 /// MGC108747 -0.15 2.04 
RODH II -0.04 0.41 
Ptgds 0.68 0.2 
  
164 
Slc16a1 0.45 0.84 
Slc9a3r1 0.3 0 
Apoe -0.58 -0.38 
Slc5a2 0.36 0.51 
Dscr1 0.52 0.46 
Adh1a -0.7 -0.51 
G6pc -0.23 0.25 
Slc7a7 0.38 0.42 
Epb4.1l3 0.46 0.96 
 
Gene Name 
01_HP_I45_R0_A_vs_ShamA_Signal 
Log Ratio 
01_HP_I45_R0_A_vs_ShamB_Signal 
Log Ratio 
Slfn3 -0.24 -0.12 
RGD:621546 0.17 -0.16 
Ccl2 -0.51 -0.56 
Dbp -0.2 -0.83 
RT1-Aw2 /// RT1-A2 
/// RT1-A3 0.72 0.83 
Pou3f1 -0.27 -1.05 
Ephx2 0.25 1.09 
Trpv1 -1.47 0.4 
Ca3 -0.62 -0.35 
Hpgd -0.28 -0.17 
Kng1 /// MGC108747 0.43 1.13 
RODH II 0.23 0.46 
Ptgds 0.87 0.49 
Slc16a1 0.6 1.06 
Slc9a3r1 0.56 0.3 
Apoe 0 0.15 
Slc5a2 0.27 0.52 
Dscr1 0.5 0.47 
Adh1a 0.39 0.44 
G6pc -0.21 0.26 
Slc7a7 0.45 0.43 
Epb4.1l3 0.52 0.97 
 
Gene Name 02_HP_I45_R0_B_vs_ShamA_Signal 
Log Ratio 
02_HP_I45_R0_B_vs_ShamB_Signal 
Log Ratio 
Slfn3 0.72 0.67 
RGD:621546 -1.02 -1.28 
Ccl2 -0.78 -0.74 
Dbp -0.04 -0.75 
RT1-Aw2 /// RT1-A2 
/// RT1-A3 
0.17 0.42 
Pou3f1 -0.52 -1.36 
Ephx2 -0.02 0.65 
  
165 
Trpv1 -0.02 1.26 
Ca3 -1.21 -0.82 
Hpgd 0.22 0.5 
Kng1 /// MGC108747 -0.16 1.65 
RODH II -0.34 0.04 
Ptgds 0.27 -0.13 
Slc16a1 -0.06 0.46 
Slc9a3r1 0.1 -0.18 
Apoe -0.47 -0.32 
Slc5a2 0.05 0.29 
Dscr1 -0.01 -0.1 
Adh1a -0.36 -0.21 
G6pc -0.22 0.25 
Slc7a7 -0.18 -0.02 
Epb4.1l3 0.29 0.77 
 
Gene Name 
03_HP_I45_R15_A_vs_ShamA_Signal 
Log Ratio 
03_HP_I45_R15_A_vs_ShamB_Signal 
Log Ratio 
Slfn3 0.15 0.07 
RGD:621546 0.84 0.43 
Ccl2 0.68 0.59 
Dbp 0.2 -0.41 
RT1-Aw2 /// RT1-
A2 /// RT1-A3 0.18 0.38 
Pou3f1 -0.13 -0.89 
Ephx2 0.12 0.84 
Trpv1 -0.06 1.18 
Ca3 0.14 0.7 
Hpgd -0.29 0.04 
Kng1 /// 
MGC108747 -0.5 -0.6 
RODH II -0.31 -0.01 
Ptgds 0.25 -0.11 
Slc16a1 -0.37 -0.01 
Slc9a3r1 0.33 0.08 
Apoe -0.76 -0.67 
Slc5a2 -0.14 -0.02 
Dscr1 -0.14 -0.19 
Adh1a -0.69 -0.54 
G6pc -0.9 -0.43 
Slc7a7 -0.54 -0.49 
Epb4.1l3 -0.19 0.3 
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Gene Name 04_HP_I45_R15_B_vs_ShamA_Signal 
Log Ratio 
04_HP_I45_R15_B_vs_ShamB_Signal 
Log Ratio 
Slfn3 -0.28 -0.14 
RGD:621546 0.51 0.1 
Ccl2 2.18 2.17 
Dbp 1.02 0.38 
RT1-Aw2 /// RT1-
A2 /// RT1-A3 
-0.98 -0.75 
Pou3f1 -0.64 -1.27 
Ephx2 0.35 1.15 
Trpv1 -0.63 0.72 
Ca3 0.34 0.9 
Hpgd -0.17 0.34 
Kng1 /// 
MGC108747 
0.59 2.08 
RODH II -0.26 0.13 
Ptgds 0.3 0.25 
Slc16a1 -0.94 -0.38 
Slc9a3r1 0.08 -0.08 
Apoe -0.41 -0.34 
Slc5a2 0.6 0.76 
Dscr1 -0.01 -0.09 
Adh1a 0.49 0.66 
G6pc -0.6 -0.2 
Slc7a7 -0.12 -0.07 
Epb4.1l3 0.12 0.43 
 
Gene Name 04_HP_I45_R15_B_vs_ShamA_Signal 
Log Ratio 
04_HP_I45_R15_B_vs_ShamB_Signal 
Log Ratio 
Slfn3 -0.28 -0.14 
RGD:621546 0.51 0.1 
Ccl2 2.18 2.17 
Dbp 1.02 0.38 
RT1-Aw2 /// RT1-
A2 /// RT1-A3 
-0.98 -0.75 
Pou3f1 -0.64 -1.27 
Ephx2 0.35 1.15 
Trpv1 -0.63 0.72 
Ca3 0.34 0.9 
Hpgd -0.17 0.34 
Kng1 /// 
MGC108747 
0.59 2.08 
RODH II -0.26 0.13 
Ptgds 0.3 0.25 
Slc16a1 -0.94 -0.38 
Slc9a3r1 0.08 -0.08 
Apoe -0.41 -0.34 
Slc5a2 0.6 0.76 
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Dscr1 -0.01 -0.09 
Adh1a 0.49 0.66 
G6pc -0.6 -0.2 
Slc7a7 -0.12 -0.07 
Epb4.1l3 0.12 0.43 
 
Gene Name 05_HP_I45_R60_A_vs_ShamA_Signal 
Log Ratio 
05_HP_I45_R60_A_vs_ShamB_Signal 
Log Ratio 
Slfn3 1.17 1.34 
RGD:621546 -0.99 -1.26 
Ccl2 -0.16 -0.19 
Dbp -1.16 -1.66 
RT1-Aw2 /// RT1-
A2 /// RT1-A3 
0.16 0.3 
Pou3f1 0 -0.65 
Ephx2 -0.16 0.52 
Trpv1 -1.79 0.04 
Ca3 -0.08 0.35 
Hpgd -0.27 -0.39 
Kng1 /// 
MGC108747 
-1.03 0.78 
RODH II -0.12 0.17 
Ptgds 0.54 0.24 
Slc16a1 0.03 0.44 
Slc9a3r1 0.03 -0.14 
Apoe -0.42 -0.27 
Slc5a2 0.31 0.45 
Dscr1 0.41 0.47 
Adh1a 0.09 0.23 
G6pc -0.35 0.08 
Slc7a7 -0.47 -0.28 
Epb4.1l3 -0.36 0.14 
 
Gene Name 
05_HP_I45_R60_A_vs_ShamA_Signal 
Log Ratio 
05_HP_I45_R60_A_vs_ShamB_Signal 
Log Ratio 
Slfn3 1.17 1.34 
RGD:621546 -0.99 -1.26 
Ccl2 -0.16 -0.19 
Dbp -1.16 -1.66 
RT1-Aw2 /// RT1-
A2 /// RT1-A3 0.16 0.3 
Pou3f1 0 -0.65 
Ephx2 -0.16 0.52 
Trpv1 -1.79 0.04 
Ca3 -0.08 0.35 
Hpgd -0.27 -0.39 
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Kng1 /// 
MGC108747 -1.03 0.78 
RODH II -0.12 0.17 
Ptgds 0.54 0.24 
Slc16a1 0.03 0.44 
Slc9a3r1 0.03 -0.14 
Apoe -0.42 -0.27 
Slc5a2 0.31 0.45 
Dscr1 0.41 0.47 
Adh1a 0.09 0.23 
G6pc -0.35 0.08 
Slc7a7 -0.47 -0.28 
Epb4.1l3 -0.36 0.14 
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APPENDIX E: MPN Index For Five Test Tubes [43] 
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